[
    {
        "pmid": "40766357",
        "title": "Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agent <i>Salmonella</i> Typhi.",
        "abstract": "Typhoid fever result systemic infection iSalmonella entericai serovar Typhi Typhi cause 10 million illness annually Disease control relies prevention water sanitation hygiene intervention vaccination effective antimicrobial treatment Antimicrobial resistant AMR Typhi lineage emerged become established many part world Knowledge local pathogen population informed genomic surveillance including lineage defined GenoTyphi scheme AMR determinants increasingly used inform local treatment guideline inform vaccination strategy Current tool genotyping Typhi require multiple read alignment assembly step validated analysis data generated Oxford Nanopore Technologies ONT longread sequencing devices Here introduce Typhi Mykrobe command line software tool rapid genotyping Typhi lineages AMR determinants plasmid replicons direct sequencing reads validated Typhi Mykrobe lineage genotyping comparison current standard read mappingbased approach demonstrated 998 concordance across nearly 13000 genome sequenced Illumina platforms isolates discordant calls show Typhi Mykrobe result better supported evidence raw sequence read data result generated using mappingbased approach also demonstrate 999 concordance detection AMR determinant compared current standard assemblybased approach similar result plasmid marker detection Typhi Mykrobe predicts clinical resistance categorisation SIR eight drug classes show strong agreement phenotypic categorisation generated reference laboratory minimum inhibitory concentration MIC data n1572 Illuminasequenced isolates 99 agreement within one doubling dilution show strong concordance 96 genotype 98 AMR plasmid call made ONT read made Illumina read isolates sequenced platform n 93 genomes Typhi Mykrobe take less minute per sample available httpsgithubcomtyphoidgenomicsgenotyphi Typhi Mykrobe provides rapid sensitive genotyping Typhi genome direct Illumina ONT reads although lower accuracy observed R9 ONT data demonstrated accurate assignment GenoTyphi lineage detection AMR determinant prediction corresponding AMR phenotypes identification plasmid replicons",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766357/"
    },
    {
        "pmid": "40754580",
        "title": "A cost-benefit analysis of using wastewater monitoring to guide typhoid vaccine campaigns.",
        "abstract": "Enteric disease leading cause mortality developing countries yet highly preventable Typhoid vaccine remain underutilized diagnostic capacity constraint impede treatment prevention Wastewater monitoring could provide accurate picture disease burden detection quantification Salmonella Typhi wastewater advanced motivate country invest improve wastewater testing methods conducted costbenefit analysis quantifying value approach could yield estimated benefit could accrue wastewater data informed early launch theoretical typhoid vaccine campaign Coxs Bazar Bangladesh empirically estimating leadtime advantage wastewater data clinical data flag case upticks simulated change case count 1 14day early campaign launch using ordinary differential equation modeling quantified benefit resulting averted case from preserved caregiver time school days wages hospitalization from saving public funds death using value statistical life calculated cumulative benefits costs ratio two varied campaign launch timing scenario fiveyear period Wastewater concentration Salmonella Typhi upticked 13 day case counts Cumulative benefit varied year launch timing 13day early launch every 100 spent wastewater monitoring could yield 295 societal benefit year 5 Cumulative benefit roughly equaled cumulative cost 5day early launch outweighed cost campaign launched even earlier wastewater data advanced reliably provide early warning new typhoid outbreaks government could reap large benefit justify spending program implementation finding could generalize highaid country that like Bangladesh experience routine enteric disease outbreak strong operational networks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754580/"
    },
    {
        "pmid": "40696437",
        "title": "Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model.",
        "abstract": "Typhoid fever systemic infection caused Salmonella enterica serovar Typhi S Typhi invasion gut lumen Transmission people occurs ingestion contaminated food water particularly setting poor water sanitation infrastructure resulting 10 million illness annually pathogen invades via gastrointestinal tract plausible gut microbiome may influence outcome S Typhi exposure evidence bacteria producing shortchain fatty acid SCFAs may create environment unfavourable invasive Salmonella data human limited investigate association gut microbiome typhoid fever analysed sample collected three allage cohort enrolled prospective surveillance study conducted across three setting typhoid fever endemic Dhaka Bangladesh Blantyre Malawi Kathmandu Nepal Cohorts consisted acute typhoid fever patient n  92 asymptomatic household contact typhoid fever patient representing individual likely exposed S Typhi develop disease n  97 asymptomatic serosurvey participant high Vi antibody titre representing individual exposed S Typhi may carriers n  69 stool microbiomes cohort characterised using shotgun metagenomics bacterial diversity composition function compared identified 4 bacterial specie significantly lower abundance typhoid fever patient compared household contact ie probably exposed two three participant population Bangladesh Malawi bacteria may represent taxon provide protection development clinical infection upon exposure S Typhi include inflammationassociated specie Prevotella copri clade Haemophilus parainfluenzae functional analysis identified 28 specific metabolic gene cluster MGCs negatively associated typhoid fever Bangladesh Malawi including seven MGCs involved SCFA metabolism putative protection provided microbiome SCFA metabolism supported data controlled human infection model conducted UK population participant develop typhoid fever following ingestion S Typhi higher abundance putative SCFAmetabolising MGC qvalue  022 study identified protective association taxonomic functional microbiota characteristic nonsusceptibility typhoid fever across multiple human populations Future research explore potential functional role SCFAs inflammationassociated bacteria resistance S Typhi enteric infections Video Abstract",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Gastrointestinal Microbiome",
            "Salmonella typhi",
            "Prospective Studies",
            "Male",
            "Female",
            "Malawi",
            "Adult",
            "Bangladesh",
            "Nepal",
            "Adolescent",
            "Child",
            "Feces",
            "Young Adult",
            "Endemic Diseases",
            "Fatty Acids, Volatile",
            "Middle Aged",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40696437/"
    },
    {
        "pmid": "40665219",
        "title": "The global burden of typhoid and paratyphoid fever from 1990 to 2021 and the impact on prevention and control.",
        "abstract": "Typhoid paratyphoid fever common infectious disease remain heavy burden especially lowincome countries Although global burden decreased past three decades analysis burden typhoid paratyphoid fever help inform public health strategies study aimed comprehensively evaluate global regional national burden typhoid paratyphoid temporal trend exploring potential association sociodemographic development three decade 19902021 Data typhoid paratyphoid fever analyzed using Global Burden Disease GBD study 2021 analysis calculated demonstrate temporal trend incidence mortality disability adjusted life year DALYs typhoid paratyphoid fever 1990 2021 1990 2021 typhoid paratyphoid fever showed declining trend globally different sociodemographic index SDI regions including incidence mortality DALYs typhoid fever worldwide new case decreased 6212 EAPC 392 414 371 death decreased 5065 EAPC  283 299 266 DALYs decreased 5230 EAPC  282 300 264 paratyphoid fever new case decreased 7315 EAPC 477 529 426 death decreased 6544 EAPC  374 424 324 DALYs decreased 6842 EAPC  387 442 331 typhoid paratyphoid fever child highest morbidity mortality rates male higher rate incidence mortality DALYs females However among older patients absolute number new case DALYs higher women burden concentrated South Asia Southeast Asia Oceania South Asia suffering severely paratyphoid fever Regarding typhoid fever top three country highest ASRs incidence Burkina Faso 32848 SDI 0285 Bangladesh 30314 SDI 0492 Papua New Guinea 29945 SDI 418 Western SubSaharan South Asia Oceania top three country term mortality DALYs Bhutan 561 43423 SDI 0473 Bangladesh 506 38238 Burkina Faso 464 35257 Regarding paratyphoid fever top three country highest ASRs mortality DALYs same including Pakistan 105 7266 India 075 5342 Nepal 072 5065 SDI 0433 located South Asia",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Paratyphoid Fever",
            "Incidence",
            "Global Burden of Disease",
            "Male",
            "Female",
            "Disability-Adjusted Life Years",
            "Adult",
            "Child",
            "Global Health",
            "Child, Preschool",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Infant",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40665219/"
    },
    {
        "pmid": "40563126",
        "title": "Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024.",
        "abstract": "report outbreak ceftriaxoneresistant Salmonella enterica serovar Typhi Bangladesh 47 case identified AprilSeptember 2024 Isolates belonged genotype 4312 harbored blasubCTXM15sub gene pCROB1 plasmid genotypeplasmid lineage represents recent introduction calling strengthened surveillance antimicrobial stewardship vaccination strategies",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Salmonella typhi",
            "Ceftriaxone",
            "Typhoid Fever",
            "Disease Outbreaks",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Bacterial",
            "Male",
            "Female",
            "Adult",
            "Child, Preschool",
            "Child",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Genotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40563126/"
    },
    {
        "pmid": "40318346",
        "title": "Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.",
        "abstract": "Enteric fever caused Salmonella enterica serovars Typhi Paratyphi and lesser extent S Paratyphi B C remains significant cause mortality morbidity resourceconstrained settings Typhoid conjugate vaccine TCVs protect S Typhi vaccine date protects paratyphoid fever several bivalent S TyphiParatyphi product development however low incidence paratyphoid fever many setting limit feasibility phase 3 efficacy studies Two bivalent vaccine adding S Paratyphi Aspecific O2 lipopolysaccharide conjugated protein carrier TCV construct successfully completed phase 1 study progress rapidly development WHOs Product Development Vaccines Advisory Committee PDVAC endorsed regulatory pathway bivalent S TyphiParatyphi vaccine contemplates demonstrating protective efficacy S Paratyphi infection controlled human infection model CHIM Since use CHIM data lieu phase 3 efficacy study identify marker immune protection yet widely accepted regulatory bodies organized consultation vaccine developers manufacturers regulators purpose meeting discus feasibility consideration licensure bivalent S TyphiParatyphi vaccine aim consultation gain alignment among key stakeholder facilitate pathway licensure endemic countries",
        "mesh_terms": [
            "Typhoid-Paratyphoid Vaccines",
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Salmonella paratyphi A",
            "Paratyphoid Fever",
            "World Health Organization",
            "Endemic Diseases",
            "Vaccine Development",
            "Advisory Committees",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40318346/"
    },
    {
        "pmid": "40252689",
        "title": "The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.",
        "abstract": "Typhoid fever remains substantial public health challenge lowincome middleincome countries 2023 typhoid conjugate vaccine TCVs introduced six country globally 50 million dos distributed TCVs deployed need observational study assess vaccine effectiveness field aimed evaluate validity different observational study design estimating vaccine protection compared different observational experimental study design assessing vaccine effectiveness reanalysing data TyVAC Bangladesh trial participantblinded observerblinded clusterrandomised controlled trial done Mirpur Dhaka Bangladesh 150 geographical cluster randomly assigned 11 receive either TCV Japanese encephalitis vaccine Eligible child aged 9 month 15 year offered single dose vaccine randomly assigned cluster residence baseline vaccination done April 15 May 15 2018 compared estimate vaccine effectiveness clusterrandomised controlled trial analysiswhich assessed risk bloodcultureconfirmed typhoid fever among recipient TCV versus recipient Japanese encephalitis vaccinewith estimate cohort study testnegative casecontrol study design TND analyses compared recipient TCV nonvaccinees 75 geographical cluster TCV administered conducted negativecontrol exposure NCE negativecontrol outcome NCO analysis bias indicators 41 344 67 62 025 ageeligible child study area received TCV Japanese encephalitis vaccine baseline vaccination campaign Among 62 025 ageeligible children 5582 bloodculture specimen collected passive surveillance including 2546 46 specimen 75 TCV clusters estimated vaccine efficacy 89 95 CI 8193 clusterrandomised controlled trial analysis 79 7086 cohort design 88 7993 TND pannegatives used testnegative controls 90 7596 TND specimen positive pathogen Salmonella enterica serotype Typhi used testnegative controls Using NCE analysis Japanese encephalitis vaccination associated increased risk typhoid fever compared nonvaccinees 75 Japanese encephalitis cluster cohort design incidence rate ratio 1·98 95 CI 1·562·52 significant association Japanese encephalitis vaccination typhoid fever found TND Similarly increased risk nontyphoid infection observed cohort NCO analysis comparing vaccinee nonvaccinees Japanese encephalitis vaccine cluster TCV clusters TND NCO analyses finding suggests TND provides reliable estimate TCV effectiveness whereas cohort design bias vaccine effectiveness estimates possibly due unmeasured confounding effects healthcareseeking behaviours NCE NCO approach useful tool identifying biases Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Typhoid Fever",
            "Bangladesh",
            "Infant",
            "Child",
            "Child, Preschool",
            "Vaccines, Conjugate",
            "Male",
            "Adolescent",
            "Female",
            "Research Design",
            "Vaccine Efficacy",
            "Japanese Encephalitis Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40252689/"
    },
    {
        "pmid": "40230444",
        "title": "Changes in enteric fever trends during the COVID-19 pandemic from the Surveillance for Enteric Fever in Asia Project: a cross-sectional study.",
        "abstract": "Surveillance Enteric Fever Asia Project SEAP conducted blood culture surveillance iSalmonella entericai serotype Typhi iSi Typhi Paratyphi iSi Paratyphi provide evidence base prevention control measure Bangladesh Nepal Pakistan October 2020 September 2022 conducted prospective clinical surveillance retrospective laboratory surveillance health facility Dhaka Bangladesh Kathmandu Kavrepalanchok Nepal Karachi Pakistan Patients eligible outpatient three day fever last week Nepal Pakistan inpatient eligible suspected confirmed enteric fever Bangladesh inpatient confirmed enteric fever enrolled Patients blood cultureconfirmed enteric fever identified hospital laboratory laboratory network site also enrolled Patients completed interview medical record reviewed abstracted enrolled patient blood culture performed Antibiograms performed characterize drug sensitivity summarized data descriptively total 17593 patient enrolled 19 facilities these 8410 patient cultureconfirmed enteric fever Case count country decreased early stage COVID19 pandemic increased time Bangladesh Pakistan Case count remained low throughout study period Nepal countries typhoid common paratyphoid proportion paratyphoid case ranged 84 Pakistan 16 Nepal Extensively drugresistant typhoid common Pakistan 69 detected Bangladesh Nepal Cases enteric fever decreased COVID19 pandemic though clear much decrease relates true change transmission versus healthseeking behavior project funded Gates Foundation INV008335",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40230444/"
    },
    {
        "pmid": "40226208",
        "title": "A case of typhoid fever with neurological presentation.",
        "abstract": "Typhoid fever leading systemic disease due Salmonella enterica serotype Typhi typically gastrointestinal manifestation however neurologic complicationsalthough uncommon arise Aseptic meningitis optic neuritis rare manifestation challenging diagnose patient 31year male presented fever 18 day associated headache rash vomiting diarrhea progressive neurological symptom form disorientation blurred vision examination bilateral sixth cranial nerve palsy Investigations positive typhoid fever aseptic meningitis optic neuritis successfully treated intravenous ceftriaxone corticosteroids Atypical neurological symptom typhoid fever must recognized prevent complications early diagnosis treatment important Typhoid fever considered febrile patient unexplainable neurological symptoms especially endemic region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40226208/"
    },
    {
        "pmid": "40106483",
        "title": "Understanding climate-sensitive diseases in Bangladesh using systematic review and government data repository.",
        "abstract": "Understanding effect climate change health outcome crucial effective policy formulation intervention strategies However Low MiddleIncome Countries like Bangladesh true extent effect remains unexplored due data scarcity study aim assess available evidence climate changerelated health outcome Bangladesh compare actual national occurrences explore challenge related climate change health data first conducted systematic review summarize climatesensitive disease examined existing literature Bangladesh review result compared 28 million sample governments data repository representing reported case climatesensitive disease 20172022 comparison aimed identify discrepancy disease currently occurring Bangladesh related climate change available knowledge existing research Additionally also explored limitation data recorded government data repository available literature Bangladesh report specific climatesensitive diseases including Diarrhea Dengue Cholera Malaria Pneumonia Cardiovascular Diseases Hypertension UrinaryTract Infections Malnutrition also considered studies represents segment total 510 reported climatesensitive disease Bangladesh 143 disease responsible 9066 total occurrences common form disease diarrhea gastroenteritis presumed infectious 2851 pneumonia 1888 anxiety disorders panic disorders generalized anxiety disorder 132 others 1315 Additionally UrinaryTract infection 787 cholera 303 typhoid fever 327 frequently reported climatesensitive diseases also explored several challenge related available data government repository include inadequate collection patients comprehensive sociodemographic information absence unique patient identifier finding underscore urgent need tackle data challenge understanding climatesensitive disease Bangladesh Policies program required prioritize digitalization healthcare system implement unique patient identification number facilitate accurate tracking analysis health data Climate Change including rising temperature extreme weather event like cyclone floods pose significant global health threat 1 World Health Organization estimate climate change already cause least 150000 death annually global level number projected double 2030 Beside impact climate change farreaching leading forced displacement malnutrition increased incidence disease dengue diarrhea pneumonia 2 Additionally climate change established link mental health issues like anxiety depression 3 effect particularly severe Low MiddleIncome Countries LMICs due limited resource inadequate infrastructure coping erratic weather disaster 4 undertook comprehensive mixedmethod study incorporating systematic review existing study conducted Bangladesh along analysis government data repository detailed description component presented below",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Climate Change",
            "Diarrhea",
            "Government"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40106483/"
    },
    {
        "pmid": "40075809",
        "title": "Enhancing Typhoid Fever Diagnosis Based on Clinical Data Using a Lightweight Machine Learning Metamodel.",
        "abstract": "bBackgroundb Typhoid fever remains significant public health challenge especially developing country diagnostic resource limited Accurate timely diagnosis crucial effective treatment disease containment Traditional diagnostic methods effective timeconsuming resourceintensive study aim develop lightweight machine learningbased diagnostic tool early efficient detection typhoid fever using clinical data bMethodsb custom dataset comprising 14 clinical demographic parametersincluding age gender headache muscle pain nausea diarrhea cough fever range °F hemoglobin gdL platelet count urine culture bacteria calcium mgdL potassium mgdLwas analyzed machine learning metamodel integrating Support Vector Machine SVM Gaussian Naive Bayes GNB Decision Tree classifier Light Gradient Boosting Machine LGBM trained evaluated using kfold crossvalidation Performance assessed using precision recall F1score area receiver operating characteristic curve AUC bResultsb proposed metamodel demonstrated superior diagnostic performance achieving precision 99 recall 100 AUC 100 outperformed traditional diagnostic method standalone machine learning algorithms offering high accuracy generalizability bConclusionsb lightweight machine learning metamodel provides costeffective noninvasive rapid diagnostic alternative typhoid fever particularly suited resourcelimited settings reliance accessible clinical parameter ensures practical applicability scalability potentially improving patient outcome aiding disease control Future work focus broader validation integration clinical workflow enhance utility",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40075809/"
    },
    {
        "pmid": "39891051",
        "title": "Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.",
        "abstract": "delivered vaccination Vipolysaccharide antigen Salmonella enterica serotype Typhi protects typhoid inducing IgG antiVi antibodies aimed determine whether presence antibody following natural infection associated lower incidence typhoid fever endemic regions analyzed data cohort study typhoid fever conducted Dhaka Bangladesh Plasma IgG antiVi antibody measured using standard enzymelinked immunosorbent assay random serosurveys population previously received typhoid vaccination Participants followed 20 month cultureconfirmed typhoid fever receiver operating characteristic ROC curve Cox proportional hazard model used evaluate association antibody level typhoid risk ROC analysis revealed IgG antiVi antibody titer predictive typhoid risk among 8261 serosurvey participant area curve 0·63 95 confidence interval CI 0·58─0·67 Detection antibody associated lower risk typhoid crude analysis hazard ratio HR 0·13 95 CI 0·03─0·52 though association declined adjustment HR 0·32 95 CI 0·07─1·40 positive correlation observed IgG antiVi titer age correlation coefficient 0·35 p  0·001 stepwise increase detectable antibody age ranging 12·0 2802333 child 5 year 54·2 463854 individual 50 year older p  0·001 typhoidendemic populations IgG antiVi antibody may indicate natural immunity typhoid increasing seroprevalence age suggests antibody could serve marker cumulative past typhoid infections Future research explore possibilities applicable",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Typhoid Fever",
            "Immunoglobulin G",
            "Antibodies, Bacterial",
            "Male",
            "Female",
            "Child",
            "Child, Preschool",
            "Adolescent",
            "Adult",
            "Young Adult",
            "Polysaccharides, Bacterial",
            "Salmonella typhi",
            "Middle Aged",
            "Infant",
            "Cohort Studies",
            "Seroepidemiologic Studies",
            "ROC Curve",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39891051/"
    },
    {
        "pmid": "39820842",
        "title": "Machine learning and spatio-temporal analysis of meteorological factors on waterborne diseases in Bangladesh.",
        "abstract": "Bangladesh facing formidable challenge mitigating waterborne disease risk exacerbated climate change However comprehensive understanding spatiotemporal dynamic disease district level remains elusive Therefore study aimed fill gap investigating spatiotemporal pattern identifying best treebased ML model determining meteorological factor associated waterborne disease Bangladesh study used districtlevel reported case waterborne disease cholera amoebiasis typhoid hepatitis A obtained Bangladesh Bureau Statistics BBS meteorological data temperature relative humidity wind speed precipitation sourced NASA period spanning 2017 2020 Exploratory spatial analysis spatial regression treebased machine learning model utilized analyze data 2017 2020 Bangladesh reported 73 606 cholera 38 472 typhoid 2 510 hepatitis 1 643 amoebiasis disease cases Among waterborne disease cholera showed higher incidence rate ChapaiNawabganj 45623 Brahmanbaria 41744 Faridpur 22507 Nilphamari 18862 Pirojpur 17162 districts spatial regression model identified mean temperature β  1216 se 391 significant risk factor waterborne diseases optimal XGBoost model highlighted mean minimum temperature relative humidity precipitation determinant associated waterborne disease Bangladesh 2017 2020 finding study incorporating One Health perspective provide insight planning early warning prevention control strategy combat waterborne disease Bangladesh similar endemic countries Precautionary measure intensified surveillance need implemented certain highrisk district waterborne disease across country",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Machine Learning",
            "Spatio-Temporal Analysis",
            "Meteorological Concepts",
            "Waterborne Diseases",
            "Cholera",
            "Typhoid Fever",
            "Incidence",
            "Temperature"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39820842/"
    },
    {
        "pmid": "39701118",
        "title": "Evaluation of a point-of-care immunochromatographic assay for enteric fever in Dhaka, Bangladesh: a prospective diagnostic accuracy study.",
        "abstract": "shortage rapid accurate lowcost assay diagnosing enteric fever dualpath platform typhoid DPPT assay high accuracy retrospective study banked plasma samples aimed evaluate diagnostic accuracy DPPT assay prospective study using fingerstick capillary blood prospective diagnostic accuracy study enrolled child younger 18 years presented Bangladesh Shishu Hospital Institute Dhaka Bangladesh least 3 day fever collected blood nasal swabs following assay assess accuracy DPPT blood culture serological assay typhoid fever DPPT assay Widal Testit molecular assay identify alternative aetiology eg respiratory syncytial virus RSV influenza dengue virus Rickettsia spp primary outcome study sensitivity specificity DPPT assay diagnosis enteric fever evaluated accuracy combined antihaemolysin E antilipopolysaccharide IgA reading using DPPT assay distinguishing cultureconfirmed enteric fever alternative aetiology using receiver operating characteristic area curve AUC Given imperfect reference standard diagnostics enteric fever used Bayesian latent class models incorporating result typhoid alternative aetiology diagnostics estimate sensitivity specificity DPPT assay also subgroup analysis assay across multiple biological variables Aug 17 2021 July 16 2022 enrolled 501 participant presented least 3 day fever 223 45 501 participant female 278 55 male 77 participant cultureconfirmed enteric fever 62 Salmonella enterica serotype Typhi 15 Salmonella enterica serotype Paratyphi A 70 culturenegative PCRconfirmed alternative aetiology 34 influenza B 22 dengue virus seven Rickettsia spp six RSV one participant coinfected RSV dengue virus AUC DPPT fingerstick capillary blood distinguishing typhoid alternative aetiology 0·969 95 CI 0·9430·994 latent class analysis sensitivity DPPT 93 95 credible interval CrI 8797 specificity 89 8593 balanced accuracy higher DPPT 91 95 CrI 8794 blood culture 81 7885 Testit 77 7479 Widal 70 6773 Assay performance vary sex age duration fever presentation antibiotic use presentation Salmonella serotype sample type pointofcare DPPT assay achieved high diagnostic accuracy enteric fever highly endemic community assay potential improve clinical outcome enteric fever allowing rapid diagnosis treatment could facilitate appropriate antimicrobial use National Institute Health Bill  Melinda Gates Foundation Child Health Research Foundation",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Bangladesh",
            "Prospective Studies",
            "Female",
            "Male",
            "Child, Preschool",
            "Child",
            "Sensitivity and Specificity",
            "Infant",
            "Point-of-Care Systems",
            "Adolescent",
            "Antibodies, Bacterial",
            "Chromatography, Affinity",
            "Salmonella typhi"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39701118/"
    },
    {
        "pmid": "39396349",
        "title": "5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.",
        "abstract": "currently recommends single dose typhoid conjugate vaccine TCV highburden country based 2year vaccine efficacy data large randomised controlled trials Given decay immunogenicity protection beyond 2 year unknown therefore extended followup TyVAC trial Bangladesh assess waning vaccine protection 5 year vaccination conducted cluster randomised controlled trial TyVAC ISRCTN11643110 Dhaka Bangladesh 2018 2021 Children aged 9 month 15 year invited receive single dose TCV Japanese encephalitis vaccine April 15 2018 November 16 2019 based randomisation cluster residence Children received Japanese encephalitis vaccine invited receive TCV final visit Jan 6 Aug 31 2021 according protocol followon study extended followup original trial Aug 14 2023 primary endpoint study compare incidence blood cultureconfirmed typhoid child received TCV 201819 the previousTCV group received vaccine 2021 the recentTCV group evaluate relative decline vaccine protection also nested study using testnegative design comparing recentTCV previousTCV group unvaccinated individuals well immunogenicity study subset 1500 children Compared recentTCV group previousTCV group increased risk typhoid fever 202123 adjusted incidence rate ratio 3·10 95 CI 1·53 6·29 p0·0001 indicating decline protection singledose TCV 35 year vaccination extrapolated vaccine effectiveness year 35 50 95 CI 13 78 validated using testnegative design analysis vaccine effectiveness 84 74 90 recentTCV group 55 36 68 previousTCV group compared unvaccinated individuals AntiViIgG response declined study period highest rate decay seen child vaccinated younger 2 year original trial inverse correlation age decay antibody also seen subgroup analysis vaccine effectiveness youngest age group 7 year fever visits exhibited fastest waning vaccine effectiveness dropping 24 95 CI 29 55 35 year vaccination decline protection conferred singledose TCV observed 35 year vaccination greatest decline protection immune response observed child vaccinated younger ages booster dose TCV around school entry age might needed child vaccinated younger 2 year sustain protection typhoid fever school year risk highest Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Child, Preschool",
            "Child",
            "Female",
            "Male",
            "Typhoid-Paratyphoid Vaccines",
            "Infant",
            "Vaccines, Conjugate",
            "Tetanus Toxoid",
            "Typhoid Fever",
            "Adolescent",
            "Vaccine Efficacy",
            "Japanese Encephalitis Vaccines",
            "Follow-Up Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39396349/"
    },
    {
        "pmid": "39365840",
        "title": "Trends in antimicrobial resistance amongst Salmonella Typhi in Bangladesh: A 24-year retrospective observational study (1999-2022).",
        "abstract": "Rising antimicrobial resistance AMR Salmonella Typhi restricts typhoid treatment options heightening concern panoral drugresistant outbreaks However lack longterm temporal surveillance data AMR country high burden like Bangladesh scarce study explores AMR trend Salmonella Typhi isolates Bangladesh drawing comparison antibiotic consumption optimize antibiotic stewardship strategy country typhoid fever surveillance 1999 2022 included two pediatric hospital three private clinic Dhaka Bangladesh Blood culture performed treating physicians discretion case confirmed microbiological serological biochemical tests Antibiotic susceptibility determined following CLSI guidelines National antibiotic consumption data cotrimoxazole ciprofloxacin azithromycin obtained IQVIAMIDAS database comparison 24 year surveillance recorded 12435 cultureconfirmed typhoid case observed declining resistance firstline drug amoxicillin chloramphenicol cotrimoxazole multidrug resistance MDR decreased 38 1999 17 2022 Cotrimoxazole consumption dropped 08 01 Daily defined dos DDD1000day 19992020 Ciprofloxacin nonsusceptibility persisted 90 unchanged consumption 1113 DDD1000day 20022020 Low ceftriaxone resistance 1 observed slightly rising MIC 003 012 mgL 19992019 Azithromycin consumption increased 01 38 DDD1000day 19992020 resistance remained ≤4 study highlight declining MDR amongst Salmonella Typhi Bangladesh firstline antimicrobial could reintroduced empirical treatment option typhoid fever MDR rate drop 5 analysis also provides baseline data monitoring impact future intervention like typhoid conjugate vaccine typhoid burden associated AMR",
        "mesh_terms": [
            "Salmonella typhi",
            "Bangladesh",
            "Humans",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Retrospective Studies",
            "Microbial Sensitivity Tests",
            "Child",
            "Male",
            "Azithromycin",
            "Adolescent",
            "Female",
            "Child, Preschool",
            "Drug Resistance, Bacterial",
            "Drug Resistance, Multiple, Bacterial",
            "Ciprofloxacin",
            "Trimethoprim, Sulfamethoxazole Drug Combination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39365840/"
    },
    {
        "pmid": "39351718",
        "title": "Clinicopathological Evaluation of the Patients with Febrile Illness and Altered Consciousness Admitted in a Tertiary Level Hospital.",
        "abstract": "important note altered mental status disease itself rather symptom wide range potential diagnoses structured approach assessing patient symptom frequently lead helpful information rule worstcase scenarios case fever followed change consciousness quick assessment patients level consciousness potential cause decisive focused history physical assessment help differentiate structural medical causes Asymmetrical neurological findings dilated fixed pupil dysconjugated extraocular movement asymmetrical motor findings suggest brainstem dysfunction due structural lesion symmetrical neurological finding usually indicate medical disorder recent study aimed identify feature different etiologies demographic patterns common cause acute prolonged febrile illness patients crosssectional type observational study conducted Department Medicine Mymensingh Medical College Hospital Bangladesh April 2014 October 2015 study period patient admitted satisfying inclusion exclusion criterion study purposively selected nonprobability hospitalized patients Total 100 case febrile illness altered consciousness meeting exclusion inclusion criterion examined investigated find actual etiology 100 patients observed 26260 patient suffering pneumonia 22220 urinary tract infection 18180 meningitis 14140 typhoid fever 880 meningoencephalitis 660 cerebral malaria 440 tuberculosis 220 tuberculoma result revealed large number patient febrile illness altered consciousness suffering pneumonia urinary tract infection",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Fever",
            "Consciousness Disorders",
            "Adult",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Tertiary Care Centers",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Child",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39351718/"
    },
    {
        "pmid": "38996496",
        "title": "Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.",
        "abstract": "Enteric fever serious public health concern causative agents Salmonella enterica serovars Typhi Paratyphi A frequently antimicrobial resistance AMR leading limited treatment option poorer clinical outcomes investigated genomic epidemiology resistance mechanisms transmission dynamic pathogen three urban site Africa Asia Typhi Paratyphi bacteria isolated blood culture febrile child adult study site Dhaka Bangladesh Kathmandu Nepal Blantyre Malawi STRATAA surveillance sequenced Isolates charactered term serotypes genotype according GenoTyphi Paratype molecular determinant AMR population structure used phylogenomic analysis incorporating globally representative genomic data previously published surveillance study ancestral state reconstruction differentiate locally circulating imported pathogen AMR variants Clusters sequence without singlenucleotide variant core genome identified used explore spatiotemporal pattern transmission dynamics sequenced 731 genome isolates obtained surveillance across three site Oct 1 2016 Aug 31 2019 24 month Dhaka Kathmandu 34 month Blantyre Paratyphi present Dhaka Kathmandu Blantyre Typhi genotype 431 H58 common sites different dominant variant 4311EA1 Blantyre 4311 Dhaka 4312 Kathmandu Multidrug resistance ie resistance chloramphenicol cotrimoxazole ampicillin common Blantyre 138 98 141 cases Dhaka 143 32 452 absent Kathmandu Quinoloneresistance mutation common Dhaka 451 99 452 Kathmandu 123 89 138 Blantyre three 2 141 Azithromycinresistance mutation acrB rare appearing Dhaka five 1 452 Phylogenetic analysis showed case derived preexisting locally established pathogen variants 702 98 713 drugresistant infection resulted local circulation AMR variants imported variant recent de novo emergence pathogen variant circulated across age groups 479 66 731 case clustered others indistinguishable point mutations individual cluster included multiple age group persisted 2·3 years AMR determinant invariant within clusters Enteric fever associated locally established pathogen variant circulate across age groups AMR infection resulted local transmission resistant strains result form baseline monitor impact control measures Wellcome Trust Bill  Melinda Gates Foundation EU Horizon 2020 UK National Institute Health Care Research",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Nepal",
            "Typhoid Fever",
            "Salmonella typhi",
            "Child",
            "Anti-Bacterial Agents",
            "Adult",
            "Phylogeny",
            "Child, Preschool",
            "Malawi",
            "Salmonella paratyphi A",
            "Male",
            "Adolescent",
            "Drug Resistance, Bacterial",
            "Female",
            "Infant",
            "Paratyphoid Fever",
            "Young Adult",
            "Genotype",
            "Genome, Bacterial",
            "Microbial Sensitivity Tests",
            "Middle Aged",
            "Genomics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38996496/"
    },
    {
        "pmid": "38913735",
        "title": "Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination.",
        "abstract": "Salmonella enterica serotype Typhi Salmonella Typhi cause severe occasionally lifethreatening disease transmitted contaminated food water Humans reservoir inadequate water sanitation hygiene infrastructure increase risk typhoid Highquality data assess spatial temporal relationship disease dynamic scarce analyzed data prospective cohort conducted urban slum area Dhaka City Bangladesh Passive surveillance study center identified typhoid case microbiological culture incident case index case matched two randomly selected index controls measured typhoid incidence population residing geographically defined region surrounding case control Spatial clustering evaluated comparing typhoid incidence resident geometric ring increasing radius surrounding index case control 28 days Temporal clustering evaluated separately measuring incidence first second 14day period following selection Incidence rate ratio IRRs calculated using Poisson regression models evaluated 141 typhoid index cases overall typhoid incidence 044 per 100000 persondays PDs 95 CI 040 049 28 day following selection highest typhoid incidence 12 per 100000 PDs 95 CI 08 16 innermost cluster surrounding index cases IRR innermost cluster 49 95 CI 24 103 relative innermost control clusters Neither typhoid incidence rate relative IRR index case control population showed substantive difference first second 14day period selection absence routine immunization programs geographic clustering typhoid case suggests higher intensity typhoid risk population immediately surrounding identified cases study needed understand spatial temporal trend evaluate effectiveness targeted vaccination disrupting typhoid transmission",
        "mesh_terms": [
            "Typhoid Fever",
            "Humans",
            "Bangladesh",
            "Poverty Areas",
            "Male",
            "Female",
            "Incidence",
            "Adolescent",
            "Child",
            "Adult",
            "Child, Preschool",
            "Young Adult",
            "Prospective Studies",
            "Salmonella typhi",
            "Typhoid-Paratyphoid Vaccines",
            "Spatio-Temporal Analysis",
            "Infant",
            "Cluster Analysis",
            "Vaccination",
            "Middle Aged",
            "Urban Population",
            "Case-Control Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38913735/"
    },
    {
        "pmid": "38681077",
        "title": "Acute non-immune hemolytic anemia in enteric fever due to nalidixic acid-resistant Salmonella enterica serotype Typhi: A case report.",
        "abstract": "Nalidixic acidresistant Salmonella enterica serotype Typhi wellknown cause enteric fever prevalence increasing worldwide However incidence enteric fever complicated nonimmune hemolytic anemia without coexisting thalassemia glucose6phosphate dehydrogenase deficiency rare case report present case acute nonimmune hemolytic anemia enteric fever caused nalidixic acidresistant Salmonella enterica serotype Typhi",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38681077/"
    },
    {
        "pmid": "38555929",
        "title": "Bivalent conjugate vaccines for typhoid and paratyphoid fever.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Paratyphoid Fever",
            "Vaccines, Conjugate",
            "Vaccines, Combined",
            "Salmonella typhi",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38555929/"
    },
    {
        "pmid": "38531727",
        "title": "Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh.",
        "abstract": "Typhoid fever cause substantial morbidity mortality Bangladesh government Bangladesh plan introduce typhoid conjugate vaccine TCV expanded program immunization EPI schedule However optimal introduction strategy addition cost benefit program unclear extended existing mathematical model typhoid transmission integrate cost data clinical incidence data recently conducted serosurveys urban semiurban rural areas primary analysis evaluated status quo ie vaccination eight vaccine introduction strategy including routine 1time campaign strategies differed age group targeted geographic focus Model outcome included clinical incidence seroincidence deaths costs disabilityadjusted life year DALYs incremental costeffectiveness ratio ICERs strategy adopted societal perspective 10year model time horizon 3  annual discount rate performed probabilistic oneway scenario sensitivity analysis including adopting healthcare perspective alternate model time horizons projected TCV strategy would cost saving compared status quo preferred strategy nationwide introduction TCV 912 month age single catchup campaign child age 115 cost saving compared strategy status quo 10 year following implementation projected strategy would avert 377 million case 95  CrI 260  518 1131 thousand death 95  CrI 377  2360 save 17235 million 95  CrI 1429  46059 compared status quo finding broadly robust change parameter value willingnesstopay thresholds projected nationwide TCV introduction catchup campaign would substantially reduce typhoid incidence likely cost saving Bangladesh",
        "mesh_terms": [
            "Child",
            "Humans",
            "Typhoid Fever",
            "Cost-Benefit Analysis",
            "Vaccines, Conjugate",
            "Public Health",
            "Typhoid-Paratyphoid Vaccines",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38531727/"
    },
    {
        "pmid": "38387472",
        "title": "Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.",
        "abstract": "Ciprofloxacin firstline drug treating typhoid fever many country Africa high disease burden emergence nonsusceptibility pose challenge public health programmes enhanced surveillance part vaccine evaluation investigated occurrence potential determinant ciprofloxacin nonsusceptibility Blantyre Malawi conducted systematic surveillance typhoid fever case antibiotic prescription two health centre Blantyre Malawi Oct 1 2016 Oct 31 2019 part STRATAA TyVAC studies addition blood culture taken eligible patient presenting Queen Elizabeth Central Hospital Blantyre part routine diagnosis Inclusion criterion measured reported fever clinical suspicion sepsis Microbiologically identified Salmonella enterica serotype Typhi S Typhi isolates ciprofloxacin nonsusceptible phenotype blood cultures used wholegenome sequencing identify drugresistance mutation phylogenetic relationships constructed generalised linear regression model investigate association number ciprofloxacin prescription given per month study participant proportion Typhi isolates quinolone resistancedetermining region QRDR mutation following month 46 989 blood culture Queen Elizabeth Central Hospital 502 Typhi isolates obtained 30 6 either decreased ciprofloxacin susceptibility ciprofloxacin resistance 11 295 blood culture STRATAA TyVAC studies 241 microbiologically confirmed case typhoid fever identified 198 isolates 195 participant sequenced mean age 12·8 year SD 10·2 53 female 47 male Oct 1 2016 Aug 31 2019 177 typhoid fever case confirmed wholegenome sequencing four 2 caused Typhi QRDR mutations compared six 33 18 case Sept 1 Oct 31 2019 increase associated preceding spike ciprofloxacin prescriptions Every additional prescription ciprofloxacin given study participant preceding month associated 4·2 increase 95 CI 1·87·0 relative risk isolating Typhi QRDR mutation p0·0008 Phylogenetic analysis showed Typhi isolates QRDR mutation September October 2019 belonged two distinct subclades encoding two different QRDR mutations closely related 410 singlenucleotide polymorphisms susceptible Typhi endemic Blantyre postulate causal relationship increased ciprofloxacin prescription increase fluoroquinolone nonsusceptibility Typhi Decreasing ciprofloxacin use improving typhoid diagnostics reducing typhoid fever case use efficacious vaccine could help limit emergence resistance Wellcome Trust Bill  Melinda Gates Foundation National Institute Health Care Research UK",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Child",
            "Salmonella typhi",
            "Ciprofloxacin",
            "Typhoid Fever",
            "Malawi",
            "Phylogeny",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38387472/"
    },
    {
        "pmid": "38358956",
        "title": "Old tools, new applications: Use of environmental bacteriophages for typhoid surveillance and evaluating vaccine impact.",
        "abstract": "Typhoidconjugate vaccine TCVs provide opportunity reduce burden typhoid fever caused Salmonella Typhi endemic areas policymakers design vaccination strategies accurate highresolution data disease burden crucial However traditional blood culturebased surveillance resourceextensive prohibiting largescale sustainable implementation Salmonella Typhi waterborne pathogen here tested potential Typhispecific bacteriophage surveillance surface water body lowcost tool identify Salmonella Typhi circulates environment 2021 water sample collected tested presence Salmonella Typhi bacteriophage two site Bangladesh urban capital city Dhaka rural district Mirzapur Salmonella Typhispecific bacteriophage detected 66 211 31 environmental sample Dhaka comparison 3 92 3 environmental sample Mirzapur year 4620 blood culture two largest pediatric hospital Dhaka yielded 215 5 cultureconfirmed typhoid cases 3788 blood culture largest hospital Mirzapur yielded 2 005 cases 75 5269 positive phage sample collected sewage isolated phage tested panel isolates different Salmonella Typhi genotype circulating Bangladesh found exhibit diverse killing spectrum indicating diverse bacteriophage isolated result suggest association presence Typhispecific phage environment burden typhoid fever potential utilizing environmental phage surveillance lowcost tool assist policy decision typhoid control",
        "mesh_terms": [
            "Humans",
            "Child",
            "Typhoid Fever",
            "Bacteriophages",
            "Bangladesh",
            "Salmonella typhi",
            "Typhoid-Paratyphoid Vaccines",
            "Water"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38358956/"
    },
    {
        "pmid": "38329937",
        "title": "Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance.",
        "abstract": "Environmental surveillance using detection Salmonella Typhi DNA emerged potentially useful tool identify typhoidendemic settings however relatively costly requires molecular diagnostic capacity sought determine whether S Typhi bacteriophage abundant water source typhoidendemic setting using lowcost assays collected drinking surface water sample urban periurban rural area 4 region Nepal performed double agar overlay S Typhi assess presence bacteriophages isolated tested phage multiple strain assess host range performed whole genome sequencing isolated phages generated phylogeny using conserved genes S Typhispecific bacteriophage detected 549 198361 river 63 116 drinking water sample Kathmandu Valley Kavrepalanchok Water sample collected within downstream populationdense area likely positive 726 193266 collected upstream population center 53 595 p0005 urban Biratnagar rural Dolakha typhoid incidence low 67 115 Biratnagar 0 016 Dolakha river water sample contained phages S Typhi phage unable infect Salmonella nonSalmonella strains Viknockout S Typhi strain Representative strain S Typhi lineage variably susceptible isolated phages Phylogenetic analysis showed S Typhi phage belonged class Caudoviricetes clustered three distinct groups S Typhi bacteriophage highly abundant surface water typhoidendemic community rarely detected low typhoid burden communities Bacteriophages recovered specific S Typhi required Vi polysaccharide infection Screening small volume water simple lowcost 2 plaque assay enables detection S Typhi phage evaluated scalable tool typhoid environmental surveillance",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Salmonella typhi",
            "Salmonella Phages",
            "Phylogeny",
            "Bacteriophages",
            "Water"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38329937/"
    },
    {
        "pmid": "38097589",
        "title": "Typhoid fever.",
        "abstract": "Typhoid fever invasive bacterial disease associated bloodstream infection cause high burden disease Africa Asia Typhoid primarily affect individual ranging infant young adults causative organism Salmonella enterica subsp enterica serovar Typhi transmitted via faecaloral route crossing intestinal epithelium disseminating systemic intracellular sites causing undifferentiated febrile illness Blood culture remains practical reference standard diagnosis typhoid fever culture testing available novel diagnostic modality important priority investigation Since 2017 remarkable progress made defining global burden typhoid fever antimicrobial resistance understanding disease pathogenesis immunological protection use controlled human infection advancing effective vaccination programme strategic multipartner collaboration targeted clinical trial multiple highincidence priority settings Primer thus offer timely update progress perspective future priority global scientific community",
        "mesh_terms": [
            "Infant",
            "Young Adult",
            "Humans",
            "Typhoid Fever",
            "Salmonella typhi",
            "Salmonella",
            "Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38097589/"
    },
    {
        "pmid": "37983081",
        "title": "Association Among Household Water, Sanitation, and Hygiene (WASH) Status and Typhoid Risk in Urban Slums: Prospective Cohort Study in Bangladesh.",
        "abstract": "Typhoid fever enteric fever highly fatal infectious disease affect 9 million people worldwide year resulting 110000 deaths Reduction burden typhoid lowincome country crucial public health requires implementation feasible water sanitation hygiene WASH interventions especially densely populated urban slums study conducted Mirpur Bangladesh aimed assess association household WASH status typhoid risk training subpopulation large prospective cohort n98087 evaluate performance machine learning algorithm creating composite WASH variable Further investigated protection associated living household improved WASH facility cluster increasing prevalence facility 2year followup period used machine learning algorithm create dichotomous composite variable Better Not Better based 3 WASH variables private toilet facility safe drinking water source presence water filter algorithm trained using data training subpopulation validated distinct subpopulation n65286 assess sensitivity specificity Cox regression model used evaluate protective effect living Better WASH household cluster increasing level Better WASH prevalence found residence household improved WASH facility associated 38 reduction typhoid risk adjusted hazard ratio062 95 CI 049078 P001 reduction particularly pronounced individual younger 10 year first census participation adjusted hazard ratio 049 95 CI 036066 P001 Furthermore observed inverse relationship prevalence Better WASH facility cluster incidence typhoid although association statistically significant multivariable model Specifically adjusted hazard typhoid decreased 0996 95 CI 09861006 percent increase prevalence Better WASH cluster P39 finding demonstrate existing variation household WASH associated difference risk typhoid densely populated urban slums suggests attainable improvement WASH facility contribute enhanced typhoid control especially setting major infrastructural improvement challenging finding underscore importance implementing promoting comprehensive WASH intervention lowincome country mean reduce burden typhoid improve public health outcome vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Water",
            "Sanitation",
            "Typhoid Fever",
            "Bangladesh",
            "Prospective Studies",
            "Poverty Areas",
            "Hygiene"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37983081/"
    },
    {
        "pmid": "37951691",
        "title": "Vaccine value profile for Salmonella enterica serovar Paratyphi A.",
        "abstract": "Asia estimated 12 million annual case enteric fever potentially fatal systemic bacterial infection caused Salmonella enterica serovars Typhi STy Paratyphi SPA recent availability typhoid conjugate vaccine TCV increasing incidence disease caused SPA growing antimicrobial resistance AMR across genus Salmonella make bivalent STySPA vaccine useful public health proposition uptake standalone paratyphoid vaccine likely low thus pipeline bivalent STySPA candidate vaccines Several candidate close entering clinical trials successful facilitate comprehensive approach enteric fever control Additionally World Health Organization WHO made advancing development vaccine protect young child working aged adult agent enteric fever priority objective Vaccine Value Profile VVP address information related predominantly invasive disease caused SPA prevalent Asia Information included standalone SPA candidate vaccine candidate vaccine targeting SPA combined STy scope first version VVP wider discussion development universal Salmonella combination candidate vaccine addressing enteric fever invasive nontyphoidal Salmonella disease use globally VVP detailed highlevel assessment existing publicly available information inform contextualize public health economic societal potential pipeline vaccine vaccinelike product SPA Future version VVP updated reflect ongoing activity vaccine development strategy Full Vaccine Value Assessment inform value proposition SPA vaccine VVP developed expert working group academia nonprofit organizations publicprivate partnerships multilateral organization well collaboration stakeholder SouthEast Asian Region contributor extensive expertise various element VVP SPA collectively aimed identify current research knowledge gaps",
        "mesh_terms": [
            "Adult",
            "Child",
            "Humans",
            "Child, Preschool",
            "Middle Aged",
            "Typhoid Fever",
            "Salmonella paratyphi A",
            "Paratyphoid Fever",
            "Salmonella typhi",
            "Typhoid-Paratyphoid Vaccines",
            "Salmonella Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37951691/"
    },
    {
        "pmid": "37939101",
        "title": "Trends in antimicrobial resistance amongst Salmonella Paratyphi A isolates in Bangladesh: 1999-2021.",
        "abstract": "Typhoid paratyphoid remain common bloodstream infection area suboptimal water sanitation infrastructure Paratyphoid caused Salmonella Paratyphi A less prevalent typhoid antimicrobial resistance AMR trend less documented Empirical treatment paratyphoid commonly based knowledge susceptibility Salmonella Typhi cause typhoid Hence rising drug resistance Salmonella Typhi lastline antibiotic like ceftriaxone azithromycin prescribed typhoid paratyphoid However unlike typhoid vaccine prevent paratyphoid Here report 23year AMR trend Salmonella Paratyphi Bangladesh 1999 2021 conducted enteric fever surveillance two major pediatric hospital three clinic Dhaka Bangladesh Blood culture performed discretion treating physicians case confirmed culture serological biochemical tests Antimicrobial susceptibility determined following CLSI guidelines 23 years identified 2725 blood cultureconfirmed paratyphoid cases 97 isolates susceptible ampicillin chloramphenicol cotrimoxazole isolate resistant three resistance ceftriaxone recorded 99 isolates sensitive azithromycin slight increase minimum inhibitory concentration MIC noticed ceftriaxone current average MIC 32fold lower resistance cutoff 99 isolates exhibited decreased susceptibility ciprofloxacin Salmonella Paratyphi remained susceptible antibiotics unlike Salmonella Typhi despite widespread usage many antibiotic Bangladesh data guide evidencebased policy decision empirical treatment paratyphoid fever especially post typhoid vaccine era availability new paratyphoid diagnostics",
        "mesh_terms": [
            "Child",
            "Humans",
            "Anti-Bacterial Agents",
            "Typhoid Fever",
            "Salmonella paratyphi A",
            "Azithromycin",
            "Ceftriaxone",
            "Bangladesh",
            "Drug Resistance, Bacterial",
            "Salmonella typhi",
            "Paratyphoid Fever",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37939101/"
    },
    {
        "pmid": "37777910",
        "title": "Can We Restart the First-Line Antibiotic as Empirical Choice When Enteric Fever is Suspected?",
        "abstract": "Enteric fever major health problem Bangladesh Antibiotic resistance especially firstline antibiotic major concern management thereby practicing physician first choice thinking resistance retrospective study carried Department Microbiology Bangladesh Medical College Hospital Dhaka Bangladesh January 2017 December 2019 identify year wise sensitivity pattern firstline antibiotic like Amoxycillin Cotrimoxazole Chloramphenocol Salmonella typhi Salmonella paratyphi blood sample sent culture sensitivity evaluated see microbiom sensitivity pattern Salmonella typhi paratyphi major isolates last 3 year 7374 1532 respectably Sensitivity pattern Amoxycillin Cotrimoxazole Chloramphenocol Salmonella typhi increased 2017 2019 660 830 800 830 840 850 respectively Similar increasing pattern sensitivity found Salmonella paratyphi 825 892 762 954 987 985 respectively also found highly sensitive 900 3rd generation cephalosporin study recommends use firstline antibiotic empirical agent choice enteric fever still highly sensitive Salmonella typhi Salmonella paratyphi",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Trimethoprim, Sulfamethoxazole Drug Combination",
            "Retrospective Studies",
            "Microbial Sensitivity Tests",
            "Bangladesh",
            "Salmonella typhi",
            "Salmonella paratyphi A",
            "Amoxicillin",
            "Drug Resistance, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37777910/"
    },
    {
        "pmid": "37697804",
        "title": "Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 <i>Salmonella</i> Typhi genomes.",
        "abstract": "Global Typhoid Genomics Consortium established bring together typhoid research community aggregate analyse iSalmonella entericai serovar Typhi Typhi genomic data inform public health action analysis mark 22 year since publication first Typhi genome represents largest Typhi genome sequence collection date n13000 metaanalysis global genotype antimicrobial resistance AMR determinant extracted previously sequenced genome data analysed using consistent method implemented open analysis platform GenoTyphi Pathogenwatch Compared previous global snapshots data highlight genotype 431 H58 spread beyond Asia EasternSouthern Africa regions distinct genotype dominate independently evolved AMR Data gap remain many part world show potential travelassociated sequence provide informal sentinel surveillance locations data indicate ciprofloxacin nonsusceptibility 1 resistance determinant widespread across geography genotypes highlevel ciprofloxacin resistance ≥3 determinants reaching 20 prevalence South Asia Extensively drugresistant XDR typhoid become dominant Pakistan 70 2020 yet become established elsewhere Ceftriaxone resistance emerged eight nonXDR genotypes including ciprofloxacinresistant lineage 43121 India Azithromycin resistance mutation detected low prevalence South Asia including two common ciprofloxacinresistant genotypes consortiums aim encourage continued data sharing collaboration monitor emergence global spread AMR Typhi inform decisionmaking around introduction typhoid conjugate vaccine TCVs prevention control strategies specific funding awarded metaanalysis Coordinators supported fellowship European Union ZAD received funding European Unions Horizon 2020 research innovation programme Marie SklodowskaCurie grant agreement 845681 Wellcome Trust SB Wellcome Trust Senior Fellowship National Health Medical Research Council DJI supported NHMRC Investigator Grant GNT1195210",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Travel",
            "Drug Resistance, Bacterial",
            "Ciprofloxacin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37697804/"
    },
    {
        "pmid": "37496432",
        "title": "Role of TaqMan array card in determining causative organisms of acute febrile illness in hospitalized patients.",
        "abstract": "Acute febrile illness AFI prevalent disease developing country difficult diagnose due diversity infectious organism poor quality clinical diagnosis TaqMan array card TAC detect 35 AFIassociated organism 15 h addressing diagnostic demands study aimed evaluate role TAC determining causative organism hospitalized AFI patients study crosssectional design enrolled 120 admitted patient persistent fever three day medicine ward Chittagong Medical College Hospital CMCH Bangladesh Institute Tropical Infectious Diseases Hospital BITID Blood sample collected subjected automated BacTAlert blood culture microbial culture TAC assay typhoidparatyphoid test total number study participant 120 among 48 40 sample showed positive result TAC card 29 2416 TP positive nine 751 culture positive number organism detected TAC card 13 bacteria three viruses one protozoan one fungus sensitivity specificity TAC assay different bacterial pathogen compared blood culture 4444 9099 respectively contrast TP test sensitivity specificity 100 80 respectively compared blood culture test TAC handful tool detecting multiple organism AFI high specificity facilitate early diagnosis different pathogen contributing AFI",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Bacteria",
            "Fever",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37496432/"
    },
    {
        "pmid": "37363565",
        "title": "Dreadful infectious disease outbreaks threaten flood-ravaged pakistan: short communication.",
        "abstract": "rise incidence waterborne communicable illnesses viral outbreak Pakistan follows period heavy rainfall Due climate change flood drought devastating effect human health facilitating spread infectious illness including cholera malaria typhoid dengue fever viral hepatitis A Food instability starvation malnutrition lack potable water indirect effect flooding health Recently one worst flood history devastated Pakistan affecting 333 million people along significant portion nation submerged Malaria dengue fever ailment rise Pakistan threatening overwhelm countrys healthcare infrastructure urgent need preventative measure Pakistan cope dreadful outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37363565/"
    },
    {
        "pmid": "37274527",
        "title": "Genomic Surveillance of <i>Salmonella</i> Paratyphi A: Neglected No More?",
        "abstract": "iSalmonella entericai serovar Paratyphi A causative agent paratyphoid fever neglected tropical disease high burden mortality low middleincome countries Limited information available regarding genomic diversity especially South Asian country collectively responsible 80 paratyphoid cases 2021 International Conference Typhoid Salmonelloses researcher around globe presented work iSalmonellai Paratyphi genomics Presentations described recent genomic data South Asia development iParatypei openaccess singlenucleotide polymorphismbased genotyping scheme segregate iSalmonellai Paratyphi genome systematic sustainable manner review attempt summarize progress made thus far iSalmonellai Paratyphi genomics discus question remain better understand pathogen develop intervention fight it",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37274527/"
    },
    {
        "pmid": "37090439",
        "title": "Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis.",
        "abstract": "clusterrandomised trial Vitetanus toxoid ViTT conjugate vaccine conducted urban Bangladeshi child found high level direct protection ViTT significant vaccine herd protection reassessed trial using fried egg analysis evaluate whether herd protection might obscured transmission typhoid cluster outside participant observerblind clusterrandomised trial conducted February 14 2018 August 12 2019 three ward Mirpur densely populated urban area Dhaka Bangladesh Children 9 month 16 year age 150 geographic clusters total 311289 person present baseline entering followup randomised cluster singledose ViTT Japanese encephalitis JE vaccine ViTT protection typhoid fever detected 8 treatment centre serving study population compared original cluster trial progressively central subclusters yolks fried egg cluster residents transmission typhoid cluster diluted observed vaccine herd protection hypothesised analysis innermost yolks would reveal vaccine herd protection evident analysis entire clusters trial registered wwwisrctncom ISRCTN11643110 ≤18 month followup total vaccine effectiveness protection ViTT recipient relative JE vaccine recipients 85 95 CI 76 90 indirect effectiveness protection nonViTT recipient ViTT cluster relative nonJE vaccine recipient JE vaccine clusters 17 95 CI 13 40 overall effectiveness protection resident ViTT cluster relative resident JE vaccine clusters 57 95 CI 44 66 Analyses subpopulation inner 75 50 25 yolks cluster failed reveal significant change estimates analysis reveal ViTT herd protection trial Consideration given exploring whether targeting adult well child ViTT yield appreciable level vaccine herd protection Bill  Melinda Gates Foundation OPP1151153 INV025388",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37090439/"
    },
    {
        "pmid": "37061369",
        "title": "Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh.",
        "abstract": "clusterrandomized trial ViTT conducted Dhaka Bangladesh using JE vaccine control subset 1500 child randomly selected 21 basis ViTT v JE assess immune response Blood collected vaccination day 28 545 730 postvaccination plasma antiViIgG response measured robust persistent antibody response induced single dose ViTT even 2 year vaccination accepted serological antibody threshold protection analyzing antibody child received ViTT provides evidence may later useful predicting population protection",
        "mesh_terms": [
            "Humans",
            "Child",
            "Typhoid Fever",
            "Tetanus Toxoid",
            "Salmonella typhi",
            "Vaccines, Conjugate",
            "Bangladesh",
            "Immunoglobulin G",
            "Typhoid-Paratyphoid Vaccines",
            "Antibodies, Bacterial",
            "Vaccination",
            "Antibody Formation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37061369/"
    },
    {
        "pmid": "36726577",
        "title": "The Prevalence of Multi-Drug Resistant <i>Salmonella typhi</i> Isolated From Blood Sample.",
        "abstract": "Typhoid major public health concern Even though antibiotic usually used treat typhoid fever spread multi drug resistant iSalmonella typhii making antibiotic much less effective study conducted assess prevalence multidrugresistant iSalmonella typhii clinical samples study 154 blood sample suspected typhoid patient collected hospital diagnostic center located Chattogram City Bangladesh Isolation identification iSalmonella typhii done biochemical tests PCR analysis also done confirmation biochemical result Antimicrobial susceptibility test performed according KirbyBauer disk diffusion method ampicillin chloramphenicol cefepime cotrimoxazole ceptriaxone ciprofloxacin nalidixic acid azithtomycin 154 21 1364 isolates identified iSalmonella typhii prevalence typhoid Chattogram Bangladesh 1364 n  21 also found child age 5 vulnerable target iSalmonella typhii infection Antibiotic resistance profiling revealed 85 isolates MultiDrug Resistant MDR highest resistance found case Nalidixic acid Although isolated iSalmonella typhii MDR first generation antibiotic Cotrimoxazile Chloramphenicol Ampicillin found effective iSalmonella typhii",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36726577/"
    },
    {
        "pmid": "36468871",
        "title": "Salmonella enterica Serovar Typhi on an Island: No H58, No Multidrug Resistance, but for How Long?",
        "abstract": "Little genomic data available typhoid fever island nations though disease moderately high burden there Sikorski et al M J Sikorski T H Hazen S N Desai S NimarotaBrown et al mBio 13e0192022 2022 httpsdoiorg101128mbio0192022 studied 306 Salmonella enterica serovar Typhi genome Samoan Islands collected 1983 2020 reported dominance rare genotype 254 H58 genotype 431 found pansusceptibility isolates three first line antimicrobial agent ampicillin chloramphenicol cotrimoxazole commentary evaluates importance finding Samoan Islands help global typhoid community microbial community environment human gut could played role lack antimicrobial resistance AMR However drugresistant strain may arrive soon island international spread common investigation would help global typhoid community better understand evolution isolated pathogen community effect vaccination there",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Ampicillin",
            "Anti-Infective Agents",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36468871/"
    },
    {
        "pmid": "36320797",
        "title": "Clinical and Laboratory Features of Enteric Fever in Children and Antibiotic Sensitivity Pattern in a Tertiary Care Hospital of a Low- and Middle-Income Country.",
        "abstract": "Globally enteric fever EF significantly give rise appalling death toll endemic illness Bangladesh South Asia condition manifest wide range clinical feature children Nowadays antibiotic resistance international stumbling block hamper appropriate treatment outcome EF study evaluated clinical laboratory characteristic antibiotic sensitivity pattern iSalmonella entericai children prospective research conducted Delta Medical College Hospital Dhaka Bangladesh January 2017 December 2019 total 200 pediatric case EF included study either culture positive significantly raised Widal test titer iSalmonellai suggestive clinical features patient fever coated tongue vomiting abdominal pain organomegaly diarrhea Among selected 200 case EF 435 iSalmonella typhii culturepositive high erythrocyte sedimentation rate ESR observed substantial number 53 patients Ceftriaxone sensitive 100 antibiotic laboratory analysis followed cefotaxime 951 Among oral antibiotic used cefixime 928 sensitive EF child present varied clinical manifestations Selective antibiotic treatment according sensitivity pattern crucial effective illness management reduce morbidity mortality pediatric population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36320797/"
    },
    {
        "pmid": "36048788",
        "title": "Acute febrile illness among outpatients seeking health care in Bangladeshi hospitals prior to the COVID-19 pandemic.",
        "abstract": "Understanding distribution pathogen causing acute febrile illness AFI important clinical management patient resourcepoor settings evaluated proportion AFI caused specific pathogen among outpatient Bangladesh May 2019March 2020 physician screened patient aged ≥2 year outpatient department four tertiary level public hospitals randomly enrolled patient measured fever ≥1004°F assessment onset within past 14 days Blood urine sample tested icddrb rapid diagnostic tests bacterial culture polymerase chain reaction PCR Acute convalescent sample sent Centers Disease Control Prevention USA Rickettsia Orientia RO Leptospira tests Among 690 patients 69 10 enteric fever Salmonella enterica serotype Typhi orSalmonella enterica serotype Paratyphi 51 74 Escherichia coli 28 41 dengue detected 441 patient tested RO 39 88 rickettsioses found 7 2 Leptospira case among 403 AFI patient tested Nine patient 1 hospitalized none died highest proportion enteric fever 15 36231 rickettsioses 14 25182 Rajshahi Dhaka dengue case 68 1928 RO affected older child young adult IQR 823 years detected frequently 2125 year agegroup 17 1270 RO likely found patient Rajshahi region Sylhet aOR 249 95 CI 085732 July December aOR 201 101523 history recent animal entry inside house aOR 20 09343 Gramnegative Enterobacteriaceae common bacterial infections dengue common viral infection among AFI patient Bangladeshi hospitals though geographic variability result help guide empiric outpatient AFI management",
        "mesh_terms": [
            "Bangladesh",
            "COVID-19",
            "Delivery of Health Care",
            "Dengue",
            "Fever",
            "Hospitals",
            "Humans",
            "Leptospira",
            "Outpatients",
            "Pandemics",
            "Rickettsia",
            "Rickettsia Infections",
            "Salmonella paratyphi A",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36048788/"
    },
    {
        "pmid": "35750070",
        "title": "The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study.",
        "abstract": "emergence increasingly antimicrobialresistant Salmonella enterica serovar Typhi S Typhi threatens undermine effective treatment control Understanding antimicrobial resistance Typhi emerging spreading crucial towards formulating effective control strategies genomic epidemiology study sequenced genome 3489 Typhi strain isolated prospective enteric fever surveillance study Nepal Bangladesh Pakistan India between 2014 2019 combined global collection 4169 Typhi genome sequence isolated 1905 2018 investigate temporal geographical pattern emergence spread antimicrobialresistant Typhi performed nonparametric phylodynamic analysis characterise change effective population size fluoroquinoloneresistant extensively drugresistant XDR azithromycinresistant Typhi time inferred timed phylogeny major Typhi sublineages used ancestral state reconstruction method estimate frequency timing international intercontinental transfers analysis revealed declining trend multidrug resistant typhoid south Asia except Pakistan XDR Typhi emerged 2016 rapidly replaced lessresistant strains Mutations quinoloneresistance determining region QRDR Typhi independently arisen propagated least 94 occasions nearly occurring south Asia Strains multiple QRDR mutations including triple mutant highlevel fluoroquinolone resistance increasing frequency displacing strain fewer mutations Strains containing acrB mutations conferring azithromycin resistance emerged Bangladesh around 2013 effective population size strain steadily increasing found evidence frequent international n138 intercontinental transfer n59 antimicrobialresistant Typhi followed local expansion replacement drugsusceptible clades Independent acquisition plasmid homoplastic mutation conferring antimicrobial resistance occurred repeatedly multiple lineage Typhi predominantly arising south Asia spreading regions Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Anti-Infective Agents",
            "Azithromycin",
            "Drug Resistance, Bacterial",
            "Fluoroquinolones",
            "Genomics",
            "Humans",
            "Prospective Studies",
            "Quinolones",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35750070/"
    },
    {
        "pmid": "35750069",
        "title": "Estimating typhoid incidence from community-based serosurveys: a multicohort study.",
        "abstract": "incidence enteric fever invasive bacterial infection caused typhoidal Salmonellae Salmonella enterica serovars Typhi Paratyphi largely unknown region without blood culture surveillance aim study evaluate whether new diagnostic serological marker typhoidal Salmonella reliably estimate populationlevel incidence collected longitudinal blood sample patient blood cultureconfirmed enteric fever enrolled surveillance study Bangladesh Nepal Pakistan Ghana 2016 2021 conducted crosssectional serosurveys catchment area surveillance site used ELISAs measure quantitative IgA IgG antibody response hemolysin E Typhi lipopolysaccharide used Bayesian hierarchical model fit twophase powerfunction decay model longitudinal antibody response among enteric fever case used joint distribution peak antibody titre decay rate estimate populationlevel incidence rate crosssectional serosurveys longitudinal antibody kinetics antigenisotypes similar across country vary clinical severity seroincidence typhoidal Salmonella infection among child younger 5 year ranged 58·5 per 100 personyears 95 CI 42·181·4 Dhaka Bangladesh 6·6 per 100 personyears 4·39·9 Kavrepalanchok Nepal followed rank order clinical incidence estimates approach described potential expand geographical scope typhoidal Salmonella surveillance generate incidence estimate comparable across geographical region time Bill  Melinda Gates Foundation Nepali Bengali Urdu translation abstract see Supplementary Materials section",
        "mesh_terms": [
            "Bangladesh",
            "Bayes Theorem",
            "Child",
            "Cross-Sectional Studies",
            "Humans",
            "Incidence",
            "Salmonella",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35750069/"
    },
    {
        "pmid": "35714648",
        "title": "Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.",
        "abstract": "Precise enteric fever disease burden data needed inform prevention control measures including use newly available typhoid vaccines established Surveillance Enteric Fever Asia Project SEAP inform strategies September 2016 September 2019 conducted prospective clinical surveillance Salmonella enterica serotype Typhi S Typhi Paratyphi S Paratyphi A B C health facility predetermined catchment area Dhaka Bangladesh Kathmandu Kavrepalanchok Nepal Karachi Pakistan Patients eligible inclusion outpatient 3 consecutive day fever last 7 days inpatient suspected confirmed enteric fever patient blood cultureconfirmed enteric fever hospital laboratory captured inpatient outpatient enrolment case laboratory network patient nontraumatic ileal perforation surgical care used hybrid surveillance model pairing facilitybased blood culture surveillance community survey healthcare use Blood culture performed enrolled patients calculated overall agespecific typhoid paratyphoid incidence estimate study site Adjusted estimate accounted sensitivity blood culture proportion eligible individual consented provided blood probability careseeking study facility influence wealth education careseeking additionally calculated incidence hospitalisation due typhoid paratyphoid total 34 747 patient enrolled across 23 facilitates six tertiary hospitals surgical ward two additional hospitals 15 laboratory network sites study period 34 303 blood culture performed enrolled patients 8705 26 positive typhoidal Salmonella Adjusted incidence rate enteric fever considered patient six tertiary hospitals Adjusted incidence Typhi expressed per 100 000 personyears 913 95 CI 7651095 Dhaka Nepal adjusted typhoid incidence rate 330 230480 Kathmandu 268 202362 Kavrepalanchok Pakistan adjusted incidence rate per hospital site 176 144216 103 85126 adjusted incidence rate paratyphoid of included case due Paratyphi A 128 107154 Bangladesh 46 3462 81 56118 Nepal sites 23 1929 1 11 Pakistan sites Adjusted incidence hospitalisation high across sites overall 2804 32 8705 patient blood cultureconfirmed enteric fever hospitalised Across diverse community three south Asian countries adjusted incidence exceeded threshold high burden enteric fever 100 per 100 000 personyears Incidence highest among children although age pattern differed across sites substantial disease burden identified highlight need control measures including improvement water sanitation infrastructure implementation typhoid vaccines Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Bangladesh",
            "Child",
            "Humans",
            "Incidence",
            "Nepal",
            "Pakistan",
            "Paratyphoid Fever",
            "Prospective Studies",
            "Salmonella",
            "Salmonella paratyphi A",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35714648/"
    },
    {
        "pmid": "35568365",
        "title": "Salmonellacidal antibody response to Salmonella enterica serovar Typhi in enteric fever and after vaccination with Vi capsular polysaccharide.",
        "abstract": "Serum salmonellacidal bactericidal antibody could used detect functional capacity antibody patient enteric fever typhoid vaccination Salmonellacidal antibody response measured colorimetric serum salmonellacidal assay 70 acute 11 convalescence serum patient infected Salmonella Typhi Paratyphi also 15 control 6 Vi capsular polysaccharide vaccinated volunteers sera Sera patient typhoid paratyphoid showed significant p  005 level salmonellacidal antibody titer 5499 ± 1085 5287 ± 1873 compared control 0133 ± 01 Moreover titer increased significantly p 005 serum collected 7 10 day 11 25 day fever titer 5357 ± 1192 7946 ± 2356 compared serum collected patient fever less 7 day 1364 ± 527 mean titer significantly p  005 decreased 55 ± 21 68 week onset illness Although low salmonellacidal titer 25 ± 15 23 ± 15 detected Vi CPS vaccine among human volunteers mean titer raised 15fold pre postvaccinated serum 016625 serum salmonellacidal antibody colorimetric salmonellacidal assay could used detect acute typhoidal case also monitor immune response typhoid vaccine",
        "mesh_terms": [
            "Antibodies, Bacterial",
            "Antibody Formation",
            "Humans",
            "Polysaccharides, Bacterial",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35568365/"
    },
    {
        "pmid": "35412603",
        "title": "Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, Bangladesh.",
        "abstract": "Typhoid fever contributes approximately 135 000 death annually Achievable improvement household water sanitation hygiene WASH combined vaccination using typhoid conjugate vaccine TCVs may effective preventive strategy However little known improved WASH vaccination interact lower risk typhoid total 61 654 urban Bangladeshi child aged 9 month 16 years residing 150 cluster baseline population 205 760 residents randomized 11 cluster Vitetanus toxoid TCV Japanese encephalitis JE vaccine Surveillance blood cultureconfirmed typhoid fever conducted 2 years Existing household WASH status assessed baseline Better Better using previously validated criteria reduction typhoid risk among resident associated living TCV clusters Better WASH households evaluated using mixedeffects Poisson regression models adjusted reduced risk typhoid among resident living cluster assigned TCV 55 95 confidence interval CI 4365 P  001 living Better WASH households regardless cluster 37 95 CI 2448 P  001 highest risk typhoid observed person living household Better WASH JE clusters comparison persons living household Better WASH TCV cluster adjusted reduced risk 71 95 CI 5980 P  001 Implementation TCV program combined achievable culturally acceptable household WASH practice independently associated significant reduction typhoid risk ISRCTN11643110",
        "mesh_terms": [
            "Humans",
            "Child",
            "Typhoid Fever",
            "Vaccines, Conjugate",
            "Sanitation",
            "Water",
            "Bangladesh",
            "Typhoid-Paratyphoid Vaccines",
            "Hygiene"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35412603/"
    },
    {
        "pmid": "35385827",
        "title": "Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.",
        "abstract": "Modest improvement household water sanitation hygiene WASH typhoid vaccination reduce typhoid risk endemic settings However empiric evaluation combined impact lacking total 62756 person residing 80 cluster Kolkata slum allocated randomly 11 either typhoid Vi polysaccharide ViPS vaccine hepatitis Hep A vaccine Surveillance conducted 2 year 2 year vaccination classified household better not better WASH calculated prevalence better WASH household cluster using previously validated criteria evaluated protection better household WASH better household WASH prevalence ViPS vaccination typhoid cluster member present baseline using Cox proportional hazard models Overall ViPS vaccination associated 55 P  0001 95 CI 3569 reduction typhoid risk similar regardless better WASH residence Living better WASH household associated typhoid risk reduction 31 P  016 95 CI 16 59 overall reduction 48 P  005 95 CI 1 73 Hep clusters 6 P  085 95 CI 82 51 ViPS clusters 57 P  005 95 CI 1578 population 2 year preceding trial finding demonstrate preventive association better household WASH nonViPS population but unexpectedly absence additional protection ViPS better WASH ViPS population analysis highlight importance assessing combination WASH conjunction typhoid vaccines implication evaluation newgeneration typhoid conjugate vaccines",
        "mesh_terms": [
            "Dietary Carbohydrates",
            "Humans",
            "Hygiene",
            "Poverty Areas",
            "Sanitation",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Water"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35385827/"
    },
    {
        "pmid": "35338009",
        "title": "Toward Typhoid Fever Elimination.",
        "abstract": "Salmonella enterica serotype Typhi S Typhi cause typhoid fever responsible estimated 9 million case 110000 death globally per annum Typhoid fever endemic area water sanitation hygiene WaSH infrastructure poor Serious complication develop approximately 1015 patient left untreated driven inadequate diagnostic method high burden antibioticresistant strains complicating clinical management ultimately prognosis Asymptomatic chronic carriers addition acutely infected patients contribute continued transmission shedding organism feces high morbidity mortality typhoid fever low middleincome country reinforce need integrated control approach may ultimately lead elimination disease 21supstsup century discus challenge faced pursuit typhoid fever elimination",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Humans",
            "Salmonella",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35338009/"
    },
    {
        "pmid": "35097222",
        "title": "Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol.",
        "abstract": "bBackgroundb Typhoid paratyphoid fever enteric fever common cause nonspecific febrile infection adult child presenting health care facility low resource setting South Asia 7day course single oral antimicrobial ciprofloxacin cefixime azithromycin commonly used treatment Increasing antimicrobial resistance threatens effectiveness treatment choices hypothesize combined treatment azithromycin active mainly intracellularly cefixime active mainly extracellularly better option treatment clinically suspected cultureconfirmed typhoid fever South Asia bMethodsb phase IV international multicenter multicountry comparative participantand observerblind 11 randomised clinical trial Patients suspected uncomplicated typhoid fever randomized one two interventions Arm A azithromycin 20mgkgday oral dose daily maximum 1gmday cefixime 20mgkgday oral dose two divided dos maximum 400mg bd 7 days Arm B azithromycin 20mgkgday oral dose daily max 1gmday 7 day cefiximematched placebo 7 days recruit 1500 patient across site Bangladesh India Nepal Pakistan assess whether treatment outcome better combination one week treatment one threemonths followup bDiscussionb Combined treatment may limit emergence resistance one component active resistant subpopulations covered antimicrobial activity combined treatment better single antimicrobial treatment important result patient across South Asia typhoid endemic areas bClinicaltrialsgov registrationb NCT04349826 16042020",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35097222/"
    },
    {
        "pmid": "34932777",
        "title": "Typhoid fever and COVID-19 pandemic in Nigeria: a call for coordinated action.",
        "abstract": "",
        "mesh_terms": [
            "COVID-19",
            "Humans",
            "Nigeria",
            "Pandemics",
            "SARS-CoV-2",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34932777/"
    },
    {
        "pmid": "34798028",
        "title": "Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study.",
        "abstract": "Enteric fever serious public health concern many lowincome middleincome countries Numerous data gap exist concerning epidemiology Salmonella enterica serotype Typhi S Typhi Salmonella enterica serotype Paratyphi S Paratyphi causative agent enteric fever aimed determine burden enteric fever three urban site Africa Asia multicentre populationbased study demographic census three urban site Africa Blantyre Malawi Asia Kathmandu Nepal Dhaka Bangladesh June 1 2016 Sept 25 2018 Households selected randomly demographic census Participants within geographical census area presenting study healthcare facility approached recruitment history fever 72 h later changed 48 h temperature 38·0°C higher Facilitybased passive surveillance done Nov 11 2016 Dec 31 2018 bloodculture collection febrile illness also communitybased serological survey obtain data Viantibody defined infections calculated crude incidence bloodcultureconfirmed Typhi Paratyphi infection calculated adjusted incidence seroincidence Typhi bloodcultureconfirmed infection 423 618 individual included demographic census contributing 626 219 personyears observation febrile illness surveillance 624 Typhi 108 Paratyphi isolates collected blood 12 082 febrile patients Multidrug resistance observed 44 Typhi isolates fluoroquinolone resistance 61 Typhi isolates Blantyre overall crude incidence bloodculture confirmed Typhi 58 case per 100 000 personyears observation 95 CI 4870 adjusted incidence 444 case per 100 000 personyears observation 95 credible interval CrI 347717 corresponding rate 74 95 CI 6287 1062 95 CrI 6831839 Kathmandu 161 95 CI 145179 1135 95 CrI 8981480 Dhaka Paratyphi found Blantyre overall crude incidence bloodcultureconfirmed Paratyphi infection 6 case per 100 000 personyears observation 95 CI 311 Kathmandu 42 95 CI 3452 Dhaka Seroconversion rate Typhi infection per 100 000 personyears estimated antiVi seroconversion episode serological surveillance 2505 episode 95 CI 16053727 Blantyre 7631 95 CI 59139691 Kathmandu 3256 95 CI 24324270 Dhaka High disease incidence rate antimicrobial resistance observed across three different transmission setting thus necessitate multiple intervention strategy achieve global control pathogens Wellcome Trust Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Census Tract",
            "Humans",
            "Malawi",
            "Nepal",
            "Population Density",
            "Population Surveillance",
            "Risk Factors",
            "Seasons",
            "Seroepidemiologic Studies",
            "Typhoid Fever",
            "Urban Population"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34798028/"
    },
    {
        "pmid": "34774362",
        "title": "Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.",
        "abstract": "CRM197 commonly used glycoconjugate carrier improves immunogenicity vaccines particularly infants Despite advantage diphtheria toxoid mutant low yields production inclusion bodies requirement specific growth condition limited breadth successful recombinant protein expression platform available expression evaluated Pichia pastoris production host using methanol inducible AOX1 promoter modified αmating factor signal peptide secretion supernatant Final purified yield 100 mg Lsup1sup culture achieved produced bioreactor equivalent productivity obtained bioprocesses using native Corynebacterium diphtheriae host Recombinant CRM197 purified ≥95 homogeneity showed expected endonuclease activity Furthermore mouse immunized Salmonella enterica serovar Typhi capsular Vi antigen conjugated recombinant CRM197 showed greater 5fold increase immune response Overall result demonstrate Pichia pastoris suitable expression host production high quality CRM197 vaccine applications",
        "mesh_terms": [
            "Animals",
            "Bacterial Proteins",
            "Mice",
            "Pichia",
            "Recombinant Proteins",
            "Saccharomycetales",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34774362/"
    },
    {
        "pmid": "34648506",
        "title": "Genetic diversity of Salmonella Paratyphi A isolated from enteric fever patients in Bangladesh from 2008 to 2018.",
        "abstract": "proportion enteric fever case caused Salmonella Paratyphi increasing may increase begin introduce typhoid conjugate vaccine TCVs numerous epidemiological genomic study conducted S Typhi limited data describing genomic epidemiology S Paratyphi especially endemic settings Bangladesh conducted whole genome sequencing WGS 67 S Paratyphi isolated 2008 2018 eight enteric disease surveillance site across Bangladesh performed detailed phylogenetic analysis sequence data incorporating sequence 242 previously sequenced S Paratyphi isolates global collection provided evidence lineage migration neighboring country South Asia data revealed majority Bangladeshi S Paratyphi isolates belonged dominant global lineage 672 remainder either lineage C 194 F 134 population structure relatively homogenous across country find significant lineage distribution study site inside outside Dhaka genomic data showed presence single point mutation gyrA gene either codon 83 87 associated decreased fluoroquinolone susceptibility Bangladeshi S Paratyphi isolates Notably identified pHCM2 like cryptic plasmid highly similar S Typhi plasmid circulating Bangladesh previously identified S Paratyphi organisms study demonstrates utility WGS monitor ongoing evolution emerging enteric pathogen Novel insight genetic structure S Paratyphi aid understanding regional global circulation pattern emerging pathogen provide framework future genomic surveillance studies",
        "mesh_terms": [
            "Bacterial Proteins",
            "Bangladesh",
            "Child, Preschool",
            "Female",
            "Genetic Variation",
            "Humans",
            "Infant",
            "Male",
            "Phylogeny",
            "Point Mutation",
            "Polymorphism, Single Nucleotide",
            "Salmonella paratyphi A",
            "Typhoid Fever",
            "Whole Genome Sequencing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34648506/"
    },
    {
        "pmid": "34619766",
        "title": "Typhoid fever in travellers: estimating the risk of acquisition by country.",
        "abstract": "Typhoid fever notifiable disease within Australia Although study endemic region give indication acquisition risk many country lack reliable data little known absolute relative risk Australian travellers combining notified case data travel statistic provided Australian Bureau Statistics aim study give indication risk typhoid acquisition among Australian travellers Australian typhoid notification 1st January 2010 30th June 2017 grouped country acquisition age category 15 ≥15 years Australian travel data used inform time risk incidence rate Australian typhoid notification pertaining country region acquisition Salmonella Paratyphi infections though notifiable excluded focus vaccine preventable illness Data New South Wales Victoria used examine incidence acquiring infection country birth COB traveller not Nine hundred twentythree case typhoid notified period review 96 acquired overseas greatest determinant risk travel destination country south Asia associated highest crude incidence rate 252 per 100 000 personyears particularly Bangladesh Younger age immigrant returning COB generally associated higher risk acquisition risk typhoid fever Australian traveller endemic region considerable Immigrants returning COB appear higher risk likely risk extends traveling dependents finding help clinician public health official plan advise pretravel vaccination strategy atrisk individual groups Additional sociodemographic data collection Australian typhoid notification would enhance surveillance differing international travel risk group leaving Australia",
        "mesh_terms": [
            "Adolescent",
            "Australia",
            "Humans",
            "Incidence",
            "Travel",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34619766/"
    },
    {
        "pmid": "34605467",
        "title": "Early and Rapid Detection of Typhoid Fever by Nested PCR in Blood.",
        "abstract": "Typhoid fever caused Salmonella typhi one major health problem developing country including Bangladesh Still blood culture gold standard method diagnosing typhoid fever method laborious requires several day detection rate low Failure early laboratory diagnosis often lead increased morbidity mortality study intended apply nested PCR blood early diagnosis typhoid fever cross sectional study blood sample collected 200 suspected typhoid fever patient attending Mymensingh Medical College Hospital Bangladesh Nested Polymerase Chain Reaction n PCR flagellin gene done blood samples time blood sample subjected culture lytic centrifugation method Culture positive isolates identified S typhi biochemical tests Among 200 blood samples 57 285 positive S typhi nested PCR blood culture positive S typhi 16 8 samples Among 57 PCR positive samples 15 263 sample culture positive S typhi rest 42 737 culture negative So culture negative case PCR used rapid diagnostic test diagnosing typhoid fever Considering time requirement PCR take one day whereas blood culture take 3 day confirm diagnosis",
        "mesh_terms": [
            "Cross-Sectional Studies",
            "Humans",
            "Polymerase Chain Reaction",
            "Salmonella typhi",
            "Sensitivity and Specificity",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34605467/"
    },
    {
        "pmid": "34586391",
        "title": "Salmonella Typhi Stool Shedding by Patients With Enteric Fever and Asymptomatic Chronic Carriers in an Endemic Urban Setting.",
        "abstract": "burden Salmonella enterica serotype Typhi S Typhi shedding stool contribution transmission endemic setting unknown passive surveillance S Typhi shedding seen convalescence 332 bacteremic patient typhoid although none persisted 1year followup Antivirulence capsule Viimmunoglobulin Ig G titer measured agestratified cohort serosurveillance participants Systematic stool sampling 303 participant high antiViIgG titer identified 1 asymptomatic carrier shedding finding suggest ongoing S Typhi transmission setting likely occur acute convalescent cases although better approach needed identify true chronic carrier community enable typhoid elimination",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Bacterial Shedding",
            "Carrier State",
            "Child",
            "Child, Preschool",
            "Endemic Diseases",
            "Feces",
            "Humans",
            "Infant",
            "Middle Aged",
            "Salmonella typhi",
            "Seroepidemiologic Studies",
            "Typhoid Fever",
            "Urban Population",
            "Virulence",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34586391/"
    },
    {
        "pmid": "34534310",
        "title": "Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi.",
        "abstract": "Antimicrobial therapy essential treatment enteric fever infection caused Salmonella serovars Typhi Paratyphi A However increase resistance key antimicrobial emergence MDR XDR Salmonella Typhi pose major threat efficacious outpatient treatments recently identified tebipenem oral carbapenem licensed use respiratory tract infection Japan potential alternative treatment MDRXDR Shigella spp Here aimed test vitro antibacterial efficacy drug MDR XDR typhoidal Salmonella determined vitro activity tebipenem timekill assay collection nonXDR XDR Salmonella Typhi Salmonella Paratyphi nonXDR isolated Nepal Bangladesh also tested efficacy tebipenem combination antimicrobials found XDR nonXDR Salmonella Typhi Salmonella Paratyphi susceptible tebipenem exhibiting low MICs killed within 824 h 24×MIC Additionally tebipenem demonstrated synergy two antimicrobial could efficiently induce bacterial killing Salmonella Paratyphi XDR Salmonella Typhi display vitro susceptibility oral carbapenem tebipenem synergistic activity antimicrobial may limit emergence resistance broadspectrum activity drug MDRXDR organism render tebipenem good candidate clinical trials",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Carbapenems",
            "Humans",
            "Salmonella",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34534310/"
    },
    {
        "pmid": "34528685",
        "title": "Typhoid Conjugate Vaccine: An Urgent Tool to Combat Typhoid and Tackle Antimicrobial Resistance.",
        "abstract": "Typhoid endemic many country South Asia subSaharan Africa high burden ageold preventable disease exacerbates constraint health system countries Currently patient treated effectively community outpatient departments rising antimicrobial resistance dearth novel antimicrobial horizon risk losing primary defense typhoid Extensively drugresistant Salmonella Typhi spreading azithromycin last oral drug continue treating typhoid community increasing azithromycin resistance emergence panoral drug resistant Salmonella Typhi imminent high burden typhoid also underlying cause unnecessary use antimicrobials addition implementing water sanitation hygiene intervention prevent typhoid imperative rapidly roll typhoid conjugate vaccine endemic countries reduce burden typhoid also help interrupt trend increasing antimicrobial resistance",
        "mesh_terms": [
            "Drug Resistance, Bacterial",
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34528685/"
    },
    {
        "pmid": "34515028",
        "title": "Multiple introductions of multidrug-resistant typhoid associated with acute infection and asymptomatic carriage, Kenya.",
        "abstract": "Understanding dynamic infection carriage typhoid endemic setting critical finding solution prevention control 3year casecontrol study investigated typhoid among child aged 16 year 4670 febrile case 8549 age matched controls living informal settlement Nairobi Kenya 148 iSi Typhi isolates case 95 control stool culture identified carriage frequency 1  Wholegenome sequencing showed 97 case 88 control genotype 431 Haplotype 58 majority 76 88 multidrugresistant strain three sublineages H58 genotype East Africa 1 EA1 EA2 EA3 sequence case carrier intermingled high rate multidrugresistant H58 iSi Typhi close phylogenetic relationship case controls provides evidence role carrier reservoir community spread typhoid setting National Institutes Health R01AI099525 Wellcome Trust 106158Z14Z European Commission TyphiNET 845681 National Institute Health Research NIHR Bill Melinda Gates Foundation OPP1175797",
        "mesh_terms": [
            "Adolescent",
            "Anti-Bacterial Agents",
            "Carrier State",
            "Case-Control Studies",
            "Child",
            "Child, Preschool",
            "Drug Resistance, Multiple, Bacterial",
            "Female",
            "Humans",
            "Infant",
            "Kenya",
            "Male",
            "Phylogeny",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34515028/"
    },
    {
        "pmid": "34428309",
        "title": "A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data.",
        "abstract": "Decisions typhoid fever prevention control based estimate typhoid incidence uncertainty Lack specific clinical diagnostic criteria poorly sensitive diagnostic tests scarcity accurate complete datasets contribute difficulty calculating agespecific populationlevel typhoid incidence Using data Strategic Typhoid Alliance across Africa Asia program integrated demographic censuses healthcare utilization surveys facilitybased surveillance serological surveillance Malawi Nepal Bangladesh account underdetection cases developed Bayesian approach adjusts count reported bloodculturepositive case blood culture detection blood culture collection healthcare seekingand factor vary agewhile combining information prior published studies validated model using simulated data ratio observed adjusted incidence rate 77 95 credible interval CrI 60124 Malawi 144 95 CrI 93249 Nepal 70 95 CrI 5692 Bangladesh probability blood culture collection led largest adjustment Malawi probability seeking healthcare contributed Nepal Bangladesh adjustment factor varied age Adjusted incidence rate within seroincidence rate limit typhoid infection Estimates bloodcultureconfirmed typhoid fever without adjustment result considerable underestimation true incidence typhoid fever approach allows phase reporting process synthesized estimate adjusted incidence typhoid fever correctly characterizing uncertainty inform decisionmaking typhoid prevention control",
        "mesh_terms": [
            "Bayes Theorem",
            "Humans",
            "Incidence",
            "Malawi",
            "Nepal",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34428309/"
    },
    {
        "pmid": "34384540",
        "title": "Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.",
        "abstract": "Typhoid fever remains major cause morbidity mortality lowincome middleincome countries Vitetanus toxoid conjugate vaccine ViTT recommended implementation highburden countries little evidence ability protect clinical typhoid settings participantmasked observermasked clusterrandomised trial preceded safety pilot phase urban endemic setting Dhaka Bangladesh 150 clusters approximately 1350 residents randomly assigned 11 either ViTT SA 14142 Japanese encephalitis JE vaccine Children aged 9 month less 16 year invited via parent guardian receive single parenteral dose vaccine according cluster residence study population followed average 17·1 months Total overall protection ViTT blood cultureconfirmed typhoid primary endpoint assessed intentiontotreat population vaccinee resident clusters subset approximately 4800 participant assessed active surveillance adverse events trial registered wwwisrctncom ISRCTN11643110 41 344 child vaccinated AprilMay 2018 another 20 412 child vaccinated catchup vaccination campaign September December 2018 April May 2019 incidence typhoid fever cases per 100 000 personyears 635 JE vaccinee 96 ViTT vaccinee total ViTT protection 85 97·5 CI 76 91 p0·0001 Total vaccine protection consistent different age groups including child vaccinated age 2 year 81 95 CI 39 94 p0·0052 incidence 213 among resident JE cluster 93 ViTT cluster overall ViTT protection 57 97·5 CI 43 68 p0·0001 observe significant indirect vaccine protection ViTT 19 95 CI 12 41 p0·20 vaccine well tolerated serious adverse event judged vaccinerelated observed ViTT provided protection typhoid fever child vaccinated 9 month less 16 years Longerterm followup needed assess duration protection need booster doses study funded Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Adolescent",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Developing Countries",
            "Encephalitis, Japanese",
            "Female",
            "Humans",
            "Infant",
            "Japanese Encephalitis Vaccines",
            "Male",
            "Polysaccharides, Bacterial",
            "Salmonella typhi",
            "Tetanus Toxoid",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34384540/"
    },
    {
        "pmid": "34351258",
        "title": "Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014-2019: a cross-sectional analytical study.",
        "abstract": "bIntroductionb Enteric fever caused iSalmonella entericai serovars Typhi Paratyphi frequently present acute undifferentiated febrile illness returning travellers requiring timely empirical antibioticsbGap Statementb Determining empirical antibiotic prescribe enteric fever requires uptodate knowledge susceptibility patternsbAimb characterising factor associated antimicrobial resistance case iSi Typhi iSi Paratyphi imported England aim guide effective empirical treatmentbMethodologyb English isolates iSi Typhi iSi Paratyphi 20142019 underwent antimicrobial susceptibility testing result compared previous survey London 20052012 Risk factor antimicrobial resistance analysed logistic regression model predict adjusted odds ratio aOR resistance individual antibiotic multidrug resistancebResultsb identified 1088 case iSi Typhi 729 iSi Paratyphi A 93 iSi Paratyphi B one iSi Paratyphi C total 93  imported Overall 90  iSi Typhi 97  iSi Paratyphi isolates resistant ciprofloxacin 26  iSi Typhi multidrug resistant ciprofloxacin amoxicillin cotrimoxazole chloramphenicol MDRFQ isolates 4  iSi Typhi showed extended drug resistance XDR phenotype MDRFQ plus resistance thirdgeneration cephalosporins case XDR rising sharply recent year none 2017 one 2017 six 2018 32 2019 iSi Typhi isolates resistance ciprofloxacin associated travel Pakistan aOR320 95  CI 154664 India aOR218 95  CI 116412 Bangladesh aOR62 95  CI 28136 compared travel elsewhere adjusting rising prevalence resistance time MDRFQ resistance iSi Typhi isolates associated travel Pakistan aOR35 95  CI 2452 less likely travel India aOR007 95  CI 004015 compared travel elsewhere XDR case imported Pakistan isolate resistant azithromycin Comparison 20052012 London survey indicates substantial increase prevalence resistance iSi Typhi isolates ciprofloxacin associated travel Pakistan from 7998  Africa from 1260 bConclusionb Thirdgeneration cephalosporin azithromycin remain appropriate choice empirical treatment enteric fever returning traveller UK endemic countries except Pakistan XDR represents significant risk",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Anti-Bacterial Agents",
            "Child",
            "Child, Preschool",
            "Clinical Decision-Making",
            "Cross-Sectional Studies",
            "Disease Management",
            "Drug Resistance, Bacterial",
            "England",
            "Female",
            "Health Care Surveys",
            "History, 21st Century",
            "Humans",
            "Infant",
            "Infant, Newborn",
            "Male",
            "Middle Aged",
            "Public Health Surveillance",
            "Travel",
            "Travel-Related Illness",
            "Typhoid Fever",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34351258/"
    },
    {
        "pmid": "34341020",
        "title": "The genomic epidemiology of multi-drug resistant invasive non-typhoidal <i>Salmonella</i> in selected sub-Saharan African countries.",
        "abstract": "Invasive nontyphoidal iSalmonellai iNTS one leading cause bacteraemia subSaharan Africa aimed provide better understanding genetic characteristic transmission pattern associated multidrug resistant MDR iNTS serovars across continent total 166 iNTS isolates collected multicentre surveillance 10 African country 20102014 fever study Ghana 20072009 genome sequenced investigate geographical distribution antimicrobial genetic determinant population structure iNTS serotypesgenotypes Phylogenetic analysis conducted context existing genomic framework various iNTS serovars Populationbased incidence MDRiNTS disease estimated study site iSalmonellai Typhimurium sequencetype ST 313 iSalmonellai Enteritidis ST11 predominant exhibited high frequency MDR iSalmonellai Dublin ST10 identified West Africa only Mutations igyrAi gene fluoroquinolone resistance identified iSi Enteritidis iSi Typhimurium Ghana ST313 isolate carrying iblaisubCTXM15sub found Kenya International transmission MDR ST313 lineage II MDR ST11 West African clade observed Ghana neighbouring West African countries incidence MDRiNTS disease exceeded 100100 000 personyearsofobservation child aged 5 year several West African countries identified circulation multiple MDR iNTS serovar STs sampled subSaharan African countries Investment development deployment iNTS vaccine coupled intensified antimicrobial resistance surveillance essential limit impact pathogen Africa",
        "mesh_terms": [
            "Child",
            "Genomics",
            "Humans",
            "Kenya",
            "Pharmaceutical Preparations",
            "Phylogeny",
            "Salmonella typhimurium"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34341020/"
    },
    {
        "pmid": "34297950",
        "title": "Use of the typhoid conjugate vaccine in endemic settings.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34297950/"
    },
    {
        "pmid": "34280530",
        "title": "Early diagnosis of kala-azar in Bangladesh: Findings from a population based mixed methods research informing the post-elimination era.",
        "abstract": "Global annual report visceral leishmaniasis kalaazar black fever reduced 200000 case 2012 23804 2015 India Bangladesh Nepal reported 80 global case 2012 39 2015 sought identify major amenable barrier early diagnosis kalaazar peripheral area Mymensingh district area Bangladesh highly endemic kalaazar conducted sequential exploratory mixed method research Qualitative data first derived indepth interview focus group discussion among 29 patient diagnosed kalaazar families neighbours Preliminary result qualitative analysis used design structured questionnaire administered collect data process leading diagnosis kalaazar 102 patients Qualitative quantitative data integrated consistent chronology kalaazar patient seeking care study conducted September 2011 May 2012 Fulbaria Gaffargaon subdistricts Mymensingh median delay fever onset confirmatory diagnosis kalaazar 60 days 38 case diagnosed within 30 days Public health facility Gaffargaon subdistrict achieved high proportion early diagnosis Individual barrier early diagnosis low awareness symptom treatment facilities poverty traditional beliefs factor remoteness health care centres wet season transport difficulty misdiagnosis typhoid limited availability rK39 testing community level inclusion splenomegaly case definition Targeted community awareness campaign appropriate underprivileged community increase care seeking consequently diagnosis Improved diagnostic guideline strong referral chain kalaazar accelerate diagnosis step contribute significantly National Kalaazar Elimination Program Bangladesh especially postelimination era",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Early Diagnosis",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Patient Acceptance of Health Care",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34280530/"
    },
    {
        "pmid": "34273168",
        "title": "Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.",
        "abstract": "Vaccine herd protection extension defense conferred immunization beyond vaccinated unvaccinated person population well enhancement protection among vaccinated due vaccination surrounding population Vaccine herd protection traditionally inferred observation disease trend inclusion vaccine national immunization schedules Rather awaiting outcome widescale vaccine deployment earlierstage evaluation vaccine herd protection trial mass vaccination project could help inform policy decision potential vaccine introduction describe components influencing factors implication vaccine herd protection discus various method assessing herd protection using example cholera typhoid vaccine studies",
        "mesh_terms": [
            "Administration, Oral",
            "Cholera",
            "Cholera Vaccines",
            "Humans",
            "Immunity, Herd",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination",
            "Vaccine Efficacy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34273168/"
    },
    {
        "pmid": "34226462",
        "title": "Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh.",
        "abstract": "Multidrug resistant Typhoid fever resistant previously used chloramphenicol ampicillin amoxicillin trimethoprimsulfamethoxazole commonly described South East Asia region recent report suggests salmonella typhi reduced response fluoroquinolones nalidixic acidresistant optimum treatment protocol type serovar established study compared different antimicrobial regimen treatment uncomplicated typhoid fever conducted medicine ward Dhaka Medical College Hospital DMCH outdoor setting private practice Dhaka metropolitan city Mymensingh Sylhet town January 2017 December 2017 Bangladeshi adult uncomplicated typhoid fever included openlabel randomized controlled trial Ciprofloxacin 20mgkg body weightday 14 days azithromycin 20mgkgday 14 days Cefixime 16mgkgday 14 days compared 81 enrolled patients 62 eligible analysis 61 S enterica serovar Typhi 1 Salmonella enterica serovar paratyphi A enterica serovar Typhi isolates 887 5562 MDR 935 5862 nalidixic acid resistant NAR clinical cure rate 62 1321 ciprofloxacin 71 1521 Cefixime 85 1720 azithromycin p0053 mean 95 confidence interval CI fever clearance time patient treated azithromycin 58 day 51 65 days shorter patient treated cefixime 71 day 62 81 days ciprofloxacin 82 day 72 92 days p0001 three antibiotic well tolerated 7day course azithromycin successfully used uncomplicated typhoid fever due isolates MDR enterica serovar Typhi",
        "mesh_terms": [
            "Adult",
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Bangladesh",
            "Cefixime",
            "Ciprofloxacin",
            "Humans",
            "Microbial Sensitivity Tests",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34226462/"
    },
    {
        "pmid": "34226458",
        "title": "Diagnostic Value of Clinical Profile and Proposed a Clinical Diagnostic Criterion of Enteric Fever.",
        "abstract": "Enteric fever common bacterial infection tropic endemic Bangladesh volatile manifestation enteric fever construct disease true diagnostic confrontation limited current objective data value individual clinical feature enteric fever diagnosis enteric fever aim study analysis clinical feature also proposed clinical diagnostic criterion enteric fever among adult Bangladesh crosssectional comparative study performed among fifty confirmed enteric fever hundred non enteric febrile adult patient Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh January 2015 December 2015 Purposive sampling technique implied convenience study study history step ladder fever diarrhoea relative bradycardia ceacal gurgle abdominal distension proved powerful marker enteric fever high specificity 1000 900 950 920 950 respectively Tender right iliac fossa RIF coated tongue hepatomegaly moderately powerful 860 880 890 specificity respectively Positive predictive value PPV highest step ladder fever 100 negative predictive value NPV highest headache 925 Highest sensitivity PPV NPV found relative bradycardia tender RIF sign good specificity Regarding accuracy highest step ladder fever 913 relative bradycardia 94 tender RIF 87 coated tongue 82 splenomegaly 84 Therefore clinical diagnostic criterion submitted diagnostic accuracy 70 taken deliberation Major criterion considered step ladder fever relative bradycardia tender RIF diagnostic accuracy 910 940 870 respectively Minor criterion included splenomegaly diarrhoea coated tongue ceacal gurgle chill diagnostic accuracy 850 850 820 760 720 respectively amalgamation various major minor criterion final diagnostic criterion submitted accuracy 600 conclusion clinical profile enteric fever culture proven patient view highlight predictive value feature would help general practitioner diagnosis empiric treatment",
        "mesh_terms": [
            "Adult",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Fever",
            "Humans",
            "Sensitivity and Specificity",
            "Splenomegaly",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34226458/"
    },
    {
        "pmid": "34223059",
        "title": "The emergence of azithromycin-resistant <i>Salmonella</i> Typhi in Nepal.",
        "abstract": "Typhoid fever remains significant cause morbidity mortality Asia Africa emergence azithromycin resistance South Asia concerning azithromycin one last effective oral drug treating typhoid describe molecular mechanism phylogenetics azithromycinresistant AzithsupRsup iSalmonellai Typhi isolates Patan Hospital Kathmandu Nepal Wholegenome sequence three AzithsupRsup iSi Typhi isolates MIC 256 mgL analysed compared global collection investigate azithromycin resistance mechanism phylogenetic structure Clinical information reported one three patient infected AzithsupRsup iSi Typhi three AzithsupRsup isolates belonged H58 lineage genetically identical distantly related contemporaneous iSi Typhi Nepal AzithsupRsup iSi Typhi recently described Bangladesh Azithromycin resistance mediated nonsynonymous mutation iacrBi gene R717L three AzithsupRsup isolates showed reduced susceptibility ciprofloxacin double mutation igyrAi S83F D87G susceptible ampicillin chloramphenicol cotrimoxazole Clinical information one patient suggested nonresponse azithromycin treatment first molecular description AzithsupRsup iSi Typhi Nepal organism showed phylogenetic link AzithsupRsup iSi Typhi Bangladesh data suggest increasing use azithromycin may pose strong selective pressure driving emergence AzithsupRsup iSi Typhi South Asia investigation needed evaluate treatment response azithromycin predict evolutionary trajectories track transmission organisms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34223059/"
    },
    {
        "pmid": "33956650",
        "title": "Detection of Salmonella genes in stool samples of children aged 5 years and younger in urban and rural areas of Bangladesh.",
        "abstract": "Typhoid incidence child higher urban area rural area Bangladesh study examined whether healthy urban child harboured higher level Salmonella gene healthy rural children Stool sample 140 child studied 70 rural area 70 urban metropolitan areas stool sample urban child contained Salmonella gene median 4 IQR 34 rural child median 3 IQR 34 suggests urban Bangladeshi child Salmonella gene gut rural children Especially 12 month age Salmonella gene prevalence urban child unique Salmonella gene median 4 IQR 45 rural child age group median 3 IQR 254 also found Salmonella gene urban child drank tap water median 4 IQR 35 rural child whose water source tube well water median 3 IQR 24 boiled pond water median 3 IQR 335 However significant difference Salmonella gene urban child drank tapwater child whose water source tube well median 4 IQR 34 data suggest urban environment including drinking water supply system increase likelihood healthy child urban area harbouring potentially pathogenic Salmonella organism gut found rural healthy children",
        "mesh_terms": [
            "Bangladesh",
            "Child, Preschool",
            "Feces",
            "Female",
            "Humans",
            "Infant",
            "Infant, Newborn",
            "Male",
            "Rural Population",
            "Salmonella typhi",
            "Typhoid Fever",
            "Urban Population",
            "Water Supply"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33956650/"
    },
    {
        "pmid": "33838068",
        "title": "Genotypic and phenotypic profiles of antibiotic-resistant bacteria isolated from hospitalised patients in Bangladesh.",
        "abstract": "Characterisation resistance phenotype genotype crucial understanding burden transmission antimicrobial resistance AMR study aim determine spectrum AMR associated gene encoding aminoglycoside macrolide βlactam class antimicrobial bacteria isolated hospitalised patient Bangladesh 430 bacterial isolates patient respiratory intestinal wound infection typhoid fever presenting clinical care 2015 2019 examined included Escherichia coli n  85 Staphylococcus aureus n  84 Salmonella typhi n  82 Klebsiella pneumoniae n  42 Streptococcus pneumoniae n  36 coagulasenegative staphylococci n  28 Enterococcus faecalis n  27 Pseudomonas aeruginosa n  26 Acinetobacter baumannii n  20 Reconfirmation clinical isolates antimicrobial susceptibility test performed PCR amplification using resistance genespecific primer done amplified product confirmed Sanger sequencing 53 isolates multidrugresistant MDR including 97 Escherichia coli yearwise gradual increase MDR isolates 2015 2018 almost twofold increase number MDR strain isolated 2019 P  000058 Among 5 extendedspectrum βlactamases investigated CTXM1 prevalent 63 followed NDM1 22 Escherichia coli major reservoir genes ermB 55 aac6Ib 35 gene frequently detected macrolide aminoglycoside resistance genes respectively MDR pathogen highly prevalent hospital setting Bangladesh",
        "mesh_terms": [
            "Acinetobacter baumannii",
            "Bangladesh",
            "Drug Resistance, Multiple, Bacterial",
            "Enterococcus faecalis",
            "Escherichia coli",
            "Genotype",
            "Humans",
            "Inpatients",
            "Klebsiella pneumoniae",
            "Phenotype",
            "Pseudomonas aeruginosa",
            "Salmonella typhi",
            "Staphylococcus aureus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33838068/"
    },
    {
        "pmid": "33808924",
        "title": "Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics.",
        "abstract": "Typhoid fever remains significant health problem subSaharan Africa incidence rate 100 case per 100000 personyears observation Despite prequalification safe effective typhoid conjugate vaccine TCV uncertainty remain around future demand Reallife effectiveness data inform public health program impact TCVs reducing typhoidrelated mortality morbidity African setting may help encourage introduction TCVs highburden settings Here describe clusterrandomized trial investigate populationlevel protection TYPBARTCVsup®sup Vipolysaccharide conjugated tetanustoxoid protein carrier ViTT bloodcultureconfirmed typhoid fever synthesis health economic evidence inform policy decisions total 80 geographically distinct cluster delineated within Agogo district Asante Akim region Ghana Clusters randomized intervention arm receiving ViTT control arm receiving meningococcal conjugate vaccine primary study endpoint total protection ViTT bloodcultureconfirmed typhoid fever Total direct indirect protection measured secondary outcomes Bloodculturebased enhanced surveillance enables estimation incidence rate intervention control clusters Evaluation realworld impact TCVs evidence synthesis improve uptake prequalifiedlicensed safe effective typhoid vaccine public health program high burden settings trial registered Pan African Clinical Trial Registry accessible Pan African Clinical Trials Registry ID PACTR202011804563392",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33808924/"
    },
    {
        "pmid": "33755582",
        "title": "Case Report: Typhoid Fever Complicated by Ileal Perforation in an Urban Slum of Dhaka, Bangladesh.",
        "abstract": "Intestinal perforation one dangerous complication typhoid fever demand urgent hospitalization diagnosis surgical management reduce morbidity prevent mortality Here report case typhoidal intestinal perforation 19 yearold young man detected passive surveillance clusterrandomized trial Vitetanus toxoid conjugate vaccine Typhoid Vaccine Acceleration Consortium TyVAC urban slum area Mirpur Dhaka Bangladesh patient presented highgrade fever lower abdominal pain vomiting admitted healthcare facility Physical examination preoperative investigation patient suggested presumptive diagnosis intestinal perforation patient transferred tertiarylevel hospital surgical management positive blood culture intraoperative findings histopathology intestinal biopsy confirmed ileal perforation due typhoid fever case report highlight need prompt diagnosis appropriate pre postoperative management patient appear symptom typhoidal intestinal perforation report demonstrates importance systematic surveillance proper evaluation determine true incidence rate typhoid fever intestinal perforation Bangladesh",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Ileal Diseases",
            "Intestinal Perforation",
            "Male",
            "Poverty Areas",
            "Randomized Controlled Trials as Topic",
            "Typhoid Fever",
            "Urban Population",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33755582/"
    },
    {
        "pmid": "33704480",
        "title": "ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi.",
        "abstract": "approximately 300 case enteric fever reported annually England Wales imported infections Clinical management enteric fever remains challenge emergence ESBLproducing strains especially XDR Salmonella Typhi Sindh Pakistan strain S Typhi Salmonella Paratyphi isolated case presenting symptom enteric fever England Wales 1 April 2014 31 March 2020 characterized using WGS Antibiotic susceptibility testing performed using agar dilution method ESBL strain contributed 69 case enteric fever S Typhi n  68 S Paratyphi n  1 68 imported Pakistan n  64 Iraq n  2 Bangladesh n  1 India n  1 Ages ranged 1 56 years 3669 52 children 52 female duration hospital stay ranged 1 23 days ESBL phenotype conferred presence blaCTXM15 S Typhi n  67 S Paratyphi n  1 blaCTXM55 S Typhi n  1 IncY plasmid harbouring blaCTXM15 qnr detected 56 strain Pakistan IncY plasmid absent remaining strain evidence 4 kb ISEcplblaCTXM15tnp gene cassette insertion chromosome one three integration points Chromosomal integration blaCTXM15 within XDR Sindh strain may lead maintenance resistance absence antibiotic selection pressure Empirical treatment case complicated enteric fever returning Pakistan henceforth include carbapenem",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Chromosomes",
            "England",
            "Female",
            "Humans",
            "India",
            "Infant",
            "Middle Aged",
            "Pakistan",
            "Salmonella typhi",
            "Typhoid Fever",
            "Wales",
            "Young Adult",
            "beta-Lactamases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33704480/"
    },
    {
        "pmid": "33637488",
        "title": "Enteric fever.",
        "abstract": "",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Dengue",
            "Diagnosis, Differential",
            "Doxycycline",
            "Drug Resistance, Bacterial",
            "Endemic Diseases",
            "Humans",
            "Malaria",
            "Paratyphoid Fever",
            "Polysaccharides, Bacterial",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Travel-Related Illness",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33637488/"
    },
    {
        "pmid": "33593966",
        "title": "Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal <i>Salmonella</i>.",
        "abstract": "rising prevalence antimicrobial resistance iSalmonella entericai serovars Typhi Paratyphi A causative agent typhoid paratyphoid led fear untreatable infections specific concern emerging resistance azithromycin remaining oral drug treat extensively drug resistant XDR typhoid Since first report azithromycin resistance Bangladesh 2019 case reported Nepal India Pakistan genetic basis resistance single point mutation efflux pump AcrB R717QL Here report 38 additional case azithromycinresistant AzmR iSalmonellai Typhi Paratyphi isolated Bangladesh 2016 2018 Using genomic analysis 56 AzmR isolates South Asia AcrBR717QL confirm mutation spontaneously emerged different iSalmonellai Typhi Paratyphi genotypes largest cluster AzmR Typhi belonged genotype 4311 Bayesian analysis predicts mutation emerged sometime 2010 travelrelated Typhi isolate AcrBR717Q belonging 4311 isolated United Kingdom increasing fear global spread realtime detection AcrBR717QL developed extractionfree rapid lowcost mismatch amplification mutation assay MAMA Validation MAMA using 113 AzmR nonAzmR isolates yielded 98 specificity sensitivity versus phenotypic wholegenome sequencing assay currently used azithromycin resistance detection increasing azithromycin use AcrBR717QL likely acquired XDR strains proposed tool active detection surveillance mutation may detect panoral drug resistance early giving u window intervenebIMPORTANCEb early 1900s mortality ∼30 typhoid paratyphoid ravaged part world improved water sanitation hygiene resourcerich country advent antimicrobials mortality dwindled 1 Today burden rest disproportionately South Asia primary mean combatting disease antimicrobials However prevalence antimicrobial resistance rising and 2016 extensively drug resistant Typhi strain triggered ongoing outbreak Pakistan leaving one oral drug azithromycin treat it Since description emergence azithromycin resistance conferred point mutation iacrBi AcrBR717QL 2019 increasing number reports Using genomics Bayesian analysis illustrate mutation emerged approximately 2010 spontaneously arisen multiple times Emergence panoral drug resistant iSalmonellai Typhi imminent developed lowcost rapid PCR tool facilitate realtime detection prevention policies",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Bayes Theorem",
            "Drug Resistance, Bacterial",
            "Genotype",
            "Humans",
            "Microbial Sensitivity Tests",
            "Point Mutation",
            "Salmonella enterica",
            "Salmonella typhi",
            "Whole Genome Sequencing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33593966/"
    },
    {
        "pmid": "33515460",
        "title": "Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India.",
        "abstract": "emergence spread antimicrobial resistance AMR pose major threat effective treatment control typhoid fever ongoing outbreak extensively drugresistant Salmonella Typhi S Typhi Pakistan left azithromycin remaining broadly efficacious oral antimicrobial typhoid South Asia Ominously azithromycinresistant S Typhi organism subsequently reported Bangladesh Pakistan Nepal Here aimed understand molecular basis AMR 66 S Typhi organism isolated crosssectional study performed suburb Chandigarh Northern India using wholegenome sequencing phylogenetic analysis identified 7 S Typhi organism R717Q mutation acrB gene recently found confer resistance azithromycin Bangladesh Six seven azithromycinresistant S Typhi isolates also exhibited triple mutation gyrA S83F D87N parC S80I gene resistant ciprofloxacin contemporary ciprofloxacinazithromycinresistant isolates phylogenetically distinct reported Bangladesh Pakistan Nepal independent emergence azithromycinresistant typhoid Northern India reflects emerging broader problem across South Asia illustrates urgent need introduction typhoid conjugate vaccine region",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Drug Resistance, Bacterial",
            "Genotype",
            "Humans",
            "India",
            "Microbial Sensitivity Tests",
            "Nepal",
            "Pakistan",
            "Phylogeny",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33515460/"
    },
    {
        "pmid": "32934993",
        "title": "Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia.",
        "abstract": "Electronic data capture system EDCs potential achieve efficiency quality collection multisite data quantify volume time accuracy cost EDC using largescale census data STRATAA consortium comprehensive programme assessing population dynamic epidemiology typhoid fever Malawi Nepal Bangladesh inform vaccine public health interventions census form developed structured iterative process implemented using Open Data Kit Collect running Androidbased tablets Data uploaded Open Data Kit Aggregate autosynced MySQLdefined database nightly Data backedup daily three site centrally autoreported weekly Precensus materials cost estimated Demographics 308348 individual 80851 household recorded within average 147 week range 1316 using 65 fieldworkers Overall 217 error 95 confidence interval 214 220 per 10000 data point found 130 95 confidence interval 126 135 245 95 confidence interval 241 249 error numeric text field respectively value meet standard quality threshold 50 error per 10000 data points EDCs total variable cost estimated US1379182 per site conclusion EDC robust allowing timely highvolume accurate data collection could adopted similar epidemiological settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32934993/"
    },
    {
        "pmid": "33258942",
        "title": "Hospitalization of Pediatric Enteric Fever Cases, Dhaka, Bangladesh, 2017-2019: Incidence and Risk Factors.",
        "abstract": "Enteric fever cause substantial morbidity mortality low middleincome countries Here analyzed Surveillance Enteric Fever Asia Project SEAP data estimate burden enteric fever hospitalization among child aged 15 year identify risk factor hospitalization Bangladesh SEAP used hospital surveillance paired communitybased healthcare utilization assessment SEAP hospital surveillance blood obtained culture child aged 15 year ≥3 day fever hospital catchment area healthcare utilization survey HCUS conducted estimate proportion febrile child hospitalized study hospitals analyzed hospital surveillance HCUS data estimate health careadjusted incidence enteric fever hospitalization conducted univariable multivariable logistic regressions July 2017 June 2019 2243 laboratoryconfirmed enteric fever case detected 2 study hospitals 673 30 hospitalized health careadjusted incidence enteric fever hospitalization among child 15 year old 303100 000 childrenyear 95 confidence interval CI 293313 Salmonella Typhi contributed enteric fever hospitalization incidence 277100 000 childrenyear 95 CI 267287 incidence highest among child aged 2 5 year 552100 000 childrenyear 95 CI 522583 followed aged 2 year 316100 000 childrenyear 95 CI 288344 Factors independently associated enteric fever hospitalization included fever duration diarrhea vomiting abdominal pain leukocytopenia estimated high burden hospitalization due enteric fever among child aged 5 year Bangladesh introduction typhoid conjugate vaccine would protect child typhoid avert typhoid hospitalizations",
        "mesh_terms": [
            "Adolescent",
            "Asia",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Hospitalization",
            "Humans",
            "Incidence",
            "Infant",
            "Risk Factors",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258942/"
    },
    {
        "pmid": "33258940",
        "title": "Typhoid and Paratyphoid Cost of Illness in Bangladesh: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II.",
        "abstract": "conducted cost illness study assess economic burden pediatric enteric fever typhoid paratyphoid Bangladesh Results inform public health policy prevent enteric fever study conducted 2 pediatric health facility Dhaka patient caregivers perspective administered questionnaire cost incurred illness onset survey date caregiver patient blood culture positive case enrollment 6 week later estimate direct medical direct nonmedical indirect costs perspective health care provider collected data quantity price resource used 2 hospital estimate direct medical economic cost treat case enteric fever collected cost Bangladeshi taka converted 2018 US dollars multiplied unit cost per procedure frequency procedure surveillance case cohort calculate average cost per case Among 1772 patient collected information median cost illness per case enteric fever patient caregiver perspective US 6403 IQR US 3390 17348 Median direct medical nonmedical cost per case 3 annual labor income across sample perspective healthcare provider average direct medical cost per case US 5864 range US 3725 Hospital B US 7327 Hospital A result show substantial economic burden enteric fever Bangladesh higher cost patient receiving inpatient care antimicrobial resistance increase globally cost illness could increase due expensive potent drug required treatment",
        "mesh_terms": [
            "Asia",
            "Bangladesh",
            "Child",
            "Cost of Illness",
            "Health Facilities",
            "Humans",
            "Paratyphoid Fever",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258940/"
    },
    {
        "pmid": "33258939",
        "title": "Utilization of Blood Culture in South Asia for the Diagnosis and Treatment of Febrile Illness.",
        "abstract": "Blood culture current standard diagnosing bacteremic illnesses yet clear physician many low middleincome country utilize blood culture diagnostic purpose inform treatment decisions screened suspected enteric fever case 6 hospital Bangladesh Nepal Pakistan enrolled patient blood culture prescribed treating physician used generalized additive regression model analyze probability receiving blood culture age linear regression model analyze change month proportion febrile case prescribed blood culture compared burden febrile illness stratified hospital used logistic regression analyze predictor receiving antibiotic empirically descriptively reviewed change antibiotic therapy susceptibility pattern coverage stratified country screened 30 809 outpatient resulting 1819 enteric fever cases 1935 additional case enrolled hospital locations Younger outpatient less likely receive blood culture association number febrile outpatient proportion prescribed blood culture varied hospital Antibiotics prescribed empirically associated severity provisional diagnoses 31 11473754 enteric fever case covered initial therapy highest Pakistan 50 many isolates resistant cephalosporins commonly prescribed empirically Understanding hospitallevel communication laboratory physician may improve patient care timeliness appropriate antibiotics important considering rise antimicrobial resistance",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Blood Culture",
            "Humans",
            "Nepal",
            "Pakistan",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258939/"
    },
    {
        "pmid": "33258937",
        "title": "Healthcare Utilization Patterns for Acute Febrile Illness in Bangladesh, Nepal, and Pakistan: Results from the Surveillance for Enteric Fever in Asia Project.",
        "abstract": "Characterizing healthcareseeking pattern acute febrile illness critical generating populationbased enteric fever incidence estimate facilitybased surveillance data used hybrid model Surveillance Enteric Fever Asia Project SEAP assess incidence enteric fever 6 study hospital 3 countries recruited individual presenting hospital obtained blood culture evaluate enteric fever analysis undertook cluster random household survey Dhaka Bangladesh 2 sites Karachi Pakistan Kathmandu Nepal Kavrepalanchok Nepal January 2017 February 2019 ascertain careseeking behavior individual 1 fever ≥3 consecutive day within past 8 weeks 2 fever resulting hospitalization within past year also collected data disease severity household demographic assets used mixedeffect multivariable logistic regression model identify determinant healthcare seeking study hospital determinant cultureconfirmed enteric fever enrolled 31 841 household 53 926 children Bangladesh 25 510 household 84 196 child adults Nepal 21 310 household 108 031 child adults Pakistan Children 5 year likely taken study hospital febrile illness sites Household wealth positively correlated healthcare seeking 4 5 study sites least one marker disease severity positively associated healthcare seeking 3 5 catchment areas Wealth disease severity variably predictive blood cultureconfirmed enteric fever Age household wealth disease severity important determinant healthcare seeking acute febrile illness enteric fever risk communities incorporated estimation model enteric fever incidence",
        "mesh_terms": [
            "Adult",
            "Bangladesh",
            "Child",
            "Fever",
            "Humans",
            "Nepal",
            "Pakistan",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258937/"
    },
    {
        "pmid": "33258936",
        "title": "Diagnostic Value of Clinical Features to Distinguish Enteric Fever From Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan.",
        "abstract": "Enteric fever bacterial infection caused Salmonella enterica serotypes Typhi Paratyphi A frequently present nonlocalizing febrile illness difficult distinguish infectious cause fever Blood culture widely available endemic setting and even available result take 5 days evaluated diagnostic performance clinical features including reported symptom clinical signs enteric fever among patient participating Surveillance Enteric Fever Asia Project SEAP 3year surveillance study Bangladesh Nepal Pakistan Outpatients presenting ≥3 consecutive day reported fever inpatient clinically suspected enteric fever 6 SEAP study hospital eligible participate evaluated diagnostic performance select clinical feature blood culture result among outpatient using mixedeffect regression model random effect study site hospital also compared clinical feature S Typhi S Paratyphi among outpatient inpatients enrolled 20 899 outpatients 2116 101 positive blood culture S Typhi 297 14 positive culture S Paratyphi A sensitivity absence cough highest among evaluated features 655 95 confidence interval CI 550747 followed measured fever presentation 590 95 CI 516659 unable complete normal activity 3 day 510 95 CI 238776 combined case definition 3 consecutive day reported fever 1 following a either absence cough b fever presentation c 3 consecutive day unable conduct usual activityyielded sensitivity 946 95 CI 934955 specificity 136 95 CI 98175 Clinical feature accurately distinguish blood cultureconfirmed enteric fever febrile syndromes Rapid affordable accurate diagnostics urgently needed particularly setting limited blood culture capacity",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Nepal",
            "Pakistan",
            "Salmonella enterica",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258936/"
    },
    {
        "pmid": "33258935",
        "title": "Antibiotic Use Prior to Hospital Presentation Among Individuals With Suspected Enteric Fever in Nepal, Bangladesh, and Pakistan.",
        "abstract": "Antibiotic use prior seeking care hospital may reduce sensitivity blood culture enteric fever implication clinical care surveillance Surveillance Enteric Fever Asia Project SEAP prospective study enteric fever incidence Nepal Bangladesh Pakistan Nested within SEAP evaluated accuracy selfreported antibiotic use investigated association antibiotic use blood culture positivity November 2016 April 2019 collected urine sample among subset SEAP participant test antibiotic use prior hospital visit using antibacterial activity assay participant asked recent antibiotic use blood culture performed used mixedeffect logit model evaluate effect antimicrobial use blood culture positivity adjusted marker disease severity enrolled 2939 patient suspected enteric fever Antibiotics detected 39 11452939 urine samples correlation measured reported antibiotic use modest κ  072 adjusting disease severity patient antibiotic urine slightly likely blood culture positive enteric fever however effect statistically significant prevalence ratio 122 95 confidence interval 99150 reliability selfreported prior antibiotic use modest among individual presenting fever tertiary hospitals antibiotic likely reduce sensitivity blood culture finding indicate still considerable value performing blood culture individual reporting antibiotic use",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Hospitals",
            "Humans",
            "Nepal",
            "Pakistan",
            "Prospective Studies",
            "Reproducibility of Results",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258935/"
    },
    {
        "pmid": "33258934",
        "title": "Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.",
        "abstract": "Clinicians limited therapeutic option enteric result increasing antimicrobial resistance therefore typhoid vaccination recommended preventive measure part Surveillance Enteric Fever Asia Project SEAP investigated extent measured burden antimicrobial resistance AMR among confirmed enteric fever case Bangladesh Nepal Pakistan September 2016September 2019 SEAP recruited study participant age group outpatient inpatient hospital laboratory laboratory network surgical site diagnosis febrile illness either suspected blood culture confirmed enteric fever Antimicrobial resistance isolates determined disc diffusion using Clinical Laboratory Standard Institute cutoff points reported frequency multidrug resistance MDRresistance ampicillin cotrimoxazole chloramphenicol extensive drug resistance XDR MDR plus nonsusceptible fluoroquinolone 3rd generation cephalosporins fluoroquinolone FQ azithromycin nonsusceptibility enrolled 8705 blood culture confirmed enteric fever cases 4873 56 Bangladesh 1602 18 Nepal 2230 26 Pakistan these 7591 87 Salmonella Typhi 1114 13 S Paratyphi MDR S Typhi identified 17 7014065 isolates Bangladesh 1 191342 Nepal Pakistan 16  3312084 S Typhi isolates MDR 64 13192074 XDR FQ nonsusceptibility among S Typhi isolates 98 Bangladesh 87 Nepal 95 Pakistan Azithromycin nonsusceptibility detected 77 2 Bangladesh 9 67 Nepal 9 59 isolates Pakistan Pakistan three 2 S Paratyphi isolates MDR MDR S Paratyphi reported Bangladesh Nepal Although AMR S Paratyphi low across three countries widespread drug resistance among S Typhi including FQ nonsusceptibility emergence XDR S Typhi Pakistan limiting treatment options typhoid conjugate vaccine TCV rolled out surveillance continue monitor change AMR inform policy monitor drug resistance S Paratyphi vaccine",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Drug Resistance, Bacterial",
            "Humans",
            "Microbial Sensitivity Tests",
            "Nepal",
            "Pakistan",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258934/"
    },
    {
        "pmid": "33258932",
        "title": "Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in Nepal.",
        "abstract": "Typhoid fever endemic urban Kathmandu Valley Nepal however populationbased study typhoid outside community past 3 decades Whether typhoid immunization prioritized periurban rural community unclear performed populationbased surveillance enteric fever 1 urban catchment Kathmandu 1 periurban rural catchment Kavrepalanchok part Surveillance Enteric Fever Asia Project SEAP recruited individual presenting outpatient emergency department 2 study hospital suspected enteric fever performed blood cultures Additionally conducted household survey catchment area characterize care seeking febrile illness evaluated spatial heterogeneity febrile illness care seeking enteric fever incidence September 2016 September 2019 enrolled 5736 participant suspected enteric fever 2 study hospitals Among these 304 53 culture positive Salmonella Typhi 249 819 Paratyphi 55 181 Adjusted typhoid incidence Kathmandu 484 per 100 000 personyears Kavrepalanchok 615 per 100 000 personyears geographic area estimate could made incidence 200 per 100 000 personyears observed spatial heterogeneity 10fold variation incidence communities urban periurban rural community around Kathmandu measured high heterogenous incidence typhoid finding provide support introduction conjugate vaccine Nepal including outside urban areas alongside measure prevent enteric fever",
        "mesh_terms": [
            "Asia",
            "Humans",
            "Nepal",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258932/"
    },
    {
        "pmid": "33258931",
        "title": "Burden of Culture Confirmed Enteric Fever Cases in Karachi, Pakistan: Surveillance For Enteric Fever in Asia Project (SEAP), 2016-2019.",
        "abstract": "Surveillance Enteric Fever Asia Project SEAP multicenter multicountry study conducted Pakistan Nepal Bangladesh objective study characterize disease incidence among patient enteric fever report burden enteric fever selected site Karachi Pakistan September 2016 September 2019 prospective surveillance conducted inpatient outpatient surgical departments laboratory network Aga Khan University Hospital Kharadar General Hospital surgery unit National Institute Child Health Jinnah Postgraduate Medical Centre Sociodemographic clinical laboratory data obtained suspected confirmed enteric fever cases Overall 22 223010 094 patient enrolled culturepositive enteric fever 94 20932230 isolates Salmonella Typhi 6 1372230 S Paratyphi 15 isolates multidrug resistant MDR firstline antibiotic 60 extensively drugresistant XDR resistant firstline antibiotics fluoroquinolones third generation cephalosporin Enteric fever case increased last 3 year large proportion drug resistant S Typhi cases However burden paratyphoid still relatively low Strengthening existing surveillance system enteric fever antimicrobial resistance national level recommended Pakistan inform prevention measures typhoid vaccination significantly decrease burden typhoid may also impact antimicrobial resistance water sanitation hygiene improvement highly recommended prevent spread enteric fever",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Child",
            "Humans",
            "Nepal",
            "Pakistan",
            "Prospective Studies",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258931/"
    },
    {
        "pmid": "33258930",
        "title": "Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.",
        "abstract": "Enteric fever remains public health concern community lacking sanitation infrastructure separate sewage drinking water bridge gap largescale civilengineering project implemented highburden countries typhoid conjugate vaccine present promising diseaseprevention technology new typhoid conjugate vaccine prequalified World Health Organization 2017 beginning introduced country around world help inform vaccine introduction Surveillance Enteric Fever Asia Project SEAP conduct prospective enteric fever surveillance Bangladesh Nepal Pakistan supplement present finding Phase II study 20162019 burden disease clinical presentation growing spread drugresistant strains policy economic ramifications finding delivered support policymakers deliberation strategy introduce typhoid conjugate vaccine preventive tool enteric fever",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Nepal",
            "Pakistan",
            "Prospective Studies",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258930/"
    },
    {
        "pmid": "33258929",
        "title": "Illness Severity and Outcomes Among Enteric Fever Cases From Bangladesh, Nepal, and Pakistan: Data From the Surveillance for Enteric Fever in Asia Project, 2016-2019.",
        "abstract": "Enteric fever lead prolonged hospital stays clinical complications death Surveillance Enteric Fever Asia Project SEAP prospective surveillance study characterized burden enteric fever including illness severity selected setting Bangladesh Nepal Pakistan assessed disease severity including hospitalization clinical complications death among SEAP participants analyzed clinical laboratory data blood cultureconfirmed enteric fever case enrolled SEAP hospital associated network laboratory September 2016 September 2019 used hospitalization duration hospital stay proxy severity conducted followup interview 6 week enrollment ascertain final outcomes 8705 blood cultureconfirmed enteric fever case enrolled identified 6 death casefatality ratio 07 95 CI 0113 2 Nepal 4 Pakistan none Bangladesh Overall 17 905205 patient recruited SEAP hospital experienced clinical complication Bangladesh 06 183032 Nepal 23 12531 Pakistan 37 601642 identified complication hepatitis n  36 septic shock n  22 pulmonary complicationspneumonia n  13 Across countries 32 28048669 patient hospitalization data available hospitalized Bangladesh 27 12954868 Nepal 29 4551595 Pakistan 48 10542206 median hospital stay 5 day IQR 37 defined clinical complication death uncommon SEAP sites high proportion hospitalization prolonged hospital stay highlight illness severity need enteric fever control measures including use typhoid conjugate vaccines",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Nepal",
            "Pakistan",
            "Prospective Studies",
            "Salmonella typhi",
            "Severity of Illness Index",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258929/"
    },
    {
        "pmid": "33258928",
        "title": "Burden of Ileal Perforations Among Surgical Patients Admitted in Tertiary Care Hospitals of Three Asian countries: Surveillance of Enteric Fever in Asia Project (SEAP), September 2016-September 2019.",
        "abstract": "Typhoid fever caused Salmonella enterica subspecies enterica serovar Typhi S Typhi lead systemic illness complications aimed characterize typhoidrelated ileal perforation context populationbased Surveillance Enteric Fever Asia Project SEAP Bangladesh Nepal Pakistan September 2016 September 2019 case nontraumatic ileal perforation clinical diagnosis typhoid enrolled 4 tertiary care hospital Karachi 2 pediatric hospital Bangladesh 2 hospital Nepal Sociodemographic data collected patient caregivers clinical outcome data retrieved medical records Tissue sample collected histopathology blood culture available 249 enrolled cases 2 Bangladesh 5 Nepal 242 Pakistan Pakistan case 015 117242 48 1630 89242 37 age groups countries male affected Pakistan 749 180242 Nepal 80 45 Bangladesh 100 22 Blood culture done 76 cases 8 11 positive S Typhi extensively drug resistant XDR S Typhi Tissue culture done 86 patients 3 3 positive S Typhi XDR S Typhi 86 sample tested histopathology 4 5 revealed ileal perforation necrosis Culture histopathology confirmed total 15 11 enteric fever case ileal perforation similar clinically diagnosed cases 16242 7 death Pakistan Cases ileal perforation survived likely sought care visiting sentinel hospital P  009 visited hospital treatment P  013 compared survived Although surveillance differed substantially country one reason higher number ileal perforation case Pakistan could circulation XDR strain S Typhi Karachi",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Child",
            "Humans",
            "Male",
            "Nepal",
            "Pakistan",
            "Salmonella typhi",
            "Tertiary Care Centers",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33258928/"
    },
    {
        "pmid": "33218076",
        "title": "CRISPR-Cas Diversity in Clinical <i>Salmonella enterica</i> Serovar Typhi Isolates from South Asian Countries.",
        "abstract": "Typhoid fever caused iSalmonella entericai serovar Typhi iSi Typhi global health concern treatment problematic due rise antimicrobial resistance AMR Rapid detection patient infected AMR positive iSi Typhi is therefore crucial prevent spreading iCilustered iRiegularly iIinterspaced iSihort iPialindromic iRiepeats CRISPRassociated gene CRISPRCas adaptive immune system initially used typing purposes Later discovered play role defense phage plasmids including one carry AMR genes and present explored usage diagnostics Despite availability wholegenome sequence WGS studied CRISPRCas system iSi Typhi let alone typing purpose relation AMR present study analyzed CRISPRCas system iSi Typhi using WGS data 1059 isolates obtained Bangladesh India Nepal Pakistan combination demographic data AMR status result reveal iSi Typhi CRISPR locus classified two groups evidence level 2 B evidence level ≤2 identified total 47 unique spacers 15 unique direct repeats analysis identified spacers repeat demonstrated specific pattern harbored significant association genotype demographic characteristics AMR status thus raising possibility usage biomarkers Potential spacer target identified and interestingly phagetargeting spacers belonged groupA plasmidtargeting spacers groupB CRISPR loci analysis spacer target led identification iSi Typhi protospacer adjacent motif PAM sequence TTTCAT New icasigenes known iDinGi iDEDDhi iWYLi also discovered iSi Typhi genome However specific variant iWYLi gene identified extensively drugresistant XDR lineage Pakistan ciprofloxacinresistant lineage Bangladesh work conclude strong correlation variation identified iSi Typhi CRISPRCas system endemic AMR positive iSi Typhi isolates",
        "mesh_terms": [
            "Bangladesh",
            "CRISPR-Cas Systems",
            "Drug Resistance, Bacterial",
            "Genetic Variation",
            "Genome, Bacterial",
            "Humans",
            "India",
            "Nepal",
            "Pakistan",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33218076/"
    },
    {
        "pmid": "32964216",
        "title": "Can Existing Improvements of Water, Sanitation, and Hygiene (WASH) in Urban Slums Reduce the Burden of Typhoid Fever in These Settings?",
        "abstract": "Sustained investment water sanitation hygiene WASH lagged resourcepoor settings incremental WASH improvement may nonetheless prevent disease typhoid diseaseendemic populations Using prospective data large cohort urban Kolkata India evaluated whether baseline WASH variable predicted typhoid risk training subpopulation n  28 470 applied machine learning algorithm training subset create composite dichotomous good good WASH variable based 4 variables evaluated sensitivity specificity variable validation subset n  28 470 evaluated Cox regression model whether resident good WASH household experienced lower typhoid risk controlling potential confounders constructed virtual cluster radius 50 m surrounding household evaluate whether prevalence good WASH practice modified typhoid risk central household members Good WASH practice associated protection analysis household hazard ratio HR  057 95 confidence interval CI 3790 P  015 protection evident person ≥5 year old baseline HR  047 95 CI 3493 P  005 suggestive though statistically significant younger age group HR  061 95 CI 27138 P  235 level surrounding household good WASH coverage also associated protection HR  0988 95 CI 979996 P  004 percent coverage increase However collinearity household WASH WASH coverage prevented assessment independent predictive contributions typhoidendemic setting natural variation household WASH associated typhoid risk replicated elsewhere finding suggest WASH improvement may enhance typhoid control short major infrastructural investments",
        "mesh_terms": [
            "Child, Preschool",
            "Humans",
            "Hygiene",
            "India",
            "Poverty Areas",
            "Prospective Studies",
            "Sanitation",
            "Typhoid Fever",
            "Water"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32964216/"
    },
    {
        "pmid": "32804950",
        "title": "Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata.",
        "abstract": "evaluated protection conferred first documented visit clinical care typhoid fever recurrent typhoid fever prompting visit study take advantage multiyear followup population endemic typhoid participating clusterrandomized control trial Vi capsular polysaccharide typhoid vaccine Kolkata India population 70566 individuals 37673 vaccinated one dose either Vi vaccine control Hepatitis A vaccine observed four years Surveillance detected 315 first typhoid visits among 4 developed subsequent typhoid 3 due reinfection defined using genomic criterion corresponding 124 95 CI 599 28 protection initial illness Point estimate protection conferred initial illness negative negligible vaccinated nonvaccinated subjects though confidence interval around point estimate wide data provide little support protective immunizing effect clinically treated typhoid illness though modest level protection cannot excluded",
        "mesh_terms": [
            "Antibodies, Bacterial",
            "Humans",
            "India",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32804950/"
    },
    {
        "pmid": "32725239",
        "title": "Methodological Considerations for Cost of Illness Studies of Enteric Fever.",
        "abstract": "article present selection practical issues questions tradeoff methodological choice consider conducting cost illness COI study enteric fever low lowermiddleincome countries experience presented based 2 largescale COI study embedded within Surveillance Enteric Fever Asia Project II SEAP II Bangladesh Nepal Pakistan Severe Typhoid Fever Surveillance Africa SETA Program Burkina Faso Ethiopia Ghana Madagascar Issues presented include study design choice controlling background patient morbidity healthcare costs time point followup data collection method sensitive income spending information estimating enteric feverspecific health facility cost information analytic approach combining patient health facility costs article highlight potential tradeoff time budget precision result assist commissioning conducting interpreting enteric fever COI studies",
        "mesh_terms": [
            "Bangladesh",
            "Burkina Faso",
            "Cost of Illness",
            "Ethiopia",
            "Ghana",
            "Humans",
            "Madagascar",
            "Nepal",
            "Pakistan",
            "Paratyphoid Fever",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32725239/"
    },
    {
        "pmid": "32725234",
        "title": "Antimicrobial Resistance in Typhoidal Salmonella: Around the World in 3 Days.",
        "abstract": "increasing antibacterial resistance typhoidal Salmonella dearth novel antimicrobial horizon risk losing primary defense widespread morbidity mortality enteric fever 2628 March 2019 researcher around world came together Hanoi Vietnam shared latest finding antimicrobial resistance 258 abstract presented conference least 50 discussed phenotypic genotypic characteristic antimicrobial resistance typhoidal Salmonella covering data least 24 different countries spanning 5 continents Here summarize key findings focusing global journey ahead",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Humans",
            "Salmonella",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever",
            "Vietnam"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32725234/"
    },
    {
        "pmid": "32725230",
        "title": "Early Insights From Clinical Trials of Typhoid Conjugate Vaccine.",
        "abstract": "Clinical trial typhoid conjugate vaccine TCV ongoing 4 countries Early data confirm safety tolerability immunogenicity typhoid conjugate vaccine early efficacy result promising data support World Health Organization recommendation planned country introductions Forthcoming trial data continue inform programmatic use typhoid conjugate vaccine",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccines, Conjugate",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32725230/"
    },
    {
        "pmid": "32725227",
        "title": "Environmental Surveillance as a Tool for Identifying High-risk Settings for Typhoid Transmission.",
        "abstract": "Enteric fever remains major cause morbidity developing country poor sanitation condition enable fecal contamination water distribution systems Historical evidence shown contamination water system used household consumption agriculture key transmission route Salmonella Typhi Salmonella Paratyphi A World Health Organization recommends typhoid conjugate vaccine TCV used setting high typhoid incidence consequently government face challenge regarding prioritize typhoid emerging diseases key issue lack typhoid burden data many low middleincome country TCV could deployed present argument utilizing environmental sampling surveillance enteric fever organism provide data communitylevel typhoid risk approach could complement traditional blood culturebased surveillance even replace setting populationbased clinical surveillance feasible review historical study characterizing transmission enteric fever organism sewage water discus recent advance molecular detection typhoidal Salmonella environment outline challenge knowledge gap need addressed establish environmental sampling tool generating actionable data inform public health response enteric fever",
        "mesh_terms": [
            "Environmental Monitoring",
            "Humans",
            "Salmonella paratyphi A",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32725227/"
    },
    {
        "pmid": "32725221",
        "title": "The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fever Studies: A Review of Methodological Similarities and Differences.",
        "abstract": "Building previous multicountry surveillance study typhoid others salmonelloses Diseases Impoverished program Typhoid Surveillance Africa Project several ongoing blood culture surveillance study generating important data incidence severity transmission clinical feature invasive Salmonella infection subSaharan Africa South Asia study also characterizing drug resistance pattern respective study sites study answer different set research question employ slightly different methodologies geography surveillance differ size population density physician practices access healthcare facilities access microbiologically safe water improved sanitation difference part reflect heterogeneity epidemiology invasive salmonellosis globally thus enable generation data useful policymakers decisionmaking introduction typhoid conjugate vaccine TCVs Moreover study evaluating largescale deployment TCVs may ultimately used assess postintroduction vaccine impact data generated study also used refine global disease burden estimates important ensure lesson learned study inform vaccination policy also incorporated sustainable lowcost integrated vaccinepreventable disease surveillance systems",
        "mesh_terms": [
            "Africa South of the Sahara",
            "Asia",
            "Humans",
            "India",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32725221/"
    },
    {
        "pmid": "32720632",
        "title": "Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.",
        "abstract": "Transcutaneous vaccination induce mucosal systemic immune responses However data antipolysaccharide response following transcutaneous vaccination polysaccharides despite role antipolysaccharide response play protecting intestinal mucosal respiratory pathogens Whether transcutaneous vaccination conjugate polysaccharide vaccine would able induce memory response also unknown address this transcutaneously vaccinated mouse virulence antigen Vi polysaccharide iSalmonella entericai serovar Typhi the cause typhoid fever either unconjugated conjugated form the latter ViDT conjugate also assessed ability immunoadjuvant cholera toxin impact response following vaccination found presenting Vi conjugate versus nonconjugate form transcutaneously resulted comparable serum IgG response higher serum lamina propria lymphocyte IgA antiVi responses well increased IgG memory responses addition immunoadjuvant increase responses however boosted fecal IgA serum IgG antiVi responses result suggest transcutaneous vaccination conjugate vaccine induce systemic well enhanced mucosal memory Bcell antipolysaccharide responses",
        "mesh_terms": [
            "Administration, Cutaneous",
            "Animals",
            "Antibodies, Bacterial",
            "Disease Models, Animal",
            "Female",
            "Humans",
            "Immunity, Humoral",
            "Immunity, Mucosal",
            "Immunization Schedule",
            "Immunoglobulin A",
            "Immunoglobulin G",
            "Immunologic Memory",
            "Mice",
            "Polysaccharides, Bacterial",
            "Salmonella typhi",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32720632/"
    },
    {
        "pmid": "32715018",
        "title": "Altered Patterns of Compositional and Functional Disruption of the Gut Microbiota in Typhoid Fever and Nontyphoidal Febrile Illness.",
        "abstract": "Experimental murine model human challenge study iSalmonellai Typhi infection suggested gut microbiome play important protective role development typhoid fever Anaerobic bacterial community hypothesized mediate colonization resistance iSalmonellai specie producing shortchain fatty acids yet composition function intestinal microbiota human patient typhoid fever remain ill defined prospectively collected fecal sample 60 febrile patient admitted Chittagong Medical College Hospital Bangladesh typhoid fever nontyphoidal febrile illness 36 healthy agematched controls collected fecal sample subjected 16 rRNA sequencing followed targeted metabolomics analysis Patients typhoid fever displayed compositional functional disruption gut microbiota compared patient nontyphoidal febrile illness healthy controls Specifically typhoid fever patient lower microbiota richness alpha diversity higher prevalence potentially pathogenic bacterial taxa addition lower abundance shortchain fatty acidproducing taxon seen typhoid fever patients difference typhoid fever nontyphoidal febrile illness could explained loss colonization resistance antibiotic treatment antibiotic exposure group similar first report composition function gut microbiota patient typhoid fever suggests restoration intestinal commensal microorganism could targeted using adjunctive preventive therapeutic strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32715018/"
    },
    {
        "pmid": "32699118",
        "title": "A Race against Time: Reduced Azithromycin Susceptibility in <i>Salmonella enterica</i> Serovar Typhi in Pakistan.",
        "abstract": "Antimicrobial resistance ongoing issue treatment typhoid fever Resistance firstline antimicrobial extensively drug resistant XDR iSalmonellai Typhi isolates Pakistan left azithromycin remaining effective oral treatment Here report emergence organism single point mutation iacrBi gene implicated azithromycin resistance iSi Typhi isolate Pakistan isolation organism worrisome highlight significance introduction typhoid conjugate vaccine South AsiabIMPORTANCEb emergence XDR iSalmonellai Typhi Pakistan left azithromycin viable oral treatment option Here report detection azithromycin resistanceassociated mutation one iSi Typhi isolate finding important possible spread azithromycin resistance iSi Typhi isolates would make nearly impossible treat outpatient setting due need injectable antibiotics finding also signify importance introduction typhoid conjugate vaccine region endemicity Pakistan",
        "mesh_terms": [
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Bacterial Proteins",
            "Drug Resistance, Multiple, Bacterial",
            "Membrane Transport Proteins",
            "Microbial Sensitivity Tests",
            "Pakistan",
            "Plasmids",
            "Point Mutation",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32699118/"
    },
    {
        "pmid": "40802699",
        "title": "Hepatitis A beyond childhood causing diagnostic and therapeutic challenges in Addis Ababa, Ethiopia.",
        "abstract": "Hepatitis acute viral infection liver caused hepatitis virus HAV acquired fecooral route highest incidence among four major acute viral hepatitis type A B C E usually occurs early childhood However prevalence acute hepatitis recently increased among teenager young adults usually misdiagnosed study emphasizes significance awareness among healthcare worker increasing incidence acute hepatitis among group ensure accurate diagnosis appropriate management hospitalbased retrospective crosssectional study employed Fiftyeight confirmed acute HAV patient visited Adera Medical Surgical Center AMSC August 2023 January 2024 enrolled Sociodemographic clinical laboratory parameter documented management data including hospitalization trial antibiotic treatment considering HAV course illness collected data entered analyzed using SPSS SPSS Version 260 sex ratio similar slight male predominance MF  107 mean age ± SD patient 193± 88 years Thirtynine 672 patient students patient Addis Ababa Vomiting 828 anorexia 707 yellowish discoloration eye 621 common presenting symptoms icteric sclera 44 759 epigastric tenderness 17 293 common physical findings half patient 552 initially misdiagnosed typhoid fever TF 468 peptic ulcer disease PUD 312 urinary tract infection UTI 156 patient recovered fully liver function test LFTs normalized supportive care within 24 weeks study revealed shift age HAV susceptibility subsequent infection towards adolescent young adult mean ± SD age 1931 ± 88 years cohort half patient 552 initially misdiagnosed TF PUD UTI causing diagnostic treatment challenges necessitates heightened awareness among healthcare worker public Early HAV diagnosis targeted laboratory investigation avoiding unnecessary antibiotic crucial effective management prevention via hygienic immunization strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802699/"
    },
    {
        "pmid": "40777931",
        "title": "The relationship between gender and cultural beliefs of malaria into typhoid progression among rural rice farmers in Central Kenya.",
        "abstract": "Women increased risk contracting malaria Kenya developing world gender role cultural belief system disease progression treatment Cultural belief system illness progression important implication genderbased health intervention main objective research explore rice farming Kikuyu ethnic group Mwea division central Kenya cultural belief malaria typhoid progression also aim examine association gender malaria typhoid progression cultural belief system study employ crosssectional study design N250 Variables related demographic cultural belief malaria typhoid progression collected using structured questionnaire 62 woman 47 men interviewed adhere malaria typhoid progression belief system Multivariable logistic analysis show woman twice likely men believe malaria typhoid progression aOR 215 95 CI 121 379 p  0009 study demonstrates underlying cultural factor related gender disparity appropriate knowledge cultural belief system malaria typhoid progression could influence overall womens health outcome developing countries",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Malaria",
            "Kenya",
            "Cross-Sectional Studies",
            "Adult",
            "Health Knowledge, Attitudes, Practice",
            "Farmers",
            "Rural Population",
            "Middle Aged",
            "Disease Progression",
            "Typhoid Fever",
            "Sex Factors",
            "Surveys and Questionnaires",
            "Oryza",
            "Culture",
            "Young Adult",
            "Socioeconomic Factors",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777931/"
    },
    {
        "pmid": "40776518",
        "title": "Immunogenicity and Safety Profile of Typhoid Conjugate Vaccine (Vi-DT) Among Nepali Children.",
        "abstract": "Typhoid fever remains major concern tropical countries availability effective vaccine could important inclusion currently available interventions reported evaluation immunogenicity safety typhoid conjugate vaccine ViDT among Nepali children study observer blinded active controlled randomized phase III clinical trial child 6 month less 18 year old Three different lot ViDTVi Diptheria Toxoid test vaccine ViTT  ViTetanus Toxoid comparator vaccine administered eligible children Seroconversion assessed blood sample collected baseline 4 week vaccination rise least 4fold viantibody titer baseline used indicate positive seroconversion Data solicited unsolicited adverse event collected Four hundred eightyeight child participated study Seroconversion rate 9861 9836 among participant received ViDT ViTT vaccine respectively One immediate adverse event observed ViDT group One hundred fortytwo 66 solicited AEs within 7 day observed test comparator vaccine respectively Unsolicited AEs within 28 day 125 test vaccine compared 77 comparator vaccine Two SAEs reported Not related study vaccine overall seroconversion Vi DT vaccine non inferior comparator vaccine safety profile vaccine good without lifethreatening events",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Nepal",
            "Male",
            "Child",
            "Female",
            "Child, Preschool",
            "Typhoid Fever",
            "Infant",
            "Vaccines, Conjugate",
            "Adolescent",
            "Immunogenicity, Vaccine",
            "Seroconversion",
            "Tetanus Toxoid",
            "Antibodies, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776518/"
    },
    {
        "pmid": "40767429",
        "title": "Tropical gastrointestinal infections of contemporary public health importance.",
        "abstract": "Several gastrointestinal disease emerged recent decade representing significant public health problem tropics aim review advance epidemiology diagnosis treatment cholera typhoid fever parasitic diseases Cholera case increasing year yet vaccine available prevent it Simplifying singledose regimen oral vaccine promising Typhoid fever incidence mortality rate decreasing antibiotic resistance rising Typhoid conjugate vaccine efficacious several issue remain unsolved regarding implementation Despite better epidemiological tools diagnostic methods therapeutic alternatives diarrheal disease reviewed remain significant public health problem tropics reduction burden aimed short term investment water access sanitation hygiene better vaccine needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767429/"
    },
    {
        "pmid": "40739272",
        "title": "Exploring patient's clinical outcomes, hospital costs, and satisfaction after the implementation of integrated clinical pathway-based nursing practice model.",
        "abstract": "Hospitals provide essential health services focusing quality safety patientcentered care rising prevalence communicable noncommunicable disease Indonesia led increased National Health Insurance NHI costs communicable disease representing significant burden despite global progress disease control Tuberculosis remains major global health concern causing 125 million death 2023 Indonesia rank second globally tuberculosis burden accounting 10 global TB case estimated 969000 case annually Despite effort improve quality Haji Labuang Baji Hospitals face challenges including financial loss suboptimal patient outcomes study aim assess impact Integrated Clinical Pathway ICPbased Professional Nursing Practice Model clinical outcomes hospital costs patient satisfaction hospitals study employed action research methodology developing implementing evaluating clinical guideline ICP 10 disease categorized high volume high risk high cost based secondary data analysis using NHI databases Data collected observation ICP implementation 40 patient interview Professional Care Providers PCPs analyzed using IBM SPSS Statistics version 28 total 40 patient Haji Hospital n  20 Labuang Baji Hospital n  20 diagnosis pulmonary tuberculosis pneumonia dyspepsia typhoid fever normal delivery COPD included analyzed Compliance ICPs hospital quite low 5002 Haji Hospital 4446 Labuang Baji Hospital However length patients stay LOS generally complied ICP standards although case exceeded benchmarks Hospital cost varied across different disease diagnoses impacting overall financial outcomes Patient satisfaction improved across diagnostic categories implementation ICP hospital showed indicator patient clinical outcome improved according time specified ICP resulting patients LOS shorter stipulated ICP increase patient satisfaction ICP implementation also led hospital earning different profit almost diagnoses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739272/"
    },
    {
        "pmid": "40735580",
        "title": "Emergence of Azithromycin-resistant Salmonella Typhi in Southeast Asia: A systematic review.",
        "abstract": "systematically review literature epidemiology antimicrobial resistance control strategy typhoid fever focusing Southeast Asia disease burden emergence drugresistant strain significant systematic review used twentyfive manuscript fulfilling inclusion criterion included human study affected typhoid fever included including systematic reviews narrative reviews metaanalyses crosssectional studies original studies editorials Commentary Manuscripts searched reviewed according PRISMA guidelines 2006 2024 six reliable sources including PubMed Web Science Scopus Cochrane Library Google Scholar Embase evaluated Typhoid fever remains significant global health burden particularly region poor sanitation 2019 92 million case 110000 deaths highest rate Eastern Mediterranean Africa Southeast Asia Treatment option exist emergence drugresistant strains including resistant firstline antibiotic like azithromycin pose serious threat misuse antibiotic primarily cause resistance Effective control strategy require improved sanitation hygiene widespread vaccination prudent antibiotic use stewardship programs enhanced surveillance drug resistance monitoring Typhoid caused Salmonella typhi remains health threat Southeast Asia due poor sanitation limited access clean water Addressing requires improved sanitation vaccination careful antibiotic use intense surveillance combat antibioticresistant strains",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735580/"
    },
    {
        "pmid": "40673322",
        "title": "A Comprehensive Guide to Typhoidal Anemia.",
        "abstract": "Typhoid fever caused primarily Salmonella Typhi Paratyphi stand significant global health concern complication extending beyond typical gastrointestinal manifestations review systematically examines intricate relationship typhoid fever hematologic complications collectively referred typhoidal anemia Hematological abnormalities including change blood profile bone marrow responses scrutinized providing comprehensive understanding diseases impact physiological systems Specific populations immunocompromised individuals sickle cell anemia patients child resourcelimited settings reveal varied susceptibility outcomes Complications psoas abscess secondary hemophagocytic lymphohistiocytosis explored highlighting multifaceted nature disease distinct contribution Salmonella Typhi Paratyphi anemia elucidated shedding light pathophysiological mechanism involved Global prevalence epidemiological variation offer valuable perspectives underscoring importance regional nuance disease manifestation Challenges accurate diagnosis treatment limitation acknowledged emphasizing need continued research enhance diagnostic precision therapeutic strategies Insights longterm effects prognosis influence host factor contribute holistic understanding typhoidal anemia review concludes identifying critical gap knowledge advocating ongoing research initiative heightened awareness campaigns synthesis diverse finding provides comprehensive overview typhoidal anemia underscoring imperative continued research awareness improved patient care global public health",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Anemia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40673322/"
    },
    {
        "pmid": "40661001",
        "title": "[Examining <i>Shang Han Zheng Jie</i> using the method of philology].",
        "abstract": "iShang Han Zheng Jiei fourvolume medical book annotation iShang Han Luni Dai Yaochi Qing Dynasty first published tenth year Tongzhi Period Qing Dynasty 1871 found existing version engraved one tenth year Tongzhi Period 1871 book consisting three full volume volume separately located library Anhui University Traditional Chinese Medicine library Shanghai University Chinese Medicine library Medical College Shanghai Jiao Tong University respectively one authors stamp collected Anhui University Traditional Chinese Medicine believed valuable version Beyond that two fragment book collected Medical Branch Wuhan University Library library Tianjin Medical College respectively author Dai Yaochi annotated iShang Han Luni revising deleting splitting merging content minimise negligence playing new tricks believed typhoid fever process identifying six meridians six meridian failed clarified clinical symptom would treated reasonably editing complicated messy provision original texts Therefore recompiled style iShang Han Luni book iShang Han Zheng Jiei reorganised book Six Meridians reinterpreted iShang Han Luni based understanding annotation previous authors",
        "mesh_terms": [
            "Medicine, Chinese Traditional",
            "History, 19th Century",
            "China",
            "Books"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40661001/"
    },
    {
        "pmid": "40660999",
        "title": "[Reexamining the authorship of <i>Wen Yi Ming Bian</i>].",
        "abstract": "authorship book iWen Yi Ming Biani iGuang Wen Yi Luni historical controversy content different names widely believed Dai Tianzhang author two book rather Zheng Dianyi study examined two authors biography diverse version author note relevant material remained compatibility content book names found Zheng Dianyi physician excellent medical skill ability compile book whereas Dai Tianzhang local celebrity gentleman medical skill medical experience author various version iWen Yi Ming Biani recorded She Yi the place Zheng Dianyi lived Zheng Dianyi author version related Dai Tianzhang normally shown Revised Dai Linjiao the penname Dai Tianzhang sense author iWen Yi Ming Biani argued Zheng Dianyi Additionally name iWen Yi Ming Biani different iGuang Wen Yi Luni meanings iBiani  iWen Yi Ming Biani mean distinguish right wrong therefore indicates distinguish example typhoid fever warm epidemic making iGuangi  iGuang Wen Yi Luni far away it Thus author iWen Yi Ming Biani Zheng Dianyi iGuang Wen Yi Luni different name iWen Yi Ming Biani hand copied concluded Dais grandson statement the two book written Dai Tianzhang subjective speculation without sufficient evidence",
        "mesh_terms": [
            "Authorship",
            "Books",
            "China",
            "History, 20th Century",
            "Medicine, Chinese Traditional"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40660999/"
    },
    {
        "pmid": "40655376",
        "title": "Antibacterial Activity, Phytochemical Analysis <i>of C. coggygria</i> Leaf Extracts Against <i>S. typhi,</i> and Computational Studies to Screen Potential Drug Candidates.",
        "abstract": "Typhoid fever serious infectious disease caused iSalmonella typhii iSalmonellai iParatyphi Ai Although several drug available treatment iSalmonellai infection however rising case bacterial resistance common drug necessitate new drug discovery iSi ityphii Typhoid fever managed better way Therefore carried phytochemical analysis iCotinus coggygriai FTIR GCMS analysis followed antibacterial activity iS typhii Moreover also conducted molecular docking find important phytochemicals methanol 48 compounds ethyl acetate 66 compounds 6 molecular targets glycosidehydrolase PDB Id 4hzm OmpF PDB Id 4kra DNA gyrase PDB Id5ZTJ AvrA PDB Id 6BE0 RamR PDB Id 6IE9 tryptophan Synthase PDB Id 7L03 Results show ethyl acetate extract iC coggygriai highest antibacterial activity iS typhii inhibition zone ranging 23 ± 28 18 ± 05 mm different concentration compared methanol extracts Based docking score DNA gyrase 5ZTJ found suitable molecular target DNA gyrase 5ZTJ molecular dynamic simulation study resulted 7 potential inhibitor ethyl acetate extract 5 potential inhibitor methanol extract lower free binding energy reference drug ciprofloxacin Based study conclude top four phytochemical may used therapeutic purpose drug development isalmonellai activity Lanosterol Lup2029en3one 919Cyclolanost24en3ol 3 beta Periplogenin acetate",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655376/"
    },
    {
        "pmid": "40630339",
        "title": "Acute Respiratory Distress Syndrome and Spondylitis Secondary to Salmonella Bacteremia.",
        "abstract": "iSalmonella entericai subsp ientericai includes typhoidal nontyphoidal serovars former likely cause systemic infection typhoid fever latter typically result localized gastroenteritis main symptom nontyphoidal iSalmonellai NTSinfection transient diarrhea typically resolve within approximately five days However cases may worsen cause multiorgan dysfunction 39yearold healthy male developed NTS infection likely manifested enteritis followed iSalmonellai bacteremia spondylitis acute respiratory failure patient required mechanical ventilatory support due rapidly progressive respiratory failure however respiratory condition improved within short period following antibiotic therapy Subsequently prolonged antibiotic treatment administered spondylitis bone manifestation NTS bacteremia frequently reported case complicated acute respiratory distress syndrome ARDS spondylitis rare mechanism pyogenic spondylitis development iSalmonellai thought involve hematogenous infection associated bacteremia hand pathogenesis ARDS remains unclear However direct lung tissue damage caused iSalmonellai secondary lung injury resulting systemic inflammatory response syndrome may play role case highlight unusual presentation relatively young otherwise healthy adult",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40630339/"
    },
    {
        "pmid": "40627588",
        "title": "Sociodemographic and clinical factors influencing typhoid fever prevalence and multidrug resistance in Niger State, Nigeria.",
        "abstract": "study investigated prevalence typhoid fever factor contributing multidrug resistance Niger State Nigeria region affected limited sanitation healthcare access crosssectional study design employed across community Niger State Nigeria participant different community state aged 18 year enrolled Salmonella enterica serotype Typhi isolation stool determination interpretation multidrug resistance performed according Clinical Laboratory Standards Institute CLSI methods examined association sociodemographic characteristics clinical factors multidrug resistant MDR Salmonella enterica serotype Typhi Among 624 participants typhoid fever prevalence recorded 365 young adult ages 1827 semiurban resident demonstrating higher infection rates Antibiotic sensitivity testing revealed 98 resistance amoxicillinclavulanic acid whereas gentamicin levofloxacin exhibited high efficacy finding underscore urgent need health education improved antibiotic regulation Water Sanitation Hygiene WASH intervention control typhoid fever mitigate MDR challenges",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Adult",
            "Nigeria",
            "Male",
            "Female",
            "Adolescent",
            "Prevalence",
            "Young Adult",
            "Drug Resistance, Multiple, Bacterial",
            "Cross-Sectional Studies",
            "Salmonella typhi",
            "Anti-Bacterial Agents",
            "Middle Aged",
            "Sociodemographic Factors",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40627588/"
    },
    {
        "pmid": "40625744",
        "title": "GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant <i>Salmonellae</i>.",
        "abstract": "Systemic disease caused nontyphoidal iSalmonellai NTS represents major cause death morbidity especially young child subSaharan Africa licensed vaccine yet available increase antimicrobial resistance make development vaccine global health priority developing bivalent formulation iSalmonellai Typhimurium iSalmonellai Enteritidis generalized module membrane antigen GMMAbased vaccine iNTSGMMA trivalent formulation iNTSTCV iNTSGMMA combined WHOprequalified TYPHIBEV Biological E India vaccine prevent typhoid fever addition invasive NTS iNTS disease Here measured ability antibody induced iNTSGMMA iNTSTCV formulation mouse rabbit kill broad panel iSalmonella vitroi complementmediated fashion organism include causing invasive disease Africa Southeast Asia global representative causing gastroenteritis iSi ientericai serovars addition iSi Typhimurium iSi Enteritidis characterized Oantigen panel isolates demonstrated serum functionality animal specie isolates providing evidence potential broad coverage GMMAbased formulations currently undergoing testing Phase III clinical trials",
        "mesh_terms": [
            "Animals",
            "Rabbits",
            "Mice",
            "Salmonella Vaccines",
            "Antibodies, Bacterial",
            "Salmonella Infections",
            "Salmonella typhimurium",
            "Female",
            "Humans",
            "O Antigens",
            "Salmonella enteritidis",
            "Antigens, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40625744/"
    },
    {
        "pmid": "40608722",
        "title": "Prevalence and antimicrobial susceptibility of Salmonella enterica Typhi in febrile patients: a cross-sectional study.",
        "abstract": "Typhoid fever caused Salmonella Typhi serious health problem especially developing country like Pakistan antibiotic usually prescribed without susceptibility testing epidemiological surveillance Consequently antibioticresistant typhoid bacteria appear reported authorities limited research prevalence antibiotic susceptibility pattern S Typhi among febrile patient Swabi Pakistan study aimed address gap Bacha Khan Medical Complex Swabi Laboratory record hospitalized patient received blood culture September 2022 August 2023 reviewed retrospective crosssectional study Every isolate S Typhi underwent antibiotic susceptibility test using modified KirbyBauer disk diffusion agardilution method measure isolates minimum inhibitory concentration MIC ciprofloxacin azithromycin data analyzed using SPSS version 240 485 febrile patient positive S Typhi higher prevalence 014 year age group Male gender seasonal variation significant factors isolates resistant ampicillin amoxicillin cefotaxime ciprofloxacin sensitive azithromycin carbapenems MICs ciprofloxacin 006 16 µgmL Among isolates 1094 sensitive 9890 resistant ciprofloxacin 100 isolates susceptible azithromycin Azithromycin carbapenem suitable empirical therapy choice However isolates highly resistant conventional firstline antibiotic ampicillin amoxicillin second generation fluoroquinolones ciprofloxacin thirdgeneration cephalosporin ceftriaxone cefotaxime considered vital typhoid treatment",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Typhoid Fever",
            "Adolescent",
            "Anti-Bacterial Agents",
            "Child, Preschool",
            "Child",
            "Pakistan",
            "Microbial Sensitivity Tests",
            "Adult",
            "Prevalence",
            "Infant",
            "Young Adult",
            "Retrospective Studies",
            "Middle Aged",
            "Infant, Newborn",
            "Ciprofloxacin",
            "Fever",
            "Aged",
            "Drug Resistance, Bacterial",
            "Azithromycin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40608722/"
    },
    {
        "pmid": "40607646",
        "title": "Mechanisms of azithromycin resistance in <i>Salmonella Typhi</i>: molecular insights from dynamics behavior to clinical implications.",
        "abstract": "widespread use azithromycin COVID19 pandemic likely contributed increased resistance iSalmonella Typhii antibiotic study focus extensive drug resistance XDR iSalmonella Typhii Pakistan analyzing 11916 suspected typhoid fever cases 424 confirmed iSalmonella Typhii Paratyphi A antimicrobial susceptibility test PCRbased Sanger sequencing R717L mutation iAcrBi gene identified signalling emergence azithromycin resistance mutation notably prevalent among XDR iSalmonella Typhii isolates high detection iblaCTXMi gp 1 93 followed iblaCTXMi 2 87 iblaTEMi 81 Detailed analysis revealed R717L mutation significantly alters iAcrBi proteins interaction azithromycin evidenced lower docking score reduced critical interactions thus diminishing antibiotics affinity Molecular Dynamics MD simulation demonstrated mutation induces considerable structural change iAcrBi impacting stability conformation Additionally binding free energy calculation showed decreased binding affinity azithromycin mutated iAcrBi protein finding underscore critical role R717L mutation conferring drug resistance highlight urgent need developing new antibiotic strategy combat growing threat evolution azithromycin resistance XDR iSalmonella Typhii underscore importance cautious antibiotic use necessity ongoing surveillance research inform effective typhoid fever treatment protocols",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40607646/"
    },
    {
        "pmid": "40553603",
        "title": "<i>Salmonella</i> Typhi Septic Arthritis: A Case Report in an Immunocompetent Adult.",
        "abstract": "iSalmonellai Typhi specie known cause acute gastroenteritis ileitis bacteremia fever case immunocompetent adult early twenty presented complaint highgrade fever pain epigastrium leftsided hip pain difficulty walking Since patient immunocompetent unique feature history fasting religious approximately 3 weeks consumed mainly liquid water may made susceptible infections Septic arthritis emergency orthopedic opinion taken routine investigation revealed leukocytosis deranged liver profile Blood culture revealed growth iSalmonellai Typhi patient started ceftriaxone 2 gm intravenous IV every 12 hours responded made remarkable recovery thus avoiding surgical intervention",
        "mesh_terms": [
            "Humans",
            "Arthritis, Infectious",
            "Salmonella typhi",
            "Female",
            "Anti-Bacterial Agents",
            "Ceftriaxone",
            "Typhoid Fever",
            "Immunocompetence",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40553603/"
    },
    {
        "pmid": "40553599",
        "title": "A Rare Case of <i>Salmonella typhi</i> Endocarditis in Pregnancy.",
        "abstract": "Enteric fever common serious disease mostly affect child adolescent developing countries present rare case Salmonella typhi endocarditis native valve complicating pregnancy presented acute abdomen diagnosed acute cholecystitis underwent cholecystectomy course stay remained febrile ill despite source control prompting u evaluate pyrexia unknown origin led identification native valve endocarditis later grew S typhi blood cultures managed 6 week parenteral antibiotics along frequent clinical echocardiogram ECHO monitoring followup systemic symptom improved resolution vegetation Prompt evaluation pyrexia unknown origin keen clinical examination appropriate investigation led timely diagnosis rare presentation isolated report Salmonella endocarditis native valve complicating pregnancy",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Salmonella typhi",
            "Typhoid Fever",
            "Endocarditis, Bacterial",
            "Pregnancy Complications, Infectious",
            "Anti-Bacterial Agents",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40553599/"
    },
    {
        "pmid": "40548130",
        "title": "Purulent pleurisy caused by Salmonella enterica subspecies arizonae: a case report.",
        "abstract": "bBackgroundb Salmonellosis commonly present clinically typhoid fever gastroenteritis Pleuropulmonary infection due iSalmonellai still rare even though often described immunocompromised patients bCase presentationb report rare case purulent pleurisy caused iSalmonella entericai subsp iarizonaei occurring 50yearold female breast cancer currently treated chemotherapy radiotherapy along chronic renal failure requiring haemodialysis presented acute chest pain dyspnoea haemodynamic instability bacteriological identification iSalmonella entericai subsp iarizonaei pleural fluid antibiotic susceptibility testing performed patient started broadspectrum antibiotic successfully improved condition bConclusionb case highlight implication iSalmonella entericai subsp iarizonaei purulent pleurisy immunocompromised patient early diagnosis proper antibiotic therapy enabled u reduce morbidity mortality risk patient",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40548130/"
    },
    {
        "pmid": "40536105",
        "title": "<i>Salmonella</i> exploits host- and bacterial-derived β-alanine for replication inside host macrophages.",
        "abstract": "iSalmonellai major foodborne pathogen effectively replicate inside host macrophage establish lifethreatening systemic infections iSalmonellai must utilize diverse nutrient growth nutrientpoor macrophages nutrient required intracellular iSalmonellai growth largely unknown Here found either acquisition host de novo synthesis nonprotein amino acid βalanine critical iSalmonellai replication inside macrophages concentration βalanine decreased iSalmonellaiinfected macrophages addition exogenous βalanine enhances iSalmonellai replication macrophages suggesting iSalmonellai uptake hostderived βalanine intracellular growth Moreover expression ipanDi ratelimiting gene required βalanine synthesis iSalmonellai upregulated iSalmonellai enters macrophages Mutation ipanDi impaired iSalmonellai replication macrophage colonization mouse liver spleen indicating de novo synthesis βalanine essential intracellular iSalmonellai growth systemic infection Additionally revealed βalanine influence iSalmonellai intracellular replication vivo virulence partially increasing expression zinc transporter gene iznuABCi turn facilitates uptake essential micronutrient zinc iSalmonellai Taken together finding highlight important role βalanine intracellular replication virulence iSalmonellai ipanDi promising target controlling systemic iSalmonellai infection",
        "mesh_terms": [
            "Macrophages",
            "Animals",
            "Mice",
            "beta-Alanine",
            "Salmonella typhimurium",
            "Virulence",
            "Bacterial Proteins",
            "Mice, Inbred C57BL",
            "Host-Pathogen Interactions",
            "Salmonella Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40536105/"
    },
    {
        "pmid": "40514190",
        "title": "Distinguishing the overlapping features of severe multi-inflammatory syndrome in children from severe dengue, scrub typhus and other endemic tropical infections-a comparative study from a tertiary care pediatric intensive care unit.",
        "abstract": "Early differentiation severe multiinflammatory syndrome child MISC severe presentation dengue scrub typhus endemic tropical infection could help clinician devise appropriate treatment strategies study aim identify diagnostic marker may used discriminate MISC versus endemic tropical infections namely dengue scrub typhus frequently occur endemic areas retrospective study conducted pediatric intensive care unit PICU tertiary care center New Delhi India 2020 2023 Comparative analysis 33 child diagnosed MISC done versus 77 child five endemic tropical infectionsdengue scrub typhus typhoid fever malaria leptospirosis Rash 6363 vs 3164 P  0005 conjunctival redness 6363 vs 886 P  0001 altered sensorium 4545 vs 2278 P  0031 seen greater proportion MISC case tropical infections Creactive protein CRP mgdl significantly higher child MISC versus tropical infection 1761 11261 19832 vs 925 2405 6938 P ≤ 0001 Ferritin lactate dehydrogenase LDH observed significantly higher child tropical infection compared MISC Using multivariable logistic regression analysis odds rash higher among child MISC dengue OR  807 95 CI 1225348 P  003 followed altered sensorium OR  1604 95 CI 20612462 P  0008 myocardial involvement OR  718 95 CI 1124593 P  0037 CRP 50 mgdl OR  1759 95 CI 26911492 P  0003 finding study suggest several clinical laboratory measure could potentially distinguish patient severe MISC endemic tropical infections Clinical marker rash altered sensorium myocardial involvement shock seen greater proportion case MISC Inflammatory marker CRP higher child MISC whereas ferritin LDH higher dengue scrub typhus typhoid fever malaria leptospirosis",
        "mesh_terms": [
            "Humans",
            "Scrub Typhus",
            "Male",
            "Female",
            "Retrospective Studies",
            "Child",
            "Child, Preschool",
            "Diagnosis, Differential",
            "Dengue",
            "India",
            "Intensive Care Units, Pediatric",
            "Systemic Inflammatory Response Syndrome",
            "Typhoid Fever",
            "Tertiary Care Centers",
            "Severe Dengue",
            "Infant",
            "Malaria",
            "Endemic Diseases",
            "Leptospirosis",
            "C-Reactive Protein",
            "Biomarkers",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40514190/"
    },
    {
        "pmid": "40513920",
        "title": "Dahuang Huanglian Decoction alleviates dysbiosis by inhibiting GBP5/NLRP3 signaling pathway-mediated pyroptosis of colonic epithelial cells.",
        "abstract": "Currently prevalence dysbiosis increasing treatment option limited Dahuang Huanglian Xiexin Decoction XXD traditional herbal prescription recorded Treatise Typhoid Fever longstanding application treatment digestive system diseases consists mainly three classical chinese medicinal herbs Dahuang Rheum palmatum L Huangqin Scutellaria baicalensis Georgi Huanglian Coptis chinensis Franch Previous study demonstrated efficacy XXD treating dysbiosis However exact underlying mechanism requires investigation effect XXD evaluated study determine impact dysbiosis reveal potential mechanism underlying alleviation using proteomics transcriptomics component XXD identified UPLCQTOFMS Dysbiosis mouse established mixing antibiotic solutions XXD employed therapeutic agent intervention Body weight changes diarrhea rates histopathology evaluated determine therapeutic effect XXD Proteomics transcriptomics subsequently employed elucidate mechanism underlying therapeutic effect XXD dysbiosis Meanwhile TEM used observe tight junction pyroptosis mouse colon Furthermore IF western blotting RTqPCR ELISA employed investigate mechanism XXD study indicates XXD promoted recovery dysbiosis repair intestinal barrier Integrative proteomic transcriptomic analysis identified NODlike receptor signaling pathway potential key mechanism GBP5 possible key protein gene verification prediction results XXD could significantly inhibit protein expression GBP5 NLRP3 ASC ProCaspase1CleavedCaspase1 NGSDMDGSDMD upregulate protein level ZO1 occludin reduce mRNA level GBP5 NLRP3 addition reduced secretion IL1β IL18 confirmed colocalization EpCAMGSDMD GBP5NLRP3 NLRP3ASC colon tissues whereas TEM suggested XXD alleviated ultrastructural damage caused pyroptosis study demonstrated XXD repair intestinal mucosal barrier regulate dysbiosis associated symptoms Multiomics approach used predict potential mechanism XXD Evidence experiment indicates regulation dysbiosis XXD may involve alleviating pyroptosis via inhibition GBP5NLRP3 pathway",
        "mesh_terms": [
            "Animals",
            "Pyroptosis",
            "NLR Family, Pyrin Domain-Containing 3 Protein",
            "Dysbiosis",
            "Drugs, Chinese Herbal",
            "Signal Transduction",
            "Mice",
            "Male",
            "Phosphate-Binding Proteins",
            "Colon",
            "Humans",
            "Mice, Inbred C57BL",
            "Epithelial Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40513920/"
    },
    {
        "pmid": "40497217",
        "title": "Early Predictors of Enteric Fever in Children Presenting With Fever Without Focus: A Prospective Study.",
        "abstract": "Objective Blood culture gold standard diagnosing enteric fever EF unavailability many health facility often lead overuse antimicrobials study aimed determine whether EF predicted early using clinical feature basic laboratory parameters thus bypassing need blood culture Methodology prospective cohort study conducted September 2015 February 2017 Delhi included child 6 month 15 year old presenting fever without focus within first week onset Based investigation results child categorized either Group I blood culture positive EF  iSalmonellai TyphiParatyphi Group II blood culture negative EF another diagnosis Group III case cause could established treated empirical antibiotics considered ambiguous group excluded study Results 350 cases blood culture confirmed EF 73 children 112 child another diagnosis subsequently 165 case could placed Group III Blood culture considered gold standard Logistic regression applied statistically significant clinical laboratory parameter child Group identify independent predictor EF Duration fever 4 days rising trend fever coated tongue splenomegaly Creactive protein CRP 25 mgL serum glutamic pyruvic transaminase SGPT 40 IUL absolute eosinopenia independent predictor EF study Conclusion resourcelimited settings short blood culture early prediction EF possible clinical feature simple laboratory investigations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40497217/"
    },
    {
        "pmid": "40481572",
        "title": "Addressing the burden of leptospirosis in Africa.",
        "abstract": "Leptospirosis zoonosis global distribution US Centers Disease Control Prevention designated leptospirosis nationally notifiable disease need raise awareness burden leptospirosis among health care giver policy maker Africa aim review highlight current situation leptospirosis Africa suggest One Health approach addressing status leading zoonosis tropical regions nonspecific symptom fever myalgia arthralgia result misdiagnosis leptospirosis malaria yellow fever typhoid fever dengue fever brucellosis rickettsiosis babesiosis Urinalysis present inexpensive diagnostic aid leptospirosis Humans leptospirosis exhibit proteinuria glucosuria pyuria haematuria granular cast resulting acute kidney injury Therapeutic guideline empirical treatment febrile patient considered Febrile patient test negative malaria yellow fever benefit doxycycline also treat brucellosis rickettsiosis typhoid fever Control leptospirosis also address Leptospira infection domestic animal reservoir vaccination cattle sheep goats pig dog endemic areas Treatment sick animal streptomycin eliminates carrier status curbing leptospiruria spread infection Rodents important transmission Leptospira human urban slum rural setting therefore rodent control strategy help reducing transmission leptospirosis Indirect transmission Leptospira occurs contact water vegetation soil contaminated infected urine Drinking water drawn protected source chlorinated household use",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40481572/"
    },
    {
        "pmid": "40466437",
        "title": "Rifampin mediated decapsulation and enhanced bacterial clearance: a new mechanism of rifamycins.",
        "abstract": "Many clinically relevant bacterial pathogen encapsulated exemplified Salmonella enterica serovar Typhi S Typhi causative agent lifethreatening systemic disease typhoid fever express Vi outermost surface glycan protects bacteria host immune responses Drug resistant S Typhi strain Vi variant spread globally Whole genome sequence WGS 24206 S Typhi clinical isolates analysed genetic trait antibiotic resistance Rifampin treated S Typhi characterised molecular cellular level effect rifampin mediated decapsulation bacterial clearance studied using human primary neutrophil mouse infection models Computational functional study encapsulated bacteria also carried out WGS analysis indicate almost S Typhi clinical isolates susceptible rifamycins azithromycin Rifampin subminimum inhibitory concentration MIC levels naturally established patient treatment eliminates protective capsule Vi process referred decapsulation thereby enhancing bacterial clearance Antibioticmediated decapsulation S Typhi appears specific rifamycins since azithromycin decapsulate S Typhi Rifampin mediated decapsulation occurs transcriptional level high content specific RpoB residue play crucial role Rifampin also effectively decapsulates Vi variants account 1 5 S Typhi isolates global level mechanistic explanation rifampin mediated decapsulation S Typhi appears applicable encapsulated pathogens including S Paratyphi C Nearly S Typhi isolates susceptible rifampin study reveals new mechanism rifamycin actions rifampin enhances bacterial clearance inhibiting expression protective capsular polysaccharide key virulence factors study important implication treating drug resistant S Typhi Vi capsule variants encapsulated bacterial pathogens National Institute Allergy Infectious Diseases",
        "mesh_terms": [
            "Rifampin",
            "Humans",
            "Animals",
            "Salmonella typhi",
            "Mice",
            "Anti-Bacterial Agents",
            "Rifamycins",
            "Microbial Sensitivity Tests",
            "Typhoid Fever",
            "Whole Genome Sequencing",
            "Bacterial Capsules",
            "Disease Models, Animal",
            "Neutrophils",
            "Drug Resistance, Bacterial",
            "Genome, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40466437/"
    },
    {
        "pmid": "40446606",
        "title": "Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study.",
        "abstract": "Typhoid fever remains major public health threat Low MiddleIncome LMIC countries typhoid conjugate vaccine TCV promising vaccine platform avert disease elicit sufficient immune response adult children However data longlasting immune response among child 2 year limited article present data collected healthy Filipino child administered ViDT vaccine longterm followup study included child vaccinated ViDT vaccine received booster dose either shortterm 24 weeks longterm 96 110 weeks 285 participant divided three cohort stratum age stratum 1 6 month less 9 months age stratum 2 9 month 12 months age stratum 3 13 month 23 months phase II clinical trial tracked enrolled observational study Blood sample collected 3rd 4th 5th year vaccination compared descriptively comparator assessed longterm immunogenicity using antiVi IgG serum bactericidal antibody SBA 24 August 2021 28 July 2023 268 healthy Filipino child enrolled study received least one dose ViDT comparator vaccine Phase II clinical trial AntiVi IgG seroconversion higher ViDT vaccine compared comparator calculating 9279  95  CI 8844 9558 8868  8371 9227 8638  81139035 ViDT group 2692  1677 4025 2909  1877 4214 2545  15813830 comparator group 3rd 4th 5th year respectively seroconversion higher ViDT longterm booster group shortterm booster group age stratum except age stratum 3 5th year 8378  68869235 8889  7469 9559 ViDT longterm booster shortterm booster group respectively SBA GMT response observed higher ViDT vaccine group age stratum compared comparator vaccine calculating 93206 69414 125153 95861 72184 127305 72438 53789 97555 ViDT vaccine group 65763 36743 117703 79627 45492 139376 61183 33810 110718 comparator group 3rd year 4th year 5th year respectively administered longterm booster dose 2 year primary singledose ViDT vaccine capable eliciting sustained immune response least 5 year following vaccination result study support inclusion ViDT vaccine routine immunization program endemic semiendemic areas",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Male",
            "Female",
            "Antibodies, Bacterial",
            "Typhoid-Paratyphoid Vaccines",
            "Philippines",
            "Typhoid Fever",
            "Vaccination",
            "Immunization, Secondary",
            "Follow-Up Studies",
            "Child, Preschool",
            "Immunogenicity, Vaccine",
            "Immunoglobulin G"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40446606/"
    },
    {
        "pmid": "40445123",
        "title": "Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience.",
        "abstract": "Typhoid fever significant health concern low middleincome countries million case thousand death year Typhoid Conjugate Vaccines Typbar TCV® developed provide longerlasting protection young children publication includes readout two different study Children elderly Comparator Study Age Extension Study first study child included whereas latter study also includes elderly subjects total 340 child enrolled subset received booster dose Typbar TCV® 180 day later Results established Typbar TCV® induced significantly higher antibody titer compared Typhim Vi day 28 90 ipi  001 significant difference adverse event found two vaccine arms Overall Typbar TCV® well tolerated inducing higher antiViIgG titer Typhim Vi® sustained response study period booster dose post6 month Typbar TCV® group significantly less immunogenic compared booster 2 year ipi  001 suggesting delayed booster might enhance anamnestic response fact confirmed previous clinical study Typbar TCV® Age Extension study 300 healthy volunteers including younger 1865 elderly adult 65 older received single dose Typbar TCV® vaccine reported safe induced similar anti ViAb geometric mean titer GMTs young elderly adults Thus Typbar TCV® studied effectively 6 month 85 years upper age limit CTRI Registration number CTRI201601006476 CTRI202406069638",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Aged, 80 and over",
            "Child",
            "Child, Preschool",
            "Female",
            "Humans",
            "Infant",
            "Male",
            "Middle Aged",
            "Young Adult",
            "Age Factors",
            "Antibodies, Bacterial",
            "Immunization, Secondary",
            "Immunoglobulin G",
            "India",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40445123/"
    },
    {
        "pmid": "40434987",
        "title": "Genomic insights into the role of Salmonella Typhi carriers in antimicrobial resistance and typhoid transmission in Urban Kenya.",
        "abstract": "Typhoid fever case carrier transmit Salmonella enterica serovar Typhi S Typhi fecal shedding remains unclear whether S Typhi shedding carrier exhibit similar phenotypic genotypic characteristic acute cases investigated multidrug resistance S Typhi individual residing urban informal settlement Nairobi Kenya recruited participant ≤ 65 year six health facility tested typhoid infection blood stool cultures S Typhi culturepositive case treated followed treatment index case household contact provided stool sample culture susceptibility S Typhi isolates tested 14 antibiotic using Kirby Bauer disc diffusion Total deoxyribonucleic acid DNA extracted selected multidrug resistant MDR S Typhi whole genome sequencing using Illumina Nextseq2000 genome analyzed Pathogenwatch 115 S Typhi isolates 81115 70 cases 34115 30 carriers S Typhi resistance ampicillin observed 3281 40 1134 32 isolates case carriers respectively resistance cotrimoxazole observed 3481 42 1034 29 isolates case carriers respectively addition resistance chloramphenicol observed 308137 1034 29 isolates case carriers respectively Multidrug resistance observed 33 38115 S Typhi isolates majority 2838 74 recovered cases subset 2238 15 case 7 carriers MDR isolates randomly selected sequencing 22 S Typhi belonged genotype 431 majority 1522 68 genotype 4312EA3 isolates carried blaTEM1D catA1 dfrA7 sul1 sul2 AMR genes GyrA point mutation conferring reduced susceptibility quinolones fluoroquinolones detected 1922 86 isolates majority 1522 79 occurring codon 83 studys finding highlight plausibility typhoid transmission within community disease endemic settings Consequently study demonstrates need surveillance antimicrobial resistance antimicrobial stewardship deployment typhoid vaccine improvement water hygiene sanitation infrastructure disease endemic settings",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Kenya",
            "Typhoid Fever",
            "Adult",
            "Male",
            "Female",
            "Anti-Bacterial Agents",
            "Drug Resistance, Multiple, Bacterial",
            "Middle Aged",
            "Microbial Sensitivity Tests",
            "Child, Preschool",
            "Child",
            "Adolescent",
            "Young Adult",
            "Carrier State",
            "Infant",
            "Feces",
            "Genome, Bacterial",
            "Urban Population"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40434987/"
    },
    {
        "pmid": "40422861",
        "title": "Comprehensive analysis of extensive drug-resistant <i>Salmonella</i> Typhi in Gujarat region, India: genomic findings and prospective alternative therapy.",
        "abstract": "Antimicrobial resistance AMR iSalmonellai Typhi iSi Typhi serious health issue complicate typhoid fever treatment increase fatality rates National Centre Disease Control Government India established National Antimicrobial Surveillance Network detect AMR highpriority infections including iSi Typhi throughout geographical area India understand AMR dissemination possible treatment options Gujarat State Biotechnology Mission Government Gujarat India funded Network Program Antimicrobial Resistance Superbugs One Health track antibiotic resistance pattern Gujarat region Given enormity AMR problem iSi Typhi Gujarat study evaluated antibiotic resistance pattern iSi Typhi isolates Ahmedabad Vadodara region Gujarat India used determine mechanism underlying antibiotic resistance developed combination treatment combat extensive drugresistant isolates collected 122 iSalmonellai isolates periodically 20222023 Ahmedabad Vadodara region Gujarat India antibiotic susceptibility 122 iSi Typhi isolates prepared using disc diffusion method VITEK II compact system Wholegenome sequencing iinsilicoi analysis performed identify potential antibiotic resistance gene ARGs addition combination antibiotic therapy investigated resistance pattern predicted key antibiotic used treatment typhoid fever study discovered notable level antibiotic resistance specifically cefuroxime 9754 doxycycline 9754 ceftriaxone 9590 cotrimoxazole 9590 ampicillinsulbactam 9590 cefotaxime 9426 ciprofloxacin 9426 Genetic analysis revealed presence iaph3Ibi 4016 iaph6Idi 9508 iblaisubCTXMsub 8939 idfrA14i 6885 plasmidmediated quinolone resistance PMQR iqnrS1i gene 9426 IncFIBK IncFIBpHCM2 detected 9671 iSi Typhi isolates Point mutation QRDR region igyrAi identified three distinct modifications Ser83Phen 9180 Ser83Leu 164 Ser83Tyr 082 Three gene exhibited point mutations igyrBi 100 Ile253Val iparCi 656 multiple mutations efflux gene imdtKi 100 Thr224Lys evaluating phenotype genotype test showed average concordance 9169 discordance 831 study revealed 9754 isolates belonged H58 haplotype lineage II ST1 4312 associated high resistance cephalosporin fluoroquinolones Southeast Asia combination therapy iβilactamiβilactamase inhibitor BLBLI demonstrated good outcomes low MICs 05 µgmL ceftazidimetazobactam cefiximetazobactam ceftriaxonetazobactam effective highly resistant iSi Typhi emergence MDRXDR iSi Typhi attributed mutation igyrAi parC H58 lineage highlight widespread resistance According research potential strategy XDR iSi Typhi combination treatment BLBLI One first study assess antimicrobial resistance pattern iSi Typhi isolates Ahmedabad Vadodara regions particular investigation provides vital information occurrence key resistance gene mechanisms study significantly contributed finding βlactamβlactamase inhibitor combination therapy appropriate treatment choice XDR potentially use iSi Typhi larger scale Additionally provides antibiotic resistance prediction key antibiotic used treating typhoidal fever outcome investigation highlight urgent need address surge XDR iSi Typhi highburden region Gujarat study highlight possibility rapid dissemination antibiotic resistance due chromosomal point mutation plasmidmediated gene transfer effectiveness βlactamβlactamase inhibitor handling XDR iSi Typhi suggests plausible strategy treatment may included among clinical guidelines",
        "mesh_terms": [
            "Salmonella typhi",
            "India",
            "Humans",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Multiple, Bacterial",
            "Genomics",
            "Drug Resistance, Bacterial",
            "Genome, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40422861/"
    },
    {
        "pmid": "40408399",
        "title": "Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaoundé-Cameroon.",
        "abstract": "Malaria typhoid fever remain major health issue developing country like Cameroon frequent coinfections potential liver damage caused respective causative pathogen overlooked health management posing significant risk severe liver injury worsening patient conditions Accordingly study investigated risk factor associated liver damage febrile patient malaria typhoid fever coinfection Obili District Medical Center MvogBetsi Dominican Hospital Center Yaoundé Cameroon 8 months 350 febrile patient evaluated adherence preventive measure concerning malaria typhoid fever using structured questionnaire Blood sample analyzed Plasmodium specie Salmonella antibody liver enzyme level measured Liver damage assessed using Roussel Uclaf Causality Assessment Method Risk factor infection liver damage identified using Fishers Exact ChiSquare tests significance set P  005 Among participant tested 129 3686 106 3029 positive malaria typhoid respectively 56 1600 coinfected Men 492 373 affected woman 306 267 malaria typhoid respectively Participants aged 20 40 year affected malaria 214 typhoid fever 174 nonuse mosquito nets presence standing water bushes garbage dump near residence significant risk factor Relative risk RR  21 P  00001 contracting malaria typhoid fever coinfection status Chi2  1830 P  00001 parasite density Chi2  98 P  00074 delay consulting Chi2  1323 P  00013 significant risk factor occurrence liver injuries finding demonstrated alteration liver enzyme activity reflecting liver damage among patient malaria typhoid malariatyphoid coinfection reality considered patient treatment",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cameroon",
            "Adult",
            "Malaria",
            "Middle Aged",
            "Coinfection",
            "Risk Factors",
            "Typhoid Fever",
            "Adolescent",
            "Young Adult",
            "Liver",
            "Health Facilities",
            "Liver Diseases",
            "Child",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40408399/"
    },
    {
        "pmid": "40390893",
        "title": "A Rare Case of Ovarian Abscess Secondary to <i>Salmonella typhi</i> Infection in Women with MRKH: A Case Report and Review of Literature.",
        "abstract": "common clinical presentation woman MRKH primary amenorrhea rare pelvic mass woman MRKH case reported literature Although many case report ovarian abscess published none published ovarian abscess secondary iSalmonella typhii infection woman MRKH report case 32 yr old woman fever unknown origin unresponsive medical management fever work up blood test suggested typhoid infection MRI suggested right sided ovarian mass high suspicion mucinous cystadenoma staging laparotomy huge right sided ovarian abscess found Right salpingooopherectomy performed Pus culture suggested iSalmonella typhii infection histopathology suggested infected ovarian endometrioma",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40390893/"
    },
    {
        "pmid": "40385822",
        "title": "Typhoid Fever Presenting With Cerebral Venous Thrombosis: A Report of a Rare Case.",
        "abstract": "Typhoid fever caused iSalmonella typhii significant infectious disease endemic regions Although primarily affect gastrointestinal system systemic complications including vascular thrombosis occur present case 47yearold previously healthy woman developed diarrhea vomiting headache context fever complicated altered consciousness Contrastenhanced computed tomography revealed sagittal sinus thrombosis Blood culture negative iSalmonellai Widal Felix serologic testing positive patient successfully treated antibiotic anticoagulants iS typhii can rare cases lead cerebral thrombotic event inducing hypercoagulable state inflammation endothelial dysfunction case highlight rare association iS typhii infection cerebral venous thrombosis emphasizing importance considering etiology similar clinical presentations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40385822/"
    },
    {
        "pmid": "40372181",
        "title": "Typhoid fever in Jakarta, Indonesia 2017-2023: spatial clustering and seasonality of hospitalization data to inform better intervention.",
        "abstract": "Typhoid fever one common enteric fever developing countries especially emerging metropolitan area Indonesia Yet study spatial temporal distribution tyhoid fever lacking study conducted analyze retrospective hospitalbased data village level period 20172023 understand spatial temporal variation typhoid fever Jakarta Spatial analysis performed Morans Local Indicators Spatial Association LISA examine spatial clustering typhoid incidence identify highrisk village typhoid fever respectively Seasonal decomposition analysis performed investigate seasonality infection total 57468 typhoid cases resulting cumulative incidence 53399 per 100000 people reported study period incidence significantly clustered I0548 p0001 village level across Jakarta Statistically significant highrisk cluster detected South East Jakarta heterogeneous time identified seven persistent highrisk cluster eastern part city two southern part Moreover typhoid incidence showed strong seasonality trend significantly associated monthly total rainfall p0018 study revealed significant spatial variation strong seasonality typhoid incidence across city suggesting variation transmission intensity need effective public health interventions especially highrisk areas Improvement water sanitation facilities hygiene awareness surveillance essential help reduce typhoid transmission Jakarta",
        "mesh_terms": [
            "Typhoid Fever",
            "Humans",
            "Indonesia",
            "Seasons",
            "Incidence",
            "Retrospective Studies",
            "Hospitalization",
            "Spatial Analysis",
            "Spatio-Temporal Analysis",
            "Cluster Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40372181/"
    },
    {
        "pmid": "40362459",
        "title": "Hypervesiculation Meets Sec-Targeting: Enhancing Heterologous Protein Loading in <i>Salmonella</i> Typhi Outer Membrane Vesicles for Delivery and Immune Response.",
        "abstract": "iSalmonella entericai serovar Typhi iSi Typhi produce outer membrane vesicle OMVs remain comparatively underexplored potential biotechnological tools Here investigated hypervesiculating iSi Typhi mutant ΔitolRi ΔidegSi engineered load deliver fluorescent reporter protein mCherry targeting human epithelial cell murine immune system Deletions itolRi idegSi led distinct OMV phenotype characterized higher vesicle production altered cargo composition underscoring impact disrupted membrane integrity envelope stress OMV biogenesis fusing mCherry iSi Typhi OmpA signal peptide SPisubompAsubi achieved robust functionally intact intravesicular packaging strains Flow cytometry confocal microscopy revealed ΔitolRi mutant exhibited particularly high cargo loading OMV fraction pronounced mCherry delivery epithelial cells highlighting potential hypervesiculation enhance OMVbased protein transport However immunization study mouse showed wildtype OMVs despite carrying less mCherry hypervesiculating counterparts induced strongest antimCherry IgG responses finding indicate that least conditions antigen loading alone sufficient fully determine immunogenicity Instead intrinsic composition adjuvantlike property OMVs play pivotal role driving robust immune activation result establish iSi Typhi OMVs especially genetically modified Secdependent targeting signal SPisubompAsubi versatile platform heterologous protein delivery Although hypervesiculation facilitates increased protein encapsulation delivery epithelial cells native OMVs appear better preserve andor present antigen effective immunogenic response vivo insight set stage optimization iSi Typhi OMVs vaccine development protein therapeutics balancing cargo loading immunostimulatory feature may key achieving maximal efficacy",
        "mesh_terms": [
            "Salmonella typhi",
            "Animals",
            "Mice",
            "Humans",
            "Bacterial Outer Membrane Proteins",
            "Bacterial Proteins",
            "Protein Transport",
            "Epithelial Cells",
            "Female",
            "Typhoid Fever",
            "Immunization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40362459/"
    },
    {
        "pmid": "40362220",
        "title": "Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever.",
        "abstract": "Enteric fever caused iSalmonella entericai serovar Typhi iSi Typhi iSalmonella entericai serovar Paratyphi iSi Paratyphi A B C Globally estimated 11 21 million case typhoid paratyphoid fever occur annually approximately 130000160000 deaths reported SouthSoutheast Asia subSaharan Africa antibiotic susceptibility iSi Typhi strain varies country within broad limits 3 97 ampicillin 9 95 ciprofloxacin 4 94 chloramphenicol India vs Pakistan 0 99 ceftriaxone India vs Iraq iSi Typhi increasingly exhibiting resistance antibiotics vaccination becomes essential preventive measure Currently three vaccine licensed typhoid fever typhoid conjugate vaccine TCV liveattenuated oral vaccine Ty21a Ty21a Vi capsular polysaccharide vaccine ViCPS specific vaccine exists paratyphoid fever genetic antigenic similarity iSi Paratyphi iSi Typhi offer potential development vaccine Early study show promising results demonstrating safety immunogenicity preclinical trials Whole genome sequencing WGS provides powerful tool assigning genotypes identifying plasmids comparing genetic elements investigating molecular factor contribute antibiotic resistance virulence",
        "mesh_terms": [
            "Salmonella typhi",
            "Typhoid Fever",
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Vaccination",
            "Virulence",
            "Animals",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40362220/"
    },
    {
        "pmid": "40354339",
        "title": "XDR typhoid in Pakistan: A threat to global health security and a wake-up call for antimicrobial stewardship.",
        "abstract": "Extensively drugresistant XDR typhoid caused Salmonella enterica serotype Typhi emerged critical global health security threat Pakistan particularly Sindh province epicenter misuse antibiotics inadequate diagnostic tools poor water sanitation infrastructure created ideal condition rise antimicrobial resistance AMR XDR typhoid strain resistant multiple firstline antibiotic linked environmental contamination urban area like Karachi demonstrating high rate waterborne transmission International travel amplified threat exporting case country including United States United Kingdom Canada thus highlighting global implications commentary examines historical context typhoid treatment driver AMR Pakistan critical role antimicrobial stewardship combating XDR typhoid advocate integrated approach would encompass improvement water quality expanded vaccination coverage typhoid conjugate vaccine TCVs stringent audit antibiotic prescription practices Immediate local global action needed contain public health crisis prevent resurgence typhoid largely untreatable disease situation underscore urgency addressing AMR safeguard global health security",
        "mesh_terms": [
            "Typhoid Fever",
            "Pakistan",
            "Humans",
            "Antimicrobial Stewardship",
            "Salmonella typhi",
            "Global Health",
            "Anti-Bacterial Agents",
            "Drug Resistance, Multiple, Bacterial",
            "Typhoid-Paratyphoid Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40354339/"
    },
    {
        "pmid": "40346656",
        "title": "The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.",
        "abstract": "Salmonella enterica subspecies enterica serovar Typhi abbreviated Typhi bacterial agent typhoid fever Effective antimicrobial therapy reduces complication mortality however antimicrobial resistance AMR major problem many endemic countries Prevention vaccination possible recentlylicensed typhoid conjugate vaccine TCVs National immunisation program currently considered deployed several country AMR prevalence known high Gavi vaccine alliance provided financial support introduction Pathogen whole genome sequence data rich source information Typhi variant genotypes lineages AMR prevalence mechanisms However information currently readily accessible nongenomics experts including driving vaccine implementation empirical therapy guidance developed TyphiNET  httpswwwtyphinet  interactive online dashboard exploring Typhi genotype AMR distribution derived publicly available pathogen genome sequences TyphiNET allows user explore countrylevel summary frequency pathogen lineages temporal trend resistance clinically relevant antimicrobials specific variant mechanism underlying emergent AMR trends Userdriven plot session report downloaded ease sharing Importantly TyphiNET populated highquality genome data curated Global Typhoid Pathogen Genomics Consortium analysed using Pathogenwatch platform identified coming nontargeted sampling frame suitable estimating AMR prevalence amongst Typhi infection no personal data included platform February 2024 data total n  11836 genome 101 country available TyphiNET outline case study illustrating dashboard used explore data gain insight relevance researcher public health policymakers TyphiNET dashboard provides interactive platform accessing genomederived data pathogen variant frequency inform typhoid control intervention strategies platform extensible term data features provides model making complex bacterial genomederived data accessible wide audience",
        "mesh_terms": [
            "Salmonella typhi",
            "Genomics",
            "Humans",
            "Typhoid Fever",
            "Public Health",
            "Genome, Bacterial",
            "Drug Resistance, Bacterial",
            "Anti-Bacterial Agents",
            "Genotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40346656/"
    },
    {
        "pmid": "40341792",
        "title": "Community engagement: the missing piece in solving the puzzle of XDR-typhoid spread in Pakistan.",
        "abstract": "Typhoid major infectious health threat mass Pakistan increasing antimicrobial resistance socioeconomic decline environmental challenges Since 2019 percentage case reduced implementation Typhoid Conjugate Vaccine TCV program report widened geographical spread particularly aftermath flooding 2022 resistance Azithromycin Meropenem adult population matter serious concern right time reconsider whether strategy like mass immunization health infrastructure development solely combat hazard Extensively DrugResistant XDRTyphoid Public health policy developed due COVID19 incorporating stakeholder especially public community engagement may provide collaborative effort lessen prevailing threat antibiotic resistance",
        "mesh_terms": [
            "Pakistan",
            "Humans",
            "Typhoid Fever",
            "COVID-19",
            "Community Participation",
            "Health Policy",
            "Typhoid-Paratyphoid Vaccines",
            "Drug Resistance, Multiple, Bacterial",
            "Public Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40341792/"
    },
    {
        "pmid": "40341334",
        "title": "Typhoid toxin causes neuropathology by disrupting the blood-brain barrier.",
        "abstract": "Typhoid fever primarily caused Salmonella Typhi result severe lifethreatening complication encephalopathy elucidate mechanism typhoid toxin unique virulence factor S Typhi mediates neuropathology associated typhoid fever Utilizing mouse engineered specific tissue protected toxin action vitro model bloodbrain barrier BBB demonstrate that rather direct action neuronal glial cells typhoid toxin cause neuropathology disrupting BBB Intravenous tracer study confirmed significant BBB permeability change following toxin exposure effect found mediated typhoid toxins CdtB catalytic subunit demonstrate corticosteroid effective mitigating BBB disruption vivo supporting use managing typhoid fever neurological complications data reveal mechanistic insight typhoid toxin cause encephalopathy suggest targeted therapeutic intervention alleviate severe neurological manifestation typhoid fever",
        "mesh_terms": [
            "Blood-Brain Barrier",
            "Animals",
            "Mice",
            "Salmonella typhi",
            "Typhoid Fever",
            "Bacterial Toxins",
            "Humans",
            "Disease Models, Animal",
            "Neurons"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40341334/"
    },
    {
        "pmid": "40339732",
        "title": "An integrated approach for genetic risk profiling of typhoid, tuberculosis, and cholera in local population of tehsil Haripur.",
        "abstract": "Despite notable progress public health throughout 21st century infectious disease like tuberculosis typhoid cholera remain serious threat global health particularly highrisk regions Understanding genetic factor influence susceptibility resistance disease essential developing effective strategy prevention treatment study investigates genetic variation associated infectious disease focus region disease prevalent aim study identify genetic variant may influence susceptibility tuberculosis typhoid cholera thorough analysis genetic variant associated susceptibility resistance tuberculosis typhoid cholera conducted Using publicly available genetic data various ethnic groups allele frequency prioritized variant calculated assess distribution within different populations including Middle Eastern Ashkenazi Jewish European NonFinnish LatinoAdmixed American South Asian East Asian European Finnish North Asian Southeast Asian African American Swedish populations variant IL1β gene exhibiting highest allele frequency South Asian population identified subsequently examined within local population Specifically variant rs1143627 rs1143629 demonstrate highest allele frequency associated typhoid tuberculosis cholera subjected detailed analysis determine distribution potential impact disease susceptibility local population statistical analysis available sample revealed allele frequency 01128  IL1β rs1143627 018  IL1β rs1143629 Furthermore finding revealed certain genetic profile may play role populations overall response infectious disease tuberculosis typhoid cholera research potential guide future public health strategy effective management prevention diseases",
        "mesh_terms": [
            "Humans",
            "Cholera",
            "Tuberculosis",
            "Typhoid Fever",
            "Genetic Predisposition to Disease",
            "Gene Frequency",
            "Polymorphism, Single Nucleotide",
            "Interleukin-1beta"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40339732/"
    },
    {
        "pmid": "40337575",
        "title": "Ascaris Peritonitis in a Pediatric Patient With Typhoid Fever.",
        "abstract": "Intestinal infestation ascaris worm common worldwide usually cause minimal abdominal symptoms Severe abdominal complication bowel obstruction may occur bowel perforation ascariasis rare present case sevenyearold boy initially presented typhoid fever developed ascaris peritonitis requiring emergent surgery discus preoperative diagnosis perioperative management well purported mechanism coinfection typhoid fever ascariasis lead small bowel perforation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40337575/"
    },
    {
        "pmid": "40326553",
        "title": "Typhoid conjugate vaccines for preventing typhoid fever (enteric fever).",
        "abstract": "Typhoid fever major cause enteric diseaserelated morbidity mortality Vaccination reduces disease burden prevents outbreaks policy programme informed recent evidence newer vaccine become available assess benefit harm typhoid conjugate vaccine TCVs compared vaccine placebo typhoidinactive agent vaccines another disease typhoid vaccine preventing morbidity mortality associated typhoid fever adult children April 2024 searched Cochrane Central Register Controlled Trials MEDLINE Embase CINAHL Global Index Medicus United States Advisory Committee Immunization Practices World Health Organization vaccine repository randomised controlled trial RCTs restrictions also searched clinical trial registry ongoing trial www gov International Clinical Trials Registry Platform grey literature bibliographic citation review key article additional studies contacted study author information ongoing studies included RCTs clusterRCTs child adult living typhoidendemic area travelling typhoidendemic areas included study comparing TCVs control ie vaccine placebo vaccine another disease nonconjugated typhoid vaccine TCVs Outcomes included acute typhoid fever defined laboratoryconfirmed isolation Salmonella typhi allcause mortality adverse event AEs serious adverse event SAEs Review author independently assessed risk bias outcomes using Cochrane RoB 2 tools resolved disagreement discussion adjudication assessed intentiontotreat effect used overall RoB judgement assess certainty evidence outcome Three review author independently screened title abstract eligible studies followed fulltext assessment Disagreements resolved discussion adjudication fourth author Four author independently extracted characteristic included study outcome data using piloted standardised data extraction form synthesised result outcome possible using MantelHaenszel statistical method randomeffects analysis model metaanalysis possible due nature data planned synthesise result based direction effect used GRADE assess certainty evidence outcome assessing risk bias inconsistency indirectness imprecision bias included 19 trial 17 RCTs two clusterRCTs 19 trial enrolled 395650 participants age ranging six week 60 years Vaccines delivered single dose 14 studies two doses ranging four 24 week apart six studies three doses four week apart one study Comparators included vaccine placebo vaccines Seven study compared TCV nonconjugated typhoid vaccines Six study compared one TCV another TCV TCV compared control may result large reduction acute typhoid fever risk ratio RR 020 95 confidence interval CI 012 032 Isup2sup  70 6 studies 101896 participants lowcertainty evidence probably result little difference allcause mortality RR 080 95 CI 035 185 Isup2sup  52 4 studies 100337 participants moderatecertainty evidence TCV result little difference AEs compared control RR 091 95 CI 076 109 Isup2sup  0 3 studies 29465 participants highcertainty evidence slight reduction SAEs compared control RR 082 95 CI 071 095 Isup2sup  0 6 studies 89625 participants highcertainty evidence TCV compared nonconjugated typhoid vaccine may result little difference acute typhoid fever RR 090 95 CI 048 169 1 study 78 participants lowcertainty evidence death included studies compared nonconjugated typhoid vaccines TCV likely result little difference AEs RR 100 95 CI 077 131 Isup2sup  0 3 studies 244 participants moderatecertainty evidence likely result slight reduction SAEs RR 030 95 CI 005 188 Isup2sup  0 2 studies 732 participants moderatecertainty evidence TCV compared another TCV none study reported acute typhoid fever Vi tetanus toxoid vaccine ViTT may result little difference allcause mortality compared different TCV RR 519 95 CI 054 4980 Isup2sup  0 2 studies 2422 participants lowcertainty evidence ViTT likely result little difference AEs compared another TCV RR 118 95 CI 092 151 Isup2sup  39 4 studies 2916 participants moderatecertainty evidence may result little difference SAEs RR 248 95 CI 074 836 Isup2sup  0 3 studies 2866 participants lowcertainty evidence certainty evidence consistently reduced due imprecision indirectness bias review highlight TCVs compared controls effective preventing typhoid fever may confer protection four years TCVs compared nonconjugated typhoid vaccine may result little difference acute typhoid fever AEs likely result slight reduction SAEs ViTT compared another TCV may result little difference allcause mortality SAEs likely result little difference AEs NG TL TK partly supported by Cochrane Infectious Diseases Group CIDG editorial base funded by Research Evidence Development Initiative READIt funded UK aid benefit low middleincome country project number 300342104 view expressed review necessarily reflect official policy UK government Protocol available via doiorg10100214651858CD015746",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Randomized Controlled Trials as Topic",
            "Vaccines, Conjugate",
            "Child",
            "Adult",
            "Salmonella typhi"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40326553/"
    },
    {
        "pmid": "40311664",
        "title": "Fever in travelers returning from tropical and subtropical areas: a hospital-based study of factors affecting investigations and diagnoses in children and adults.",
        "abstract": "global travel surge postpandemic era healthcare system must prepare proper management disease encountered returning travelers retrospective study management returning traveler tropical subtropical regions fever adult paediatric emergency department Karolinska University Hospital Stockholm Sweden Demographics travel history clinical microbiology data extracted health records Multivariate regression analysis identified factor affecting investigation diagnoses total 2441 patient 2197 adults 244 children included etiological diagnosis confirmed 633  n  1546 patients malaria 56  n  138 dengue 40  n  98 typhoid fever 09  n  22 common tropical infections Patients fever 38 °C aOR 148 95  CI 120184 hospitalization aOR 468 95  CI 323680 higher odds etiological diagnosis Children less likely adult cause fever diagnosed OR 064 95  CI 049084 Malaria testing lower child adult visited SubSahara Africa 806  v 904  Overall lower proportion child underwent blood cultures compared adult 295  v 687  VFR traveler migrant lower probability microbiological investigation malaria testing negative aOR 069 95  CI 054090 aOR 067 95  CI 050090 management febrile patient following tropical travel varied significantly across different patient groups Children migrant VFR traveler often receive less thoroughly investigations highlight need equitable management investigation especially vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Retrospective Studies",
            "Female",
            "Male",
            "Child",
            "Adult",
            "Travel",
            "Fever",
            "Child, Preschool",
            "Adolescent",
            "Middle Aged",
            "Typhoid Fever",
            "Malaria",
            "Tropical Climate",
            "Young Adult",
            "Sweden",
            "Infant",
            "Dengue",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40311664/"
    },
    {
        "pmid": "40305823",
        "title": "The discovery of chloramphenicol treatment for both scrub typhus and typhoid fever.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40305823/"
    },
    {
        "pmid": "40280572",
        "title": "Rare complication of Salmonella Typhi infection: rhabdomyolysis.",
        "abstract": "Salmonella Typhi S Typhi wellknown pathogen responsible typhoid fever characterised gastrointestinal systemic symptoms Complications typically involve gastrointestinal tract extraintestinal manifestation rare Rhabdomyolysis unusual complication iS Typhii infection exact pathophysiology rhabdomyolysis context unknown may due multitude factors present case iS Typhii infection resulting rhabdomyolysis acute kidney injury",
        "mesh_terms": [
            "Humans",
            "Acute Kidney Injury",
            "Anti-Bacterial Agents",
            "Rhabdomyolysis",
            "Salmonella typhi",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40280572/"
    },
    {
        "pmid": "40277824",
        "title": "Prevalence and Antimicrobial Resistance of Typhoid Fever in Ghana: A Systematic Review and Meta-Analysis.",
        "abstract": "bBackgroundObjectivesb Typhoid fever caused iSalmonella enterica serovari Typhi remains important public health problem Ghana Understanding epidemiology antimicrobial resistance pattern iSi Typhi crucial guide treatment control typhoid fever systematic review metaanalysis aimed estimate prevalence typhoid fever Ghana describe antibiotic susceptibility profiles bMethodsb Literature search conducted using PubMed repository three databases Scopus Web Science ScienceDirect Observational study reporting typhoid fever prevalence among Ghanaian participant diagnosed culture Widal test published 1 January 2004 16 August 2024 eligible Quality assessed using standardized JBI critical appraisal checklists Randomeffects metaanalysis 95 confidence interval performed estimate pooled prevalence conduct subgroup analyses bResultsb total 22 study involving 228107 participant included systematic review pooled prevalence typhoid fever 414 95 CI 278575 Blood culture detected case 368 stool culture 116 Multidrug resistance documented 2066 isolates ciprofloxacin lowest prevalence resistance 017 bConclusionsb review highlight substantial typhoid fever burden evolving antimicrobial resistance Ghana Continuous surveillance disease warranted optimize empiric treatment control strategies given resistance firstline drugs Enhanced prevention water sanitation vaccination program imperative",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40277824/"
    },
    {
        "pmid": "40258867",
        "title": "Antimicrobial susceptibility trends of S. Typhi and S. Paratyphi in a post-COVID-19 pandemic India, from a multicenter surveillance network.",
        "abstract": "conducted multicenter surveillance study identify change antimicrobial susceptibility pattern Salmonella Typhi S Paratyphi India since COVID19 pandemic began collected S Typhi S Paratyphi isolates blood bone marrow cultureconfirmed enteric fever case eight site seven city across India 2021 2024 tested antibiotic susceptibility 1150 S Typhi isolates 265 S Paratyphi isolates via disc diffusion determined minimum inhibitory concentration MICs ceftriaxone azithromycin via broth dilution identified 18 S Typhi isolates Ahmedabad resistant ceftriaxone indicating larger emergence thirdgeneration cephalosporinresistant S Typhi Western India novel plasmid profile Furthermore observed yearly increase mean median 90th percentile azithromycin MICs S Typhi S Paratyphi isolates throughout India 2021 2023 Finally found 070 S Typhi isolates 113 S Paratyphi isolates exhibited susceptibility ciprofloxacin result indicate necessity shift ciprofloxacin treatment enteric fever importance implementing longterm monitoring resistance alternative antibiotic azithromycin ceftriaxone",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "India",
            "COVID-19",
            "Microbial Sensitivity Tests",
            "Salmonella paratyphi A",
            "Anti-Bacterial Agents",
            "Typhoid Fever",
            "Azithromycin",
            "Ceftriaxone",
            "SARS-CoV-2",
            "Drug Resistance, Bacterial",
            "Paratyphoid Fever",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40258867/"
    },
    {
        "pmid": "40252838",
        "title": "Standard protocols for performance evaluation of typhoid fever in-vitro diagnostic assays in laboratory and field settings.",
        "abstract": "Typhoid fever leading public health problem India South East Asian countries diagnosis traditionally relies culture method poor sensitivity serological method limited role endemic areas Incorrect diagnosis result antibiotic misuse disease complications emergence spread multidrugresistant strains need develop quality diagnostic test effective early diagnosis typhoid fever help early patient management disease burden estimation assessing impact public health intervention including vaccines paper describes standard protocol conducting prelicensure analytical field clinical performance evaluation invitro diagnostic test detect S Typhi antigen antibody gene segment bloodserumplasma samples analytical performance evaluation protocol describes diagnostic accuracy study three different IVD format using wellcharacterized clinical samples field validation protocol describes methodology conducting crosssectional study assessing IVD performance acute undifferentiated febrile illness latter may also used establish typhoid sample biobank protocol use statistically significant sample size describe detailed sample panel including cross reactive specimens protocol help robust evaluation IVDs typhoid especially endemic area absence predicate device best knowledge first comprehensive guidance document kind may adapted across similar settings",
        "mesh_terms": [
            "Typhoid Fever",
            "Humans",
            "Salmonella typhi",
            "India",
            "Diagnostic Tests, Routine",
            "Antibodies, Bacterial",
            "Sensitivity and Specificity",
            "Antigens, Bacterial",
            "Cross-Sectional Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40252838/"
    },
    {
        "pmid": "40241726",
        "title": "Modeling solutions for microbial water contamination in the global south for public health protection.",
        "abstract": "Microbial contamination water source pressing global challenge disproportionately affecting developing region inadequate infrastructure limited access safe drinking water Global South waterborne pathogen bacteria viruses protozoa helminth contribute disease like cholera dysentery typhoid fever resulting severe public health burdens Predictive modeling emerges pivotal tool addressing challenges offering datadriven insight anticipate contamination event optimize mitigation strategies review highlight application predictive modeling techniquesincluding machine learning hydrological simulations quantitative microbial risk assessment to identify contamination hotspots forecast pathogen dynamics inform water resource allocation Global South Predictive model enable targeted action improve water safety lower prevalence waterborne disease combining environmental socioeconomic climatic factors Water resource Global South increasingly vulnerability microbial contamination challenge exacerbated rapid urbanization climate variability insufficient sanitation infrastructure review underscore importance regionspecific modeling approaches Case study subSaharan Africa South Asia demonstrated efficacy predictive modeling tool guiding public health action connected environmental matrices prioritizing water treatment effort implementing earlywarning system extreme weather events Furthermore review explores integrating advanced technologies remote sensing artificial intelligence predictive frameworks highlighting potential improve accuracy scalability resourceconstrained settings Increased funding data collecting predictive modeling tools crosssectoral cooperation local communities nongovernmental organizations government recommended review effort critical developing resilient water system capable withstanding environmental stressor ensuring sustainable access safe drinking water leveraging predictive modeling core component water management strategies stakeholder address microbial contamination challenge effectively safeguard public health contribute achieving United Nations Sustainable Development Goals",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40241726/"
    },
    {
        "pmid": "40234082",
        "title": "Typhoid and viral hepatitis in a child: revisiting the role of water, sanitation and hygiene (WASH) and vaccines in the epidemiology of faecal-orally transmitted diseases.",
        "abstract": "case report describes Hepatitis typhoid infection child hailing urban site India within 4 weeks thereby highlighting systemic issue water quality public health case shed light broader public health challenge faced low middleincome countries including inadequate WASH water sanitation hygiene facilities contributing high incidence faecalorally transmitted diseases 2016 poor WASH responsible 60 diarrhoeal deaths Sustainable Development Goals aim improve global water sanitation 2030 emphasising need equitable access Interim solution like vaccination pointofuse water treatment vital Vaccination typhoid hepatitis especially crucial area high disease prevalence rising antimicrobial resistance must advocate vaccine included National Immunisation Schedules ensure widespread equitable coverage support public health",
        "mesh_terms": [
            "Humans",
            "Hepatitis A",
            "Hygiene",
            "India",
            "Sanitation",
            "Typhoid Fever",
            "Typhoid-Paratyphoid Vaccines",
            "Water Supply",
            "Female",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40234082/"
    },
    {
        "pmid": "40208005",
        "title": "Recent emergence of cephalosporin-resistant <i>Salmonella</i> Typhi in India due to the endemic clone acquiring IncFIB(K) plasmid encoding <i>bla</i><sub>CTX-M-15</sub> gene.",
        "abstract": "emergence spread iSalmonellai Typhi iSi Typhi resistant thirdgeneration cephalosporin serious global health concern study genomically characterized 142 cephalosporinresistant iSi Typhi strain isolated India Comparative genome analysis revealed emergence new clone ceftriaxoneresistant iSi Typhi harboring three plasmid incompatibility group IncFIBK IncX1 IncFIBpHCM2 Among these IncFIBK plasmid confers resistance thirdgeneration cephalosporin iblaisubCTXM15sub gene along resistance determinant iaph3i iaph6i isul2i idfrA14i iqnrSi itetAi Phylogenetic analysis showed isolates Gujarat ini  140142 belong distinct subclade genotype 43122 within genotype 4312 H58 lineage II Single nucleotide polymorphismbased phylogenetic analysis core gene IncFIBK suggested close relatedness plasmid backbone IncFIBK Enterobacteriales indicating H58 lineage II possesses capability acquire MDR plasmid organisms could indicate potential onset new wave ceftriaxoneresistant iSi Typhi India implementation control measuressuch vaccination improved water sanitation hygiene systemsis crucial area MDR extensively drugresistant iSi Typhi strain prevalent curb spread impact resistant strains Typhoid fever remains global health concern especially area lacking sanitation clean water rise drugresistant strain complicates treatment increasing illness death healthcare expenses Travel facilitates spread strain worldwide Multidrugresistant extensively drugresistant XDR strains including resistant firstline antibiotic fluoroquinolones pose significant challenges Azithromycin thirdgeneration cephalosporin preferred treatments Recently XDR typhoid emerged Pakistan resistant even thirdgeneration cephalosporins India also face challenges sporadic case initially declining reemerging New strain India show resistance thirdgeneration cephalosporin due plasmid acquisition bacteria particularly iblaisubCTXMsubcarrying IncFIBK Due ongoing nature outbreak data study deserve consideration order control spread India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40208005/"
    },
    {
        "pmid": "40200624",
        "title": "An Elusive Diagnosis Hiding in Plain Sight.",
        "abstract": "case report highlight diagnostic therapeutic challenge faced management middleaged female patient presenting persistent left gluteal pain history remote pulmonary tuberculosis Despite multiple hospital admission diagnostic procedures cause debilitating symptom remained elusive diagnosis clinched repeat investigation including bone biopsy bone marrow aspirate revealed growth Salmonella Typhi S Typhi patients symptom markedly improved following treatment appropriate antibiotics underscoring importance considering atypical clinical presentation common organisms",
        "mesh_terms": [
            "Humans",
            "Female",
            "Middle Aged",
            "Typhoid Fever",
            "Salmonella typhi",
            "Anti-Bacterial Agents",
            "Tuberculosis, Pulmonary"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40200624/"
    },
    {
        "pmid": "40184637",
        "title": "Microarray patch vaccines for typhoid conjugate vaccines: A global cost-effectiveness analysis.",
        "abstract": "novel typhoid conjugate vaccine TCV presentation microarray patch MAP earlystage development could potentially help increase coverage hardtoreach population beyond achieved current TCV vial presentation administered needle syringe TCVNS However TCVMAPs may come higher price per dose TCVNS analysis evaluated potential costeffectiveness TCVMAPs alongside TCVNS compared TCVNS alone global extended costeffectiveness analysis taking health care perspective conducted 133 low uppermiddleincome country time horizon 20 year 20332052 Health outcome expressed disabilityadjusted life year DALYs cost 2021 US dollars discounted 3  assumed TCVMAP would cost 133 3 time price TCVNS vaccine calculated incremental costeffectiveness ratio evaluated various costeffectiveness thresholds five selected countries conducted additional subnational analysis understand potential value districtspecific TCVMAP implementation instead national rollout Across 133 low uppermiddleincome countries national rollout TCVMAPs could avert additional 52 million cases 47000 deaths 24 million DALYs compared TCVNS only additional cost US35 billion 20 years largest proportion averted burden would subSaharan African region TCVMAPs could costeffective 33  country 78  subSaharan African countries subnational implementation could benefit country national implementation may costeffective averting 215  case less 13  additional cost compared national rollout MAP price key driver results Regional subnational implementation coupled lower price point could significantly improve TCVMAP value proposition",
        "mesh_terms": [
            "Cost-Benefit Analysis",
            "Typhoid-Paratyphoid Vaccines",
            "Humans",
            "Typhoid Fever",
            "Vaccines, Conjugate",
            "Disability-Adjusted Life Years",
            "Global Health",
            "Developing Countries",
            "Cost-Effectiveness Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40184637/"
    },
    {
        "pmid": "40182771",
        "title": "Global burden, subtype, risk factors and etiological analysis of enteric infections from 1990-2021: population based study.",
        "abstract": "Enteric infection represent prevalent global health issue contribute significantly global disease burden study aim investigate pattern trend enteric infection 1990 2021 providing valuable insight health policy formulation medical resource allocation optimization patient management plans analyzed Global Burden Disease GBD 2021 21 region 204 country understand better health burden using prevalence incidence mortality disabilityadjusted life year DALYs subtype risk factors etiology tested correlation Sociodemographic Index SDI using decomposition analysis dissect reason behind change epidemiological indicator disease 2021 agestandardized rate prevalence incidence deaths DALYs per 100000 population enteric infection 87958 57721 1783 102015 respectively Compared 1990 rate exhibited 018 012 073 072 changes Gender age analysis revealed higher burden among females 15 year old elderly Regions low SDI higher epidemiological indicators burden Typhoid fever decline highdevelopment regions Unsafe water source identified primary risk factor globally 1990 2021 Rotavirus leading cause death DALYs study highlight complex epidemiological landscape enteric infections revealing variation burden risk factors etiological characteristic across age gender geographical regions underscore urgent need healthcare professional policymakers develop innovative prevention healthcare strategy based current evolving burden enteric infections alleviate global disease burden",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Adolescent",
            "Child, Preschool",
            "Child",
            "Middle Aged",
            "Adult",
            "Infant",
            "Prevalence",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Global Health",
            "Incidence",
            "Aged",
            "Infant, Newborn",
            "Typhoid Fever",
            "Cost of Illness",
            "Quality-Adjusted Life Years"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40182771/"
    },
    {
        "pmid": "40163994",
        "title": "Environmental surveillance for Salmonella Typhi to detect the typhoid burden in Yogyakarta, Indonesia.",
        "abstract": "low middleincome country LMICs understanding burden typhoid disease challenging clinical surveillance based blood culture data alone often poorly represents community burden Underreported cases unclear case definitions presence chronic carrier state emerging antimicrobial resistance necessitate alternative approach assess disease prevalence target public health interventions vaccine introduction study aimed assess feasibility wastewater environmental surveillance WES measuring prevalence typhoid infection Indonesia October 11 2022 August 31 2023 WES conducted 18 location across 3 district Yogyakarta province Indonesia Samples collected fortnightly wastewater treatment plant WWTPs manholes river public spaces using grab passive sampling methods Salmonella Typhi S Typhi detection conducted using quantitative PCR S Typhi gene ttr tviB staG  positive 406 sample collected 13  51406 tested positive S Typhi monthly positivity rate ranging 2  151 March 2023 47  1634 October 2022 Mean concentration in log10 ttr tviB staG grab sample 067 SD ± 099 023 SD ± 114 011 SD ± 105 highest detection rate observed sample river compared central WWTPs OR 1268 95  CI 2037920 P  0007 correlation observed rainfall S Typhi gene detection P  005 genes WES feasible Indonesia used monitor typhoid disease burden endemic region High positivity rate river septic tank traditional market support broad approach sampling LMICs formal wastewater management system may accurately represent community disease prevalence due low population coverage WES valuable tool inform public health responses including vaccine introduction",
        "mesh_terms": [
            "Indonesia",
            "Salmonella typhi",
            "Typhoid Fever",
            "Humans",
            "Environmental Monitoring",
            "Wastewater",
            "Prevalence",
            "Rivers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40163994/"
    },
    {
        "pmid": "40163403",
        "title": "Undifferentiated tropical fever: a case series of three Rickettsial infections.",
        "abstract": "report three case rickettsial infection diagnosed performing multiplex molecular syndromic panel patient presented undifferentiated tropical fever nonspecific clinical sign symptoms three patient region endemic agent tropical fever dengue fever leptospirosis typhoid fever considered differential diagnosis initial investigative workup case highlight need rapid syndromic diagnostic approach tropical fever enable timely diagnosis institution appropriate antibiotic therapy typical empirical antibiotic undifferentiated febrile illness targeting bacterial cell wall ineffective treating rickettsial infections",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Dengue",
            "Diagnosis, Differential",
            "Leptospirosis",
            "Rickettsia Infections",
            "Typhoid Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40163403/"
    },
    {
        "pmid": "40163397",
        "title": "Fever of unknown origin: An atypical presentation of typhoid in a child with glucose-6-phosphate dehydrogenase (G6PD) deficiency.",
        "abstract": "Typhoid acute febrile illness primarily caused Salmonella enterica serotype typhi S Typhi could challenging diagnose children owing nonspecific clinical sign symptom may resemble febrile illnesses Here present case typhoid atypically presented fever unknown origin FUO twoyearold boy underlying glucose6phosphate dehydrogenase G6PD deficiency child initially diagnosed managed acute tonsillopharyngitis however remained febrile despite medications series investigation performed S Typhi isolated bone marrow culture almost month admission antibiotic started based antibiotic susceptibility testing recovered well case underscore challenge diagnosis establishment clinical management typhoid paediatric patient underlying disease emphasizes importance high index clinical suspicion ascertain timely proper diagnosis",
        "mesh_terms": [
            "Humans",
            "Male",
            "Typhoid Fever",
            "Fever of Unknown Origin",
            "Glucosephosphate Dehydrogenase Deficiency",
            "Salmonella typhi",
            "Child, Preschool",
            "Anti-Bacterial Agents",
            "Bone Marrow",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40163397/"
    },
    {
        "pmid": "40157401",
        "title": "Exploring the mechanism of Sinisan in the treatment of ulcerative colitis with depression based on UPLC-Q-Orbitrap-MS combined with network pharmacology, molecular docking, and experimental validation.",
        "abstract": "SiniSan SNS traditional formula Treatise Typhoid Fever shown modern clinical practice effectively treat ulcerative colitis UC depression although underlying mechanism remain incompletely understood study employed UPLCQOrbitrapMS network pharmacology molecular docking experimental validation investigate SNSs mechanism treating UC comorbid depression UPLCQOrbitrapMS conjunction network pharmacology molecular docking identified active constituent potential target SNS UC model induced 3  dextran sulfate sodium DSS solution used experimental validation Therapeutic efficacy assessed behavioral tests ELISA routine blood tests histopathology immunofluorescence Western blot qRTPCR SNS alleviated weight loss inflammation DSSinduced colitis mouse exhibiting antidepressant effect open field test forced swim test tail suspension test Furthermore SNS improved intestinal mucosal barrier function restored hippocampal bloodbrain barrier integrity inhibited microglial proliferation neuroinflammation Hippocampus Cornu Ammonis 1 dentate gyrus regions Mechanistic analysis revealed SNS mediates effect UC modulating target PI3KAKT signaling pathway SNS ameliorates UC comorbid depression restoring integrity intestinal mucosal barrier bloodbrain barrier alleviating DSSinduced colitis neuroinflammation",
        "mesh_terms": [
            "Animals",
            "Colitis, Ulcerative",
            "Molecular Docking Simulation",
            "Depression",
            "Network Pharmacology",
            "Mice",
            "Male",
            "Dextran Sulfate",
            "Antidepressive Agents",
            "Drugs, Chinese Herbal",
            "Mice, Inbred C57BL",
            "Disease Models, Animal",
            "Behavior, Animal",
            "Chromatography, High Pressure Liquid",
            "Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40157401/"
    },
    {
        "pmid": "40140378",
        "title": "Helminth driven gut inflammation and microbial translocation associate with altered vaccine responses in rural Uganda.",
        "abstract": "Vaccine response sometimes impaired rural lowincome settings Helminthassociated gut barrier dysfunction microbial translocation MT may implicated used sample trial praziquantel treatmenteffects vaccine response Schistosoma mansoni Smendemic Ugandan islands measuring intestinal fatty acidbinding protein 2 IFABP2 lipopolysaccharidebinding protein antiendotoxin core antibody EndoCab soluble CD14 sCD14 plasma faecal lipocalin2 occult blood FOB calprotectin fCAL evaluating association baseline helminth infection praziquantel treatment response BCG yellow fever typhoid HPV tetanusdiphtheria vaccines Sm associated positively fCAL FOB hookworm IFABP2 helminth EndoCab IgM fCAL FOB Sm associated inversely sCD14 Praziquantel treatment reduced marker concentrations significantly fCAL FOB implying Smassociated gut inflammation MT reversible Associations assessed marker vaccinespecific response predominantly inverse Interventions improve gut barrier function may enhance vaccine responsiveness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40140378/"
    },
    {
        "pmid": "40126322",
        "title": "Imported Typhoid Fever in Romania Between 2010 and 2024.",
        "abstract": "Although forgotten disease developed countries typhoid fever remains significant global health problem especially region inadequate sanitation overcrowding Despite medical advances systemic bacterial infection caused iSalmonellai Typhi continues affect million worldwide Accurate diagnosis timely treatment crucial prevent severe complication mortality Even though antibiotic therapy effective emergence drugresistant strain growing challenge present series case encountered tertiary infectious disease hospital Romania 15 years hospitalised patient mainly SubSaharan Africa Indian subcontinent median time onset first symptom hospital admission 15 days symptom encountered along fever headache chills cough diarrhoea tachycardia unusual feature clinical picture disease Aneosinophilia the absence peripheral eosinophilic granulocytes frequently encountered laboratory finding followed increased serum transaminase inflammatory syndrome iSi Typhi generally identified blood culture demonstrating except one case resistance ciprofloxacin and several cases multidrug resistance MDR series cases strain sensitive ceftriaxone",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40126322/"
    },
    {
        "pmid": "40111964",
        "title": "Spatial analysis of unimproved drinking water source in East Africa: Using Demographic and Health Survey (DHS) data from 2012-2023.",
        "abstract": "According WHOUNICEF Joint Monitoring Programme unimproved drinking water source include unprotected well springs surface water eg rivers lakes vendorprovided water bottled water without improved alternatives tanker truckprovided water East Africa 687 water high risk come sources Using unimproved drinking water source lead serious health risks including waterborne disease cholera dysentery typhoid fever hepatitis Therefore study aimed map spatial distribution unimproved drinking water source region analyzed recent Demographic Health Survey DHS data 12 East African country Burundi Comoros Ethiopia Kenya Madagascar Mozambique Malawi Rwanda Tanzania Uganda Zambia Zimbabwe total 206748 household sampled 12 East African countries Data management analysis carried several stages beginning data cleaning followed statistical weighting data merging followed geospatial analysis mapping finally spatial cluster detection Spatial cluster unimproved drinking water source identified within study area Global Morans I 0018 zscore 8710 p  005 total 167 significant spatial window containing primary secondary cluster identified first spatial window contained primary clusters remaining 166 spatial window contained secondary clusters Primary cluster found Madagascar coastal Mozambique secondary cluster distributed across 12 country analyzed study identified significant clusters hotspots outlier highhigh clusters unimproved drinking water source across various East African countries address issue effectively priority given identified clusters hotspots highhigh clusters Primary recommendation include expanding water treatment facilities improving water distribution systems protecting drinking water sources Secondary recommendation emphasize strengthening regulations conducting research fostering publicprivate partnership ensure sustainable access clean water Finally urge collaboration among governments international organizations NGOs enhance water infrastructure effort focus providing technical assistance financial support capacity building project implementation advocacy financing drinking water infrastructure region research integrating health outcome data spatial analysis could help identify highrisk region impact unimproved water source pronounced",
        "mesh_terms": [
            "Drinking Water",
            "Africa, Eastern",
            "Humans",
            "Water Supply",
            "Spatial Analysis",
            "Health Surveys",
            "Demography",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40111964/"
    },
    {
        "pmid": "40100610",
        "title": "Approach to Short Duration Fever in Children in Office Practice.",
        "abstract": "Fever second common symptom respiratory complaint pediatric practice often causing parental anxiety despite usually resulting selflimiting viral infections Without localized symptoms diagnosing hidden bacterial infection challenging Tropical region like India present additional diagnostic challenge due endemic disease like malaria dengue typhoid review provides algorithmic approach evaluate manage shortduration fever children tailored Indian epidemiological context approach requires careful clinical assessment consideration bacterial tropical etiologies case selflimited viral infections early identification serious bacterial infection SBI crucial reducing morbidity mortality structured approach outlined based clinical symptoms signs age vaccination status Children divided three groups neonate 028 d young infant 2990 d older infantstoddlers 336 mo Neonates sicktoxicappearing child fever warrant immediate hospital admission empirical antibiotic diagnostic workup Management young infant stratified according risk factor SBI bacteremia urinary tract infection UTI pneumonia Wellappearing older infantstoddlers often managed outpatients investigation tailored specific clinical epidemiological contexts",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Fever",
            "Child, Preschool",
            "Infant, Newborn",
            "Child",
            "India",
            "Bacterial Infections",
            "Algorithms",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40100610/"
    },
    {
        "pmid": "40092020",
        "title": "Prolonged Fever in a Multidrug-Resistant Typhoid Fever Patient Despite Appropriate Antimicrobial Therapy: A Case Report.",
        "abstract": "Typhoid fever caused iSalmonella entericai serovar Typhi iS Typhii remains significant global health concern emergence multidrugresistant MDR iS Typhii strains including extendedspectrum betalactamase ESBL producers complicated treatment limiting effectiveness firstline secondline antibiotics present case 10yearold boy developed prolonged febrile illness traveling typhoidendemic region Initial treatment ceftriaxone proved ineffective due presence ESBLproducing iS Typhii necessitating change meropenem combined azithromycin Despite persistent fever patient showed clinical improvement day five became afebrile day 11 improvement inflammatory marker resolution bacteremia confirmed sterile blood culture day 12 case underscore challenge managing MDR typhoid fever highlight critical need maintain appropriate antibiotic regimens even context prolonged febrile responses Furthermore draw attention global spread MDR extensively drugresistant XDR iS Typhii often facilitated international travel emphasizing need vigilant resistance monitoring empiric treatment adjustments Effective antibiotic stewardship adherence evidencebased guidelines heightened clinical awareness essential address complex public health clinical challenge posed MDR XDR iS Typhii",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40092020/"
    },
    {
        "pmid": "40084731",
        "title": "Acute promyelocytic leukemia presenting as isolated femoral granulocytic sarcoma.",
        "abstract": "Granulocytic sarcoma GS myeloid sarcoma chloroma tumoral mass containing myeloblast immature granulocyte anatomic site bone marrow GS rare child acute promyelocytic leukemia APL case report present rare case GS manifesting solitary bone mass 15yearold female presented left knee pain Complete blood count biochemistry normal blast early granulocytic element observed peripheral blood smear Magnetic resonance imaging MRI revealed 4x4cm solid lesion extending physis line distal metaphyseal section left femur Trucut biopsy mass confirmed GS immature promyelocytic cell infiltration containing Auer rod immature myeloid cells t1517 mutation highly positive tissue suspension Bone marrow aspiration performed afterward showed abnormalities acute myeloid leukemia acute lymphoblastic leukemia mutation panel negative patient diagnosed APL presenting GS isolated femoral origin Treatment standardrisk chemotherapy including alltrans retinoic acid ATRA according BFM 2013 protocol initiated 2 months repeat biopsy showed pathologic promyelocytic infiltration negative t1517 mutation However patient died severe neutropenia sepsis typhoid fever case contributes literature rare presentation APL isolated femoral GS first reported case isolated femoral mass context best knowledge",
        "mesh_terms": [
            "Humans",
            "Female",
            "Leukemia, Promyelocytic, Acute",
            "Sarcoma, Myeloid",
            "Adolescent",
            "Femoral Neoplasms",
            "Diagnosis, Differential",
            "Magnetic Resonance Imaging",
            "Femur"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40084731/"
    },
    {
        "pmid": "40083303",
        "title": "Mathematical modelling of the dynamics of typhoid fever and two modes of treatment in a Health District in Cameroon.",
        "abstract": "paper propose novel mathematical model indirectly transmitted typhoid fever disease incorporates use modern traditional medicine mode treatment Theoretically provide two Lyapunov function prove global asymptotic stability diseasefree equilibrium DFE endemic equilibrium EE basic reproduction number  mathcalR0  less one greater one respectively model calibrated using number cumulative case reported PenkaMichel health district Cameroon parameter estimate thus obtained give value  mathcalR0   12058  1 indicates disease endemic region forecast outbreak November 2026 suggests number case 21270 call urgent attention endemic disease sensitivity analysis respect basic reproduction number conducted main parameter impact widespread disease determined analysis highlight environmental transmission rate  beta  decay rate  mub  bacteria environment influential parameter  mathcalR0  underscore urgent need potable water adequate sanitation within area reduce spread disease Numerically illustrate usefulness recourse mode treatment lessen number infected case necessity switching modern treatment traditional treatment useful adjuvant therapy Conversely show relapse phenomenon increase burden disease Hence adopting synergistic therapy approach significantly mitigate typhoid disease case overcome cycle poverty within afflicted communities",
        "mesh_terms": [
            "Typhoid Fever",
            "Cameroon",
            "Humans",
            "Basic Reproduction Number",
            "Disease Outbreaks",
            "Endemic Diseases",
            "Computer Simulation",
            "Models, Theoretical",
            "Mathematical Concepts",
            "Salmonella typhi"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40083303/"
    },
    {
        "pmid": "40081980",
        "title": "10-year diagnosis-specific antibiotic prescribing trends among paediatric inpatients at two private-sector hospitals in central India: a prospective observational study.",
        "abstract": "analyse compare present 10year diagnosisspecific antibiotic prescribing trend paediatric inpatient nonteaching hospital NTH teaching hospital TH India prospective observational study antibiotic prescription paediatric department two privatesector hospital central India Inpatients grouped clinically confirmed infections suspected infection infections Patients NTH TH duration antibiotic prescription ratio prescribed daily dose defined daily dose ie PDD per 100 bed days diagnosisspecific pattern trends adherence Access Watch Reserve AWaRe classification prescribing guideline significant p value005 19 027 17 458 inpatient aged less 18 year stayed least one night NTH 11 415 TH 6043 patient prescribed antibiotic NTH TH NTH 80 TH 23 p0001 shorter antibiotic treatment NTH 3 days TH 5 days p0001 NTH 43 prescribed antibiotic Not recommended TH 56 Watch group AWaRe Ceftriaxone betalactamase inhibitor Not recommended 39 prescribed NTH ceftriaxone Watch 31 THThe reduction prescription rate prescribed antibiotic class PDD100 bed day observed 10 years infectious acute gastroenteritis typhoid fever lung infections especially NTH hernia patients antibiotic prescribing trend thirdgeneration cephalosporin increased significantly β013 p002 decreased secondgeneration cephalosporin β0002 p001 trend decreased hospital common confirmed infection 10 years decadal study observes practice overuse antibiotic hospital yet NTH High prescribing rate Not recommended Watch warrant understanding underlying reason targeted interventions Nonetheless significant overtime decrease prescribing antibiotic infectious diagnosis indicates potential success antibiotic stewardship future",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Prospective Studies",
            "India",
            "Child",
            "Male",
            "Child, Preschool",
            "Female",
            "Practice Patterns, Physicians'",
            "Hospitals, Private",
            "Adolescent",
            "Infant",
            "Hospitals, Teaching",
            "Inpatients",
            "Drug Prescriptions"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40081980/"
    },
    {
        "pmid": "40058502",
        "title": "Genomic epidemiology and antimicrobial resistance reveal local transmission dynamics of enteric fever in Shenzhen, one of the mega cities in China.",
        "abstract": "Outbreak enteric fever spread antimicrobialresistant Salmonella Typhi S Paratyphi pose significant public health challenge low middleincome countries Understanding transmission dynamic pathogen essential developing effective control strategies conducted phylogenomic analysis integrated epidemiological data 135 S Typhi 271 S Paratyphi isolates collected Shenzhen 2001 2017 Phylogenetic temporal analysis performed identify prevalent genotype assess transmission patterns Analyses S Typhi isolates Shenzhen revealed high genetic diversity genotype 321 378 217 20 prevalent Genotype 321 formed independent lineage due mutation quinolone resistancedetermining region QRDR multidrugresistant haplotype 58 genotype 431 present since 2006 S Paratyphi isolates predominantly genotype 233 985 Pathogen exchange occurred least four provinces cutoff ≤3 single nucleotide polymorphism SNPs effective outbreak investigation 22 genomic cluster found suggesting undetected outbreak transmission events 80 isolates susceptible firstline antibiotics 169 S Paratyphi isolates multidrugresistant study provides insight transmission dynamic enteric fever Shenzhen underscoring need ongoing genomic surveillance manage control outbreak effectively",
        "mesh_terms": [
            "Humans",
            "China",
            "Typhoid Fever",
            "Salmonella typhi",
            "Genotype",
            "Salmonella paratyphi A",
            "Phylogeny",
            "Anti-Bacterial Agents",
            "Polymorphism, Single Nucleotide",
            "Male",
            "Cities",
            "Female",
            "Drug Resistance, Bacterial",
            "Drug Resistance, Multiple, Bacterial",
            "Molecular Epidemiology",
            "Adult",
            "Child, Preschool",
            "Child",
            "Disease Outbreaks",
            "Adolescent",
            "Paratyphoid Fever",
            "Microbial Sensitivity Tests",
            "Middle Aged",
            "Young Adult",
            "Genetic Variation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40058502/"
    },
    {
        "pmid": "40047496",
        "title": "Typhoid conjugate vaccines: is a single dose enough for durable protection?",
        "abstract": "Typhoid fever widespread developing countries typhoid vaccine gone disrepute substantial side effect low efficacy latest typhoid vaccine use iSalmonellasi Vicapsular polysaccharide ViCPS conjugated protein carrier recommends single typhoid conjugate vaccine TCV dose six month endemic countries However schedule contested molecular structure ViCPS emerging Vi capsule variants impact deO acetylation vaccine immunogenicity key feature effective ViPS conjugate vaccine immunological correlate protection impact boosting TCV Viantibodies knowledge gap examined also reviewed TCV efficacy durability data analysis show vaccine effective although immunity wane five years especially child two also offered way improve TCV efficacy briefly discussed new typhoid vaccine development believe TCV schedule necessitates revision Extending primary immunization age incorporating booster upon school enrollment reasonable alternatives Regionspecific universal modification require deliberation",
        "mesh_terms": [
            "Typhoid-Paratyphoid Vaccines",
            "Humans",
            "Typhoid Fever",
            "Vaccines, Conjugate",
            "Polysaccharides, Bacterial",
            "Immunization Schedule",
            "Vaccine Efficacy",
            "Vaccine Development",
            "Immunogenicity, Vaccine",
            "Child",
            "Salmonella typhi",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40047496/"
    },
    {
        "pmid": "40020336",
        "title": "Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine.",
        "abstract": "Invasive nontyphoidal Salmonella iNTS infections primarily caused Salmonella enterica serovars Typhimurium S Typhimurium Enteritidis S Enteritidis represent significant public health concern particularly subSaharan Africa multidrugresistant MDR strain increasingly prevalent Despite substantial disease burden vaccine currently licensed iNTS study aimed develop iNTS conjugate vaccine conjugating Ospecific polysaccharide OSP antigen carrier protein using chemical conjugation proven method known efficiency scalability licensed glycoconjugate vaccines Various carrier protein chemical conjugation process evaluated optimize iNTS OSP conjugate vaccine candidates optimization diphtheria toxoid DT identified carrier protein significantly enhances antiOSP immunogenicity iNTS conjugates Key properties molecular weight OSPDT ratio iNTS OSP conjugate found controllable adjusting ratio CDAP conjugate reagent DT iNTS OSP Optimal conjugation process parameter identified evaluating relationship property immunogenicity test mice optimized iNTS conjugate S Typhimurium S Enteritidis developed bivalent formulation formulation selected based dosedependent immunogenicity study included alum adjuvant enhance immune response Ultimately trivalent drug product formulation developed combining bivalent iNTS conjugate vaccine typhoid conjugate vaccine finding demonstrated iNTS OSPDT conjugates optimal conjugation ratios induced robust immune response high antiOSP IgG titer iNTS serovars comparable exceeding formulations inclusion alum enhanced immunogenicity across formulations Notably trivalent vaccine formulation showed promising results maintaining robust immunogenic response iNTS OSP antigen Vi polysaccharide antigen Salmonella Typhi without compromising immunogenicity individual antigens study suggests bivalent iNTS vaccine combined typhoid conjugate vaccine could provide broad protection iNTS infection typhoid fever addressing critical unmet need region limited resources",
        "mesh_terms": [
            "Vaccines, Conjugate",
            "Animals",
            "Typhoid-Paratyphoid Vaccines",
            "Mice",
            "Antibodies, Bacterial",
            "Salmonella Vaccines",
            "Salmonella typhimurium",
            "Female",
            "O Antigens",
            "Mice, Inbred BALB C",
            "Typhoid Fever",
            "Salmonella Infections",
            "Vaccine Development",
            "Diphtheria Toxoid",
            "Immunogenicity, Vaccine",
            "Polysaccharides, Bacterial",
            "Salmonella enteritidis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40020336/"
    },
    {
        "pmid": "40018621",
        "title": "Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey.",
        "abstract": "India high typhoid fever burden 2022 National Technical Advisory Group Immunisation recommended introducing typhoid conjugate vaccine TCV Universal Immunisation Programme study aim identify research priority support ongoing TCV decisionmaking India identified 45 evidence factor TCV decisionmaking India adapting WHOs EvidencetoRecommendation framework assigned evidence gap score evidence factor 0 low 4 high based availability sufficiency quality breadth applicability evidence identified literature review end date 30 November 2023 assigned evidence factor importance score based result online survey conducted among national immunisation stakeholder n22 1 July 202331 October 2023 ranked importance seven WHOs EvidencetoRecommendation criterion several evidence factor within them rescaled mean stakeholder ranking importance score 0 low 4 high Finally added evidence gap score importance score used overall score identify research priority support ongoing TCV decisionmaking India estimated highest evidence priority score public perception typhoid fever vaccination budget impact vaccine availability socioeconomic impact fiscal space antimicrobial resistance tracking typhoid fever mortality public perception TCV immunisation managers acceptance vaccine schedule preference among caregivers adapting WHOs EvidencetoRecommendation framework Indian context systematically identified several research priority support ongoing decisionmaking TCV India priority evolve new research study question emerge optimal scheduling rollout implementation TCV India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40018621/"
    },
    {
        "pmid": "40009631",
        "title": "Evaluation of Moore and grab sampling method for Salmonella Typhi detection in environmental samples in Ghana.",
        "abstract": "Typhoid fever cause substantial mortality morbidity low middleincome country LMICs result inadequate water hygiene sanitation facilities gold standard typhoid diagnosis blood culture however method expensive mostly unavailable LMICs Environmental surveillance ES could offer low cost alternative identify circulation Salmonella enterica serovar Typhi STyphi help inform public health intervention including vaccination implemented standardized protocol ES 40 validated site periurban community Ghana July 2022 August 2023 Grab sample GS Moore swab MS collected monthly initial 6 month subsequently monthly MS maintained rest study period Wastewater sample tested S Typhi target gene ttr staG tviB biomarker human faecal contamination Bacteroides HF183 using multiplex quantitative PCR qPCR Clinical surveillance typhoid fever performed blood culture febrile case presenting local hospital lived study area first 6 month wastewater ES observed higher prevalence S Typhi MS compared GS 100240 42 95 Confidence Interval CI 3450 vs 24240 10 95 CI 616 pvalue  0001 Overall detection S Typhi throughout study period based MS 421 202480 95 CI 3550 prevalence S Typhi blood culture surveillance 021 125576 95 CI 012038 Precipitation 11 95 CI 102110 number wet day 20 95CI 140288 positively associated increased odds S Typhi detection MS GS Generally proportion STyphi detection wastewater sample less blood culturebased detections Limited detection confirmed typhoid fever case local hospital may reflect healthcare seeking behaviours access well early treatment overthecounter antibiotics work required confirm qPCR detection amplicon sequencing methods Strategies also need developed integration ES public health decision making prevention typhoid fever",
        "mesh_terms": [
            "Salmonella typhi",
            "Ghana",
            "Humans",
            "Typhoid Fever",
            "Environmental Monitoring",
            "Wastewater",
            "Feces"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40009631/"
    },
    {
        "pmid": "39991360",
        "title": "Carbapenems: The Final Line of Defense in Typhoid Fever Treatment at Hayatabad Medical Complex, Peshawar.",
        "abstract": "Typhoid fever caused iSalmonella entericai serovar Typhi remains significant public health issue particularly lowincome country inadequate sanitation rise extensively drugresistant XDR strain iSalmonellai Typhi led growing reliance carbapenems final line defense study aim evaluate effectiveness carbapenems treating multidrugresistant MDR XDR typhoid Hayatabad Medical Complex Peshawar study aim assess efficacy carbapenems treating MDR XDR typhoid fever identify alternative therapeutic strategies retrospective cohort study conducted Hayatabad Medical Complex January June 2024 total 501 patient confirmed typhoid fever included Data demographics drug sensitivity resistance pattern extracted hospitals Health Management Information System HMIS analyzed using IBM SPSS Statistics Windows Version 25 Released 2017 IBM Corp Armonk New York Statistical significance set p  005 Among 501 patients 299 597 male mean age 2384 ± 024 years MDR observed 106 36 patients XDR carbapenem resistance present three 06 cases Imipenem demonstrated high sensitivity 466 93 meropenem 380 758 sensitivity resistance Noncarbapenem antibiotics polymyxin 468 934 sensitivity colistin 446 89 sensitivity exhibited higher efficacy carbapenems Alarmingly cephalosporin cefepime exhibited 454 91 resistance Resistance carbapenems rare affecting three 06 patients Carbapenems remain highly effective MDR XDR typhoid noncarbapenem option polymyxin colistin offer viable alternative reducing carbapenem dependence Enhanced antimicrobial stewardship critical preserving lastresort treatments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39991360/"
    },
    {
        "pmid": "39949373",
        "title": "Seroprevalence of Typhoid Fever and Its Associated Risk Factors Among Clinically Diagnosed Febrile Patients Visiting the Outpatient Department at Debark Hospital and Drug Susceptibility Patterns of Isolates.",
        "abstract": "Typhoid fever caused bacterium iSalmonellai Typhi pose major health problem developing countries including Ethiopia However limited information regarding typhoid fever contributing factor it drug susceptibility pattern research area aim study determine seroprevalence typhoid fever associated risk factor among clinically diagnosed febrile patient Debark Hospital evaluate drug susceptibility pattern isolates hospitalbased crosssectional study conducted among 158 febrile patient December 2022 April 2023 Blood stool sample collected febrile patient Widal test used test iSalmonellai Typhi H antigen serum blood bacteria cultured stool Gram staining biochemical analysis carried isolate Antibiotic susceptibility testing performed isolates using KirbyBauer disk diffusion techniques Descriptive statistic logistic regression used analysis study seroprevalence typhoid fever among febrile patient Debark Hospital 228 Gender adjusted odds ratio AOR 95 confidence interval CI 002 031 ipi ≤ 0001 marital status AOR 95 CI 263 466 ipi ≤ 0001 family size AOR 95 CI 001 031 ipi ≤ 0001 residence AOR 95 CI 009 083 ipi  0021 practice using toilet AOR 95 CI 008 0086 ipi  0027 washing fruit vegetable eating AOR 95 CI 012 087 ipi  0025 awareness typhoid fever transmission prevention AOR 95 CI 012 091 ipi  0032 associated risk factor typhoid fever Fifty percent isolates showed multidrug resistance two antibiotics suggested improving personal hygiene providing safe drinking water careful use antibiotic could considerably reduce prevalence typhoid fever study area",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Male",
            "Female",
            "Risk Factors",
            "Adult",
            "Salmonella typhi",
            "Ethiopia",
            "Seroepidemiologic Studies",
            "Middle Aged",
            "Adolescent",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Cross-Sectional Studies",
            "Young Adult",
            "Child",
            "Fever",
            "Outpatients",
            "Hospitals",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39949373/"
    },
    {
        "pmid": "39928006",
        "title": "Typhoid Fever Complicated by Sepsis and ARDS in Pregnancy: A Rare Case.",
        "abstract": "woman thirty second trimester pregnancy presented fever shaking chills shortness breath 56 day duration developed progressive hypoxemia tachypnea leading development acute respiratory distress syndrome ARDS aerobic blood culture showed positivity Salmonella typhi worsening respiratory distress treated oxygenation highflow nasal cannula stabilized intravenous IV antibiotic supportive measure discharged home live fetus utero",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Respiratory Distress Syndrome",
            "Pregnancy Complications, Infectious",
            "Typhoid Fever",
            "Adult",
            "Sepsis",
            "Anti-Bacterial Agents",
            "Salmonella typhi"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39928006/"
    },
    {
        "pmid": "39882094",
        "title": "Melioidosis - An under-recognized dreaded disease in Southeast Asia.",
        "abstract": "Melioidosis disease endemic India often go unrecognized leading considerable illness death present case 31yearold man fever unknown origin abnormal renal liver function tests negative test dengue typhoid leptospirosis scrub typhus Imaging revealed multiple splenic infarcts Initially suspected malaria due prevalence South India investigation uncovered pneumonia along several liver splenic abscesses raising possibility melioidosis Blood culture eventually identified iBurkholderia pseudomalleii confirming diagnosis malaria case decline Southeast Asia emergency physician consider melioidosis differential diagnosis acute febrile illnesses especially endemic areas Early detection prompt antibiotic treatment vital managing often underrecognized disease high fatality rate Thus melioidosis considered patient unexplained fever endemic regions early diagnosis intervention lifesaving",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39882094/"
    },
    {
        "pmid": "39866847",
        "title": "A systematic review of recent outbreaks and the efficacy and safety of drugs approved for the treatment of <i>Salmonella</i> infections.",
        "abstract": "systematic review conducted critically analyze outbreaks efficacy safety drug used treat various iSalmonellai infections Four drugsazithromycin ceftriaxone ciprofloxacin amoxicillinare commonly used treat iSalmonellai infections four drug included review review found that these azithromycin ceftriaxone effective treating iSalmonellai infection based patients length stay hospital rate fever resolved Fluoroquinolones also effective treating iSalmonellai infection approved use children Azithromycin found physicians preferred choice medication iSalmonellai infection due less resistance development Almost drug produce varying degree adverse events mild moderate However azithromycin shown comparatively safer three drug term side effects adverse events relapse associated iSalmonellai treatment Developing effective safe therapy strain iSalmonellai remains priority especially given increasing prevalence antibioticresistant variants",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39866847/"
    },
    {
        "pmid": "39866528",
        "title": "Live Typhoid and Yellow Fever Vaccines Administered to a Patient With Ulcerative Colitis on Vedolizumab.",
        "abstract": "Patients inflammatory bowel disease receive immunosuppressive therapy increased risk infection Live vaccine contraindicated patient increased risk unchecked replication attenuated vaccine microorganisms Vedolizumab gutselective biological agent low risk infection approved treatment inflammatory bowel disease limited data risk providing live vaccine patient receiving vedolizumab patient may receive live vaccine benefit outweigh risks describe patient ulcerative colitis treated vedolizumab received 2 live vaccines typhoid yellow fever without postimmunization adverse events",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39866528/"
    },
    {
        "pmid": "39839218",
        "title": "An exploration of unusual antimicrobial resistance phenotypes in Salmonella Typhi from Blantyre, Malawi reveals the ongoing role of IncHI1 plasmids.",
        "abstract": "Typhoid fever significant public health problem endemic Southeast Asia SubSaharan Africa Antimicrobial treatment typhoid however threatened increasing prevalence antimicrobial resistant AMR iSi Typhi especially globally successful lineage 431 rapidly spread East Southern Africa AMR element found either plasmid one three chromosomal integration sites variability across lineage Several previous study Malawian isolates indicated clonal locally spreading lineage chromosomally integrated resistance genes recent study however noted three isolates predicted resistance gene unusual region present resolved genome isolates using long shortread sequencing work show isolates potentially imported cases closely related recently described sublineage 431EA1 although encode IncHI1 plasmid reduced resistance gene repertoire compared main IncHI1 plasmid spreading East Africa Similar reduced plasmid reported recent largescale study five isolates Tanzania highlighting urgency better coverage African continent genome study better understand dynamic potentially cocirculating plasmids",
        "mesh_terms": [
            "Malawi",
            "Plasmids",
            "Salmonella typhi",
            "Humans",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Phenotype",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39839218/"
    },
    {
        "pmid": "39828002",
        "title": "Bacterial enteritis caused by Salmonella Kedougou after returning from Thailand: A case report.",
        "abstract": "Nontyphoid Salmonella NTS includes many serotypes differ host geographic distribution virulence report case 64yearold man developed enteritis caused Salmonella Kedougou without bacteremia returning Thailand patient stayed Chiang Mai Thailand 10 day play golf hospitalized fever chills watery diarrhea vomiting day patient returned Japan patient treated intravenous azithromycin followed ceftriaxone 6 days NTS detected patients stool culture additional strain analysis performed Polymerase chain reaction Oantigen sequence analysis fliC fliB gene determined serotype strain O13 i lw strain assigned sequence type 1543 using multilocus sequence typing result confirmed strain S Kedougou Considering incubation period salmonellosis patient likely infected S Kedougou Thailand consistent epidemiological information S Kedougou frequently detected northern Thailand identification NTS serovars may affect clinical management however believe important accumulate epidemiological information understand interaction environment animals humans",
        "mesh_terms": [
            "Humans",
            "Male",
            "Thailand",
            "Middle Aged",
            "Salmonella Infections",
            "Enteritis",
            "Salmonella",
            "Anti-Bacterial Agents",
            "Multilocus Sequence Typing",
            "Azithromycin",
            "Ceftriaxone",
            "Travel",
            "Serogroup",
            "Feces"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39828002/"
    },
    {
        "pmid": "39800039",
        "title": "Costs of typhoid vaccination for international travelers from the United States.",
        "abstract": "United States typhoid vaccination recommended international traveler area recognized risk typhoid exposure Using MarketScan® Commercial Database 2016 2022 estimated typhoid vaccination cost route injectable vs oral provider setting clinic vs pharmacy 165930 vaccinated individuals 99471 received injectable 66459 received oral typhoid vaccines 88  17  respectively administered clinics Average cost injectable vaccination 13291 per person 95  confidence interval CI 1326813313 clinic pharmacy cost 13638 95  CI 1361413663 10745 95  CI 1071310777 respectively Oral vaccination cost averaged 8123 per person 95  CI 81148133 encompassing 8661 95  CI 86138710 clinic 8014 95  CI 80098019 pharmacies Outofpocket cost comprised 21  33  total cost injectable oral vaccinations finding may inform clinical decisionmaking protect international travelers health",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Typhoid Fever",
            "United States",
            "Travel",
            "Vaccination",
            "Administration, Oral",
            "Female",
            "Male",
            "Adult",
            "Health Care Costs",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39800039/"
    },
    {
        "pmid": "39719116",
        "title": "Pericardial Abscess Due to Salmonella Typhi Infection.",
        "abstract": "Typhoid fever humanspecific disease caused subspecies Salmonella enterica Salmonella Typhi spread ingestion contaminated food water diagnosed blood culture bone marrow culture typically present intestinal infection patient developing severe disseminated infections Here report rare case purulent pericarditis secondary S Typhi infection 67yearold elderly male suffered recurrent fever diarrhea abdominal pain 7 days Initial blood stool culture positive Salmonella followup blood culture confirmed S Typhi Magnetic resonance imaging showed pericardial abscess hepatic abscess pericardiocentesis pericardial fluid culture grew S Typhi confirming diagnosis pericardial abscess secondary S Typhi infection percutaneous drainage pericardial abscess administration effective antibiotics patients symptom improved significantly subsequently recovered discharged hospital followup recurrences Disseminated infection secondary Salmonella Typhi extremely rare lead serious lifethreatening conditions patient found pericardial abscess caused S Typhi Effective adequate antibiotics along pericardial abscess drainage improve symptoms assist diagnosis enhance quality life",
        "mesh_terms": [
            "Humans",
            "Male",
            "Aged",
            "Salmonella typhi",
            "Typhoid Fever",
            "Abscess",
            "Anti-Bacterial Agents",
            "Pericarditis",
            "Liver Abscess",
            "Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39719116/"
    },
    {
        "pmid": "39717519",
        "title": "A Rare and Life-Threatening Complication of Salmonella Typhi Infection: A Case Report From India Highlighting Diagnostic and Therapeutic Challenges in Salmonella Sepsis.",
        "abstract": "Salmonella infection widely known cause gastroenteritis especially area poor hygiene sanitation Common symptom include sustained fever chills abdominal pain Sepsis disseminated intravascular coagulation DIC various neurological manifestations multiorgan failure uncommon presentations Raising appropriate awareness clinical spectrum therefore crucial even absence typical symptoms following case 34yearold Indian female developed iSalmonella Typhiiinduced sepsis address various challenge involved diagnosing treating condition case successfully managed rapid diagnostics targeted antibiotic therapy supportive care Recognizing condition early providing necessary treatment therefore vital preventing substantial morbidity mortality improve outcome critically ill patients important causative organism identified quickly appropriate treatment commenced Here present case Salmonella sepsis complicated DIC clinical course diagnostic treatment modality followed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39717519/"
    },
    {
        "pmid": "39697915",
        "title": "Triple Co-infection With Salmonella typhi, Leptospira, and Campylobacter coli in a Patient From Guayaquil, Ecuador: Clinical and Diagnostic Challenges.",
        "abstract": "case report describes unusual presentation 32yearold male Guayaquil Ecuador diagnosed rare triple infection caused iSalmonella typhii iLeptospirai iCampylobacter colii patient presented persistent high fever severe gastrointestinal symptoms abdominal pain jaundice following consumption street food resourcelimited area Important clinical finding included hepatosplenomegaly elevated liver enzymes initially complicated differential diagnosis Laboratory test confirmed presence three pathogens presenting significant diagnostic therapeutic challenge due overlapping symptom potential antimicrobial resistance AMR main diagnosis included typhoid fever leptospirosis campylobacteriosis requiring distinct yet coordinated treatment approaches patient managed combination antibiotic targeting pathogen supportive care address dehydration liver dysfunction prolonged hospital stay patient recovered residual symptoms underscoring success tailored multidisciplinary approach context limited healthcare resources case underscore importance clinical awareness regarding coinfections particularly area inadequate sanitation infectious disease endemic successful management complex case highlight necessity rapid accurate diagnostics coordinated therapeutic strategy improve outcome patient multipathogen infections report also emphasizes critical need surveillance tailored intervention region facing rising AMR enhancing understanding approach emerging infectious disease underserved populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39697915/"
    },
    {
        "pmid": "39691069",
        "title": "Live-attenuated vaccines for multiple sclerosis patients living in regions with endemic infections: A complex decision.",
        "abstract": "Liveattenuated vaccine provide robust immunity disease like tuberculosis measles mumps rubella polio yellow fever dengue typhoid fever varicella one doses However concern arise regarding potential pathogen reversion virulence particularly risky immunocompromised individuals contraindicating administration multiple sclerosis MS patient modified disease treatment due possibility triggering infections stimulating immune system precipitating new exacerbations contrary vaccine offer enduring immunity crucial protecting MS patient endemic infectious diseases leading severe complication contracted concern underscore complex balance vaccination benefit risk exacerbating MS patient residing region endemic diseases review explores challenge consideration associated use MS patients aiming maximize benefit minimizing risks",
        "mesh_terms": [
            "Humans",
            "Multiple Sclerosis",
            "Vaccines, Attenuated",
            "Endemic Diseases",
            "Immunocompromised Host",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39691069/"
    },
    {
        "pmid": "39677234",
        "title": "Laparoscopic Management of Spontaneous Gallbladder Perforation in Acalculous Cholecystitis: A Case Series.",
        "abstract": "Gallbladder perforation acalculous cholecystitis rare high mortality rate due biliary peritonitis sepsis Here present case series successful laparoscopic management Spontaneous gallbladder perforation acalculous cholecystitis first case 44yearold male patient presented emergency room history three day fever chill acute pain abdomen two days case typhoidinduced acalculous cholecystitis gallbladder perforation rare clinical entity second case 62yearold male known diabetic presented pain abdomen fever four days case acalculous spontaneous gallbladder perforation third case 53yearold female patient gallbladder perforation acalculous cholecystitis Radiological investigation suggested gallbladder perforation confirmed diagnostic laparoscopy cases Laparoscopic cholecystectomy peritoneal lavage performed patient well postoperatively discharged postoperative day 4 drain removal One clinically vigilant gallbladder perforation case acalculous cholecystitis Minimal access surgery technique like laparoscopy applied confirm diagnosis well definitive management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39677234/"
    },
    {
        "pmid": "39676206",
        "title": "The Vanishing Infarct: A Rare Presentation of MERS Due to Salmonella Infection in Middle-Aged Patient.",
        "abstract": "Enteric fever caused Salmonella typhi Salmonella paratyphi B present clinically variety symptoms report case middleaged gentleman salmonella infection developed reversible corpus callosum splenium infarcts unusual presentation enteric fever condition reversed antibiotic routinely used treat enteric fever country",
        "mesh_terms": [
            "Humans",
            "Male",
            "Middle Aged",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Salmonella typhi",
            "Cerebral Infarction",
            "Salmonella Infections",
            "Corpus Callosum",
            "Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39676206/"
    },
    {
        "pmid": "39632644",
        "title": "Adult vaccination in India: A rapid review of current status & implementation challenges.",
        "abstract": "Background  objective expanded programme immunization launched India 1978 focus preventing six disease child tetanus diphtheria pertussis poliomyelitis typhoid childhood tuberculosis widened scope 198586 new avtaar Universal Immunization Programme UIP incorporated measles vaccine child rubella adult diphtheria vaccine pregnant women conducted rapid review adult immunization relevant India recent COVID19 experience revealed newly emergent reemergent pathogen could onslaught elderly adult comorbidities Methods Three different bibliographic databases namely PubMed Scopus Ovid searched electronically access article published peerreviewed journals Relevant consensus guideline incountry professional group also collated conducted deduplication screening output search 1242 bibliographical records Finally 250 article found eligible inclusion trial reduction morbidities mortality hospitalization adult due proposed vaccine Indian consensus guideline available metaanalysis conducted Results Evidence article finally included synthesis grouped i preventing viral bacterial infection adults ii adult vaccination awareness tools iii vaccine hesitancyacceptance iv adult vaccination guidelines Incountry research revealed need introducing Human Papilloma Virus HPV vaccine adolescence earlyadulthood prevent anogenital cancer elderly later life Importantly HPV prevalence among cervical cancer patient varied 88 98 per cent Andhra Pradesh Odisha Delhi importance conducting regular surveillance pneumococcal disease influenza well tweaking vaccine accordingly revealed articles poor uptake influenza vaccine ≤2 adult ≥45 yr documented uptake hepatitis B vaccine Health Care Workers HCWs Delhi Mumbai concern ranged 55 64 per cent vulnerability HCWs rubella investigated paediatric ophthalmic hospital Madurai tenth selected HCWs rubella seronegative mounted good protective immunity following RA 273 vaccine administration outbreak measles college student Pune emphasized phenomenon waning immunity Similarly study infectious disease hospital Kolkata inpatients Delhi revealed lack protective immunity diphtheria tetanus adults researcher estimated economic benefit providing typhoid vaccine household US 23 middleincome neighbourhood US 14 slum settings author highlighted importance preventive strategies finding cost severe typhoid fever US 1191 18 centre across India qualitative quantitative investigation explored vaccine hesitancy studied COVID19 pandemic earlier Interpretation  conclusion Vaccination programme India would require i increasing awareness around vaccinepreventable disease among adult HCWs ii actively engaging health care system communitybased organizations iii developing producing affordable safe countryappropriate vaccines Effective communication strategy tool key success interventions",
        "mesh_terms": [
            "Humans",
            "India",
            "Adult",
            "Vaccination",
            "Immunization Programs",
            "COVID-19",
            "Female",
            "Pregnancy",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39632644/"
    },
    {
        "pmid": "39632634",
        "title": "Typhoid & paratyphoid vaccine development in the laboratory: a review & in-country experience.",
        "abstract": "Enteric fever caused infection Gramnegative bacteria Salmonella enterica serovar Typhi Salmonella enterica serovar Paratyphi S Paratyphi A B C contaminated food water disease almost exclusively affect population living low middleincome countries World Health Organization Southeast Asian Region WHO SEAR highest endemicity Despite human sole reservoir infection antibiotic vaccine made available disease taken elimination recently due several biological technical reasons including lack accurate regionspecific disease surveillance data realtime diagnostic inaccuracy acute infections difficulty identifying chronic asymptomatic carrier major reservoir infection absence political will However renewed interest effort control disease endemic area help better surveillance tool monitor disease burden wider availability accurate blood culture method diagnosis all costeffective typhoid conjugate vaccine TCVs provide high level durable protection particularly multidrugresistant strain age group commonly affected disease However despite commercial availability TCVs still development stage Several question need answered taken routine immunization country like India Furthermore typhoid vaccine wider coverage including additional efficacy Salmonella Paratyphi B preferably nontyphoidal Salmonella NTS serovars vaccine currently available would desirable developed several subunit vaccine candidate containing glycoconjugates surface polysaccharide typhoidal nontyphoidal Salmonellae intrinsic Salmonella protein function antigen adjuvant also developed novel mouse model oral Salmonella Typhi infection test candidate vaccines demonstrated broad protective efficacy Salmonella spp induction humoral cellmediated immunity well memory response",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Typhoid Fever",
            "Paratyphoid Fever",
            "Salmonella typhi",
            "Vaccine Development",
            "Vaccines, Conjugate",
            "Salmonella paratyphi A",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39632634/"
    },
    {
        "pmid": "39629437",
        "title": "A clinicoepidemiological study of serologically diagnosed acute febrile illness in a teaching hospital, Kolkata.",
        "abstract": "Similar presenting manifestation early phase lack awareness aetiology acute febrile illness AFI major challenge management AFI retrospective observational crosssectional study conducted Department Microbiology NRS Medical College 1 July 2022 30 June 2023 serologically diagnosed febrile patient attending outpatient department admitted Clinical epidemiological data laboratory parameter recorded pretested structured questionnaire study tool collected data analysed MSExcel sheet various chart tables total 1711 serologically diagnosed febrile patient showed preponderance dengue 383 followed leptospirosis 25 scrub typhus 239 malaria 126 enteric fever 192 majority case male less 40 year age rural population 732 except malaria urban  796 mean duration fever 9 days Febrile case recorded maximum monsoon postmonsoon period 665 common manifestation fever headache 462 pain abdomen 78 nausea vomiting 94 Thrombocytopenia bleeding manifestation higher dengue 18 cases Mortality dengue case recorded multiorgan dysfunction syndrome MODS Scrub typhus case showed seizure 83 altered sensorium 5 due fatal meningoencephalitis Fatality leptospirosis mostly due acute kidney injury 295 Weils disease 44 Misdiagnosis incorrect diagnosis delay initiation appropriate treatment result increased morbidity mortality AFI Determination epidemiological feature clinical manifestation AFI along timely correct diagnosis benefit clinician proper treatment initiation thereby reducing morbidity mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39629437/"
    },
    {
        "pmid": "39623850",
        "title": "CLINICAL EFFICACY OF ORAL AZITHROMYCIN VERSUS OTHER ANTIMICROBIAL DRUGS IN THE TREATMENT OF TYPHOID PATIENTS ACROSS ALL AGE GROUPS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS.",
        "abstract": "Typhoid major health concern Drugresistant case typhoid given rise new debates Azithromycin shown adequate results study designed determine clinical efficacy oral azithromycin versus antimicrobial drug typhoid patients study included systematic review randomized controlled trials comparing clinical efficacy azithromycin antimicrobial drug typhoid patients searched 1180 article Google Scholar PubMed Central Cochrane Library PLOS ONE JSTOR 16th October 2023 risk bias analyzed visualizing funnel plot Beggs Eggers test plotting risk bias graphs Forest plot created display findings identified 14 research article 1556 participants Odds ratio treatment outcome extracted forest plot overall effect treatment outcome CI95 azithromycin comparison fluoroquinolones appeared favourable Random Effect Model REM215 heterogeneity I237 τ2 01729 p015 overall pooled effect towards right side Compared chloramphenicol azithromycin showed high odds ratio 123 However difference outcome among ceftriaxone azithromycin group REM067 heterogeneity I20 τ20 p078 overall pooled effect touched noeffect line Azithromycin clinically efficacious fluoroquinolones chloramphenicol drug fewer documented relapse comparison antimicrobial drugs Fever clearance time azithromycin greater ceftriaxone chloramphenicol",
        "mesh_terms": [
            "Humans",
            "Azithromycin",
            "Typhoid Fever",
            "Randomized Controlled Trials as Topic",
            "Anti-Bacterial Agents",
            "Administration, Oral",
            "Treatment Outcome",
            "Ceftriaxone",
            "Chloramphenicol",
            "Fluoroquinolones"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39623850/"
    },
    {
        "pmid": "39613102",
        "title": "Two cases with extensively drug-resistant Salmonella Typhi infection returning from Pakistan.",
        "abstract": "report two case patient extensively drugresistant Salmonella Typhi infection recently traveled Pakistan case suggest obtaining detailed travel history considering epidemiology drugresistant S Typhi suspected area acquisition crucial managing patient typhoid fever",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Pakistan",
            "Anti-Bacterial Agents",
            "Male",
            "Drug Resistance, Multiple, Bacterial",
            "Travel",
            "Adult",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39613102/"
    }
]